<SEC-DOCUMENT>0001193125-24-215264.txt : 20240906
<SEC-HEADER>0001193125-24-215264.hdr.sgml : 20240906
<ACCEPTANCE-DATETIME>20240906172831
ACCESSION NUMBER:		0001193125-24-215264
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		26
CONFORMED PERIOD OF REPORT:	20240906
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Changes in Control of Registrant
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240906
DATE AS OF CHANGE:		20240906

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Innovex International, Inc.
		CENTRAL INDEX KEY:			0001042893
		STANDARD INDUSTRIAL CLASSIFICATION:	OIL & GAS FILED MACHINERY & EQUIPMENT [3533]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				742162088
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13439
		FILM NUMBER:		241285326

	BUSINESS ADDRESS:	
		STREET 1:		19120 KENSWICK DRIVE
		CITY:			HUMBLE
		STATE:			TX
		ZIP:			77338
		BUSINESS PHONE:		3463980000

	MAIL ADDRESS:	
		STREET 1:		19120 KENSWICK DRIVE
		CITY:			HUMBLE
		STATE:			TX
		ZIP:			77338

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DRIL-QUIP INC
		DATE OF NAME CHANGE:	19970723
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d802924d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:invx="http://www.dril-quip.com/20240906" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_CurrentFiscalYearEndDate_duration_2024-09-06_to_2024-09-06" name="dei:CurrentFiscalYearEndDate" contextRef="duration_2024-09-06_to_2024-09-06">--12-31</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2024-09-06_to_2024-09-06" name="dei:EntityCentralIndexKey" contextRef="duration_2024-09-06_to_2024-09-06">0001042893</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2024-09-06_to_2024-09-06" name="dei:AmendmentFlag" contextRef="duration_2024-09-06_to_2024-09-06">false</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="invx-20240906.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-09-06_to_2024-09-06"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001042893</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-09-06</xbrli:startDate> <xbrli:endDate>2024-09-06</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2024-09-06_to_2024-09-06_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001042893</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:FormerAddressMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-09-06</xbrli:startDate> <xbrli:endDate>2024-09-06</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p><p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p><p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p><p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_1">8-K</ix:nonNumeric></span></p><p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p><p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-09-06_to_2024-09-06" format="ixt:date-monthname-day-year-en" id="Fact_0">September&#160;6, 2024</ix:nonNumeric></p><p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_14">INNOVEX INTERNATIONAL, INC.</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p><p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-09-06_to_2024-09-06" format="ixt-sec:stateprovnameen" id="Fact_7">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_8">001-13439</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_9">74-2162088</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr> </table><p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_29">19120 Kenswick Drive</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_25">Humble</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-09-06_to_2024-09-06" format="ixt-sec:stateprovnameen" id="Fact_26">Texas</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_24">77338</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr> </table><p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <span style="white-space:nowrap"><span style="white-space:nowrap"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_28">346</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_27">398-0000</ix:nonNumeric></span></span></p><p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityInformationFormerLegalOrRegisteredName" contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_2">Dril-Quip, Inc.</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-09-06_to_2024-09-06_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember" id="Fact_3">2050 West Sam Houston Parkway S.</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2024-09-06_to_2024-09-06_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember" id="Fact_4">Suite 1100</ix:nonNumeric>,</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-09-06_to_2024-09-06_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember" id="Fact_5">Houston</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-09-06_to_2024-09-06_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember" format="ixt-sec:stateprovnameen" id="Fact_6">Texas</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-09-06_to_2024-09-06_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember" id="Fact_32">77042</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p><p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="font-style:italic">see</span> General Instruction A.2):</p><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-09-06_to_2024-09-06" format="ixt-sec:boolballotbox" id="Fact_11">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-09-06_to_2024-09-06" format="ixt-sec:boolballotbox" id="Fact_16">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-09-06_to_2024-09-06" format="ixt-sec:boolballotbox" id="Fact_18">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-09-06_to_2024-09-06" format="ixt-sec:boolballotbox" id="Fact_20">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr> </table><p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p><p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">symbol(s) <sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_21">Common Stock, par value $0.01 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_22">INVX</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-09-06_to_2024-09-06" format="ixt-sec:exchnameen" id="Fact_23">New York Stock Exchange</ix:nonNumeric></td></tr> </table><p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top">(1)</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Innovex International, Inc.&#8217;s common stock is expected to commence trading under the ticker symbol &#8220;INVX&#8221; on September&#160;9, 2024.</p></td></tr> </table><p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p><p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-09-06_to_2024-09-06" format="ixt-sec:boolballotbox" id="Fact_13">&#9744;</ix:nonNumeric></p><p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p><p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p><p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Introduction.</p><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As previously disclosed, on March&#160;18, 2024, Innovex International, Inc., a Delaware corporation formerly named Dril-Quip, Inc. (the &#8220;<span style="text-decoration:underline">Company</span>&#8221;), entered into an Agreement and Plan of Merger, as amended by the First Amendment to the Agreement and Plan of Merger, dated as of June&#160;12, 2024 (the &#8220;<span style="text-decoration:underline">Merger Agreement</span>&#8221;), with Innovex Downhole Solutions, Inc., a Delaware corporation (&#8220;<span style="text-decoration:underline"><span style="white-space:nowrap">Pre-Merger</span>&#160;</span><span style="text-decoration:underline">Innovex</span>&#8221;), Ironman Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of the Company (&#8220;<span style="text-decoration:underline">Merger Sub Inc.</span>&#8221;), and DQ Merger Sub, LLC, a Delaware limited liability company and a direct wholly owned subsidiary of the Company (&#8220;<span style="text-decoration:underline">Merger Sub LLC</span>&#8221;), which provided for, among other things, (i)&#160;the merger of Merger Sub Inc. with and into <span style="white-space:nowrap">Pre-Merger</span> Innovex, with <span style="white-space:nowrap">Pre-Merger</span> Innovex continuing as the surviving entity (the &#8220;<span style="text-decoration:underline">Surviving Corporation</span>&#8221;) (the &#8220;<span style="text-decoration:underline">First Merger</span>&#8221;) and (ii)&#160;immediately following the First Merger, the merger of the Surviving Corporation with and into Merger Sub LLC (the &#8220;<span style="text-decoration:underline">Second Merger</span>&#8221; and, together with the First Merger, the &#8220;<span style="text-decoration:underline">Mergers</span>&#8221;), with Merger Sub LLC continuing as the surviving entity under the name &#8220;Innovex Downhole Solutions, LLC&#8221; (the &#8220;<span style="text-decoration:underline">Surviving Company</span>&#8221;). On September&#160;6, 2024, following approval by the stockholders of the Company at a special meeting held on September&#160;5, 2024, the Mergers and the other transactions contemplated by the Merger Agreement (collectively, the &#8220;<span style="text-decoration:underline">Transactions</span>&#8221;) were consummated and <span style="white-space:nowrap">Pre-Merger</span> Innovex became a wholly owned subsidiary of the Company. In connection with the completion of the Mergers, the Company changed its name from &#8220;Dril-Quip, Inc.&#8221; to &#8220;Innovex International, Inc.&#8221;</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#8201;1.01</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Credit Agreement </span></p><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In connection with the Mergers, on September&#160;6, 2024, the Company, TIW Corporation, a Texas corporation and a wholly-owned subsidiary of the Company (&#8220;<span style="text-decoration:underline">TIW</span>&#8221;), and the Surviving Company entered into a joinder agreement (the &#8220;<span style="text-decoration:underline">Joinder Agreement</span>&#8221;) with Tercel Oilfield Products USA L.L.C., a Texas limited liability company (&#8220;<span style="text-decoration:underline">Tercel</span>&#8221;), Pride Energy Services, LLC, a Texas limited liability company (&#8220;<span style="text-decoration:underline">Pride</span>&#8221;), <span style="white-space:nowrap">Top-Co</span> Inc., an Alberta corporation (&#8220;<span style="text-decoration:underline"><span style="white-space:nowrap">Top-Co</span></span>&#8221; and, together with Tercel and Pride, each an &#8220;<span style="text-decoration:underline">Existing Borrower</span>&#8221; and collectively, the &#8220;<span style="text-decoration:underline">Existing Borrowers</span>&#8221; and together with the Company, TIW and the Surviving Company, the &#8220;<span style="text-decoration:underline">Borrowers</span>&#8221; and each a &#8220;<span style="text-decoration:underline">Borrower</span>&#8221;) and PNC Bank, National Association (&#8220;<span style="text-decoration:underline">PNC</span>&#8221;), pursuant to which the Company, TIW and the Surviving Company became parties to that certain Second Amended and Restated Revolving Credit, Term Loan, Guaranty and Security Agreement, dated June&#160;10, 2022, as amended by that certain First Amendment to Second Amended and Restated Revolving Credit, Term Loan, Guaranty and Security Agreement, dated November&#160;28, 2022, that certain Second Amendment to Second Amended and Restated Revolving Credit, Term Loan, Guaranty and Security Agreement, dated April&#160;3, 2023, that certain Third Amendment to Second Amended and Restated Revolving Credit, Term Loan, Guaranty and Security Agreement, dated December&#160;15, 2023 and that certain Fourth Amendment to Second Amended and Restated Revolving Credit, Term Loan, Guaranty and Security Agreement, dated June&#160;28, 2024, (as may be amended, amended and restated, joined, extended, supplemented or otherwise modified from time to time, the &#8220;<span style="text-decoration:underline">Credit Agreement</span>&#8221;), by and among the <span style="white-space:nowrap">Pre-Merger</span> Innovex, Existing Borrowers, the financial institutions from time to time party to the Credit Agreement as lenders (collectively, the &#8220;<span style="text-decoration:underline">Lenders</span>&#8221; and each individually, a &#8220;<span style="text-decoration:underline">Lender</span>&#8221;) and PNC, as agent for the Lenders.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Credit Agreement provides for (i)(x) a term loan tranche in a principal amount of the lesser of $25.0&#160;million and a certain amount determined based, in part, on appraised values of certain assets of the Company and certain of its subsidiaries and (y)&#160;an additional term loan in a principal amount of approximately $4.9&#160;million, which was outstanding under the prior credit agreement (collectively, the &#8220;<span style="text-decoration:underline">Term Loan</span>&#8221;) and (ii)&#160;a revolving credit facility of up to $110.0&#160;million with a $5.0&#160;million sublimit for letters of credit and a $11.0&#160;million swing loan (collectively, the &#8220;<span style="text-decoration:underline">Revolver</span>&#8221; and, together with the Term Loan, the &#8220;<span style="text-decoration:underline">Credit Facility</span>&#8221;).</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Credit Facility matures on June&#160;10, 2026. The Term Loan is amortized in an amount equal to $1.25&#160;million each quarter. Amounts borrowed under the Credit Facility are subject to an interest rate per annum equal to, at the Company&#8217;s option, either (a)&#160;an alternate base rate determined as the highest of (i)&#160;the base commercial lending rate of PNC Bank, National Association, (ii)&#160;the overnight federal funds rate (subject to a 0% floor) plus 0.5% and (iii)&#160;Daily Simple SOFR (as defined in the Credit Agreement) plus 1% (such base rate to be subject to a 0% floor) or (b)&#160;the forward-looking term rate based on the secured overnight financing rate (&#8220;<span style="text-decoration:underline">SOFR</span>&#8221;) divided by a number equal to 1.00 minus any SOFR reserve percentage (such term rate to be subject to a 0% floor), plus, in each</p></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> case of clauses (a)&#160;and (b) above, an applicable margin of 0.75% for swing loans and alternate base rate revolving loans, 1.75% for term SOFR revolving loans, 1.00% for alternate base rate term loans and 2.00% for term SOFR term loans. Interest is payable monthly for alternate base rate loans and at the end of the applicable interest period for term SOFR loans (or quarterly if the applicable interest period is longer than three months).</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In addition to paying interest on outstanding borrowings under the Credit Facility, the Company is required to pay a quarterly commitment fee to the Lenders under the Credit Agreement equal to 0.25% per annum on the amount by which $110.0&#160;million exceeds the daily unpaid balance of the Revolver on any day.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Credit Facility is secured by liens on substantially all of the assets of the Borrowers and certain future subsidiaries of the Company and guarantees from certain future subsidiaries of the Company. The Credit Facility requires the Borrowers to make mandatory prepayments on the outstanding amount of (i)&#160;the Term Loan in an amount equal to 25% of excess cash flow for each fiscal year, (ii)&#160;the Credit Facility if Borrowers issue debt other than certain permitted debt and (iii)&#160;the Term Loan and/or the Revolver if the Borrowers issue equity interests the proceeds of which are not used for certain purposes.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Credit Agreement contains restrictive covenants that may limit the Borrowers&#8217; ability to, among other things, incur additional indebtedness, guarantee obligations, incur liens, make investments, loans or capital expenditures, sell or dispose of assets, enter into mergers or consolidations, enter into transactions with affiliates, or make or declare dividends. The Credit Agreement also requires the Borrowers to maintain as of the last day of each fiscal quarter, a total leverage ratio of not more than 2.50 to 1.00 for the four-quarter period then ending as long as the Term Loan is outstanding. In addition, the Credit Facility contains a springing covenant that requires the Borrowers to maintain, as of the last day of each fiscal quarter, a fixed charge coverage ratio of not less than 1.10 to 1.00 for the four quarter period then ending if (i)&#160;an event of default occurs and is continuing or (ii)&#160;the lesser of (x)&#160;the undrawn availability of the Revolver and (y)&#160;a certain amount determined based, in part, on appraised values of certain assets of the Company and certain of its subsidiaries, is less than 20% of $110.0&#160;million plus any increases to the maximum principal amount of the Revolver in accordance with the terms of the Credit Agreement.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If an event of default exists under the Credit Agreement, the Lenders will be able to accelerate the maturity of the Credit Facility and exercise other rights and remedies. An event of default includes, among other things, the nonpayment of principal, interest, fees or other amounts, the failure of any representation or warranty to be correct when made or deemed made in all material respects, the failure to perform or observe covenants in the Credit Agreement or other loan documents, subject, in limited circumstances, to certain grace periods, a cross default to certain other indebtedness if the effect of such default is to cause, or permit the holders of such indebtedness to cause, the acceleration of such indebtedness, the occurrence of bankruptcy or insolvency events, the rendering of material monetary judgments, the invalidity of any guaranty, security agreement or pledge agreement and the occurrence of a Change of Control (as defined in the Credit Agreement).</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On June&#160;28, 2024, <span style="white-space:nowrap">Pre-Merger</span> Innovex and the Existing Borrowers entered into the Fourth Amendment to the Credit Agreement to permit, among other things, the Transactions and a cash dividend to be declared to the holders of <span style="white-space:nowrap">Pre-Merger</span> Innovex&#8217;s Common Stock (as defined below) as of a record date on or prior to the consummation of the Transactions not to exceed $75&#160;million; provided that the amount of borrowing with respect to such dividend is required to be paid within five business days of the Transactions. The foregoing description of the Joinder Agreement is qualified in its entirety by the full text of the Joinder Agreement, which is filed as Exhibit 10.1 hereto and incorporated herein by reference. The foregoing description of the Credit Agreement is qualified in its entirety by the full text of the Credit Agreement filed as Exhibits 10.2, 10.3, 10.4, 10.5 and 10.6 hereto and incorporated herein by reference.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Registration Rights Agreement </span></p><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On September&#160;6, 2024, the Company and certain entities affiliated with Amberjack Capital Partners, L.P. (&#8220;<span style="text-decoration:underline">Amberjack</span>&#8221;) (collectively, the &#8220;<span style="text-decoration:underline">Innovex</span><span style="text-decoration:underline"> Investors</span>&#8221;), entered into a registration rights agreement (the &#8220;<span style="text-decoration:underline">Registration Rights Agreement</span>&#8221;), pursuant to which, among other things, the Company agreed to provide for the registration and resale of certain shares of Company Common Stock (as defined below) that are held by the Innovex Investors from time to time.</p></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to the Registration Rights Agreement, any of the Innovex Investors will have the right to require the Company, at any time after 180 days from the closing date of the Mergers, and subject to certain limitations, to prepare and file a registration statement registering the offer and sale of their shares of Company Common Stock. Subject to certain exceptions, the Company will not be obligated to effect a demand registration if a then effective registration statement is available for use or to effect such a demand registration or an underwritten offering within 90 days after the closing of any requested underwritten offering of shares of Company Common Stock, unless certain requirements are met. In addition, as promptly as reasonably practicable, but in no event later than 10 business days after the date the Registration Rights Agreement is executed, the Company will be required to prepare and file with the Securities and Exchange Commission (the &#8220;<span style="text-decoration:underline">SEC</span>&#8221;) a shelf registration statement on Form <span style="white-space:nowrap">S-3</span> (which shall be automatic shelf registration statement, if available) to permit the public resale of all of the registrable securities thereunder in accordance with the terms of the Registration Rights Agreement.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Registration Rights Agreement also generally obligates the Company to cooperate with the Innovex Investors in effecting the disposition of their shares of Company Common Stock by such methods as the Innovex Investors may request, including through underwritten offerings and block trades.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Registration Rights Agreement includes provisions, subject to certain exceptions, that if at any time the Company proposes to register an offering of Company Common Stock or conduct an underwritten offering, whether or not for its own account, then the Company would be required to notify the Innovex Investors and allow them to include a specified number of their shares of Company Common Stock in that registration statement or underwritten offering, as applicable.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">These registration rights are subject to certain conditions and limitations, and the Company will generally be obligated to pay all registration expenses in connection with these registration obligations, regardless of whether or not any registrable securities are sold pursuant to a registration statement. The Registration Rights Agreement will also require the Company to indemnify each of the Innovex Investors against certain liabilities under the Securities Act of 1933, as amended (the &#8220;<span style="text-decoration:underline">Securities Act</span>&#8221;).</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Registration Rights Agreement is qualified in its entirety by the full text of the Registration Rights Agreement, which is filed as Exhibit 4.1 hereto and incorporated herein by reference.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stockholders Agreement </span></p><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On September&#160;6, 2024, the Company, Amberjack and the Innovex Investors entered into a Stockholders Agreement (the &#8220;<span style="text-decoration:underline">Stockholders Agreement</span>&#8221;). It provides, among other things, that as of the effective time of the Mergers (the &#8220;<span style="text-decoration:underline">Effective Time</span>&#8221;):</p><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Amberjack will have the right, but not the obligation, to designate for nomination by the Company to the board of directors of the Company (the &#8220;<span style="text-decoration:underline">Board</span>&#8221;) a number of designees (the &#8220;<span style="text-decoration:underline">Amberjack Designees</span>&#8221;) equal to: (i)&#160;four directors, so long as the Stockholders (as defined in the Stockholders Agreement) collectively beneficially own 40% or more of the number of shares of Company Common Stock outstanding as of the Effective Time; (ii)&#160;three directors, in the event that the Stockholders collectively beneficially own less than 40% but at least 30% of the number of shares of Company Common Stock outstanding as of the Effective Time; (iii)&#160;two directors in the event that the Stockholders collectively beneficially own less than 30% but at least 20% of the number of shares of Company Common Stock outstanding as of the Effective Time; and (iv)&#160;one director in the event that the Stockholders collectively beneficially own less than 20% but at least 10% of the number of shares of Company Common Stock outstanding as of the Effective Time;</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">for so long as Amberjack has the right to designate at least one Amberjack Designee to the Board, the Company has agreed to take all necessary action, and, if applicable, Amberjack, the Innovex Investors and their permitted transferees (collectively, the &#8220;<span style="text-decoration:underline">Stockholders</span>&#8221;) agree to vote their respective shares, to cause the election of the person who is then serving as the Chief Executive Officer of the Company (the &#8220;<span style="text-decoration:underline">CEO Director</span>&#8221;) and each Amberjack Designee to the Board;</p></td></tr></table></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the Board will be divided into three classes of directors, with each class serving staggered three-year terms in accordance with the certificate of incorporation of the Company and, unless otherwise requested by Amberjack, each Amberjack Designee, if any, will be assigned (or continue to be assigned) to the classes specified in the Merger Agreement;</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">during the period from and after the closing date of the Mergers until the date that Amberjack ceases to have the right to nominate any designees to the Board pursuant to the Stockholders Agreement (the &#8220;<span style="text-decoration:underline">Standstill Period</span>&#8221;) and subject to certain exceptions, Amberjack will have the right to request that a representative of Amberjack attend meetings of the Board (and any committee of which an Amberjack Designee is a member, to the extent consistent with applicable law) from time to time;</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">until the end of the Standstill Period and subject to certain exceptions, the Company will provide Amberjack or its authorized representatives, at reasonable times and upon reasonable prior notice to the Company, with (i)&#160;reasonable access to the books and records of the Company or any of its material subsidiaries and (ii)&#160;the right to discuss the Company&#8217;s or its material subsidiaries&#8217; affairs, finances and condition with its and their officers;</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">to the fullest extent permitted by the Delaware General Corporation Law (the &#8220;<span style="text-decoration:underline">DGCL</span>&#8221;) and subject to applicable legal requirements and any express agreement, the Company has agreed that the Innovex Investors and their respective affiliates and each Amberjack Designee that is also a director, officer, employee or other representative of Amberjack (collectively, the &#8220;<span style="text-decoration:underline">Covered Persons</span>&#8221;) may, and shall have no duty not to, (i)&#160;invest in, carry on and conduct any business of any kind, nature or description, whether or not such business is competitive with or in the same or similar lines of business as the Company or any of its subsidiaries, (ii)&#160;do business with any client, customer, vendor or lessor of any of the Company or its affiliates, and/or (iii)&#160;make investments in any kind of property in which the Company or its subsidiaries may make investments. To the fullest extent permitted by the DGCL or any other applicable law, the Company renounces any interest or expectancy to participate in any business, business opportunity, transaction, investment or other matter of any Covered Person as currently conducted or as may be conducted in the future, and waives any claim against a Covered Person and shall indemnify a Covered Person against any claim that such Covered Person is liable to the Company or its stockholders for breach of any fiduciary duty or otherwise solely by reason of such Covered Person&#8217;s participation in, or failure to offer or communicate to the Company, its subsidiaries or any controlled affiliates any information regarding, any such business opportunity;</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">during the Standstill Period and subject to certain exceptions, the Stockholders and each of their respective affiliates will be subject to certain restrictions relating to (i)&#160;the acquisition of additional shares of Company Common Stock, (ii)&#160;the solicitation of proxies with respect to voting of any Voting Securities (as defined in the Stockholders Agreement) of the Company, (iii)&#160;the deposit of any Voting Securities into a voting trust or subjecting such Voting Securities to any voting agreement, pooling arrangement or similar arrangement, or the grant of any proxy with respect to such Voting Securities, (iv)&#160;actions to change management of the Company or the Board other than pursuant to the provisions of the Stockholders Agreement, (v)&#160;actions regarding any merger, consolidation, business combination, tender or exchange offer, restructuring, recapitalization or other extraordinary transaction of or involving the Company or any of its subsidiaries or their securities or assets, or (vi)&#160;actions that would reasonably be expected to cause or require the Company to make a public announcement regarding any actions prohibited by the Stockholders Agreement;</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">during the Standstill Period, the Stockholders will cause all Voting Securities then owned by the Stockholders to be present, in person or by proxy, at any meeting of the stockholders of the Company occurring at which an election of directors is to be held, so that all such Voting Securities will be counted for the purpose of determining the presence of a quorum at such meeting; and</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">during a period of 180 days from the closing date, the Stockholders will be subject to certain transfer restrictions on the Stockholder Shares (as defined in the Stockholders Agreement) without the prior written consent of the Company.</p></td></tr></table></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Stockholders Agreement is qualified in its entirety by the full text of the Stockholders Agreement, which is filed as Exhibit 4.2 hereto and incorporated herein by reference.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Indemnification Agreements </span></p><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On September&#160;6, 2024, the Company entered into indemnification agreements with each of its directors (the &#8220;<span style="text-decoration:underline">Indemnification Agreements</span>&#8221;). The Indemnification Agreements, among other things, require the Company to indemnify these individuals to the fullest extent permitted by Delaware law, including for certain expenses (including attorneys&#8217; fees) actually and reasonably incurred by such person in any action or proceeding, including any action by or in the Company&#8217;s right, on account of any services undertaken by such person on behalf of the Company or that person&#8217;s status as a member of the Board.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Indemnification Agreements is qualified in its entirety by the full text of the form of Indemnification Agreement, which is filed as Exhibit 10.7 hereto and incorporated herein by reference.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#8201;2.01</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Completion of Acquisition or Disposition of Assets.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The information set forth in the Introduction above regarding the Transactions is incorporated by reference into this Item 2.01.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As discussed in the Introduction, on September&#160;6, 2024, the Mergers were consummated in accordance with the terms of the Merger Agreement. In connection with the consummation of the Mergers, subject to certain exceptions set forth in the Merger Agreement, the shares of common stock, par value $0.01 per share, of <span style="white-space:nowrap">Pre-Merger</span> Innovex (&#8220;<span style="text-decoration:underline"><span style="white-space:nowrap">Pre-Merger</span>&#160;</span><span style="text-decoration:underline">Innovex</span><span style="text-decoration:underline"> Common Stock</span>&#8221;) (including each <span style="white-space:nowrap">Pre-Merger</span> Innovex stock option and restricted stock unit) issued and outstanding immediately prior to the Effective Time (including restricted stock awards) were converted into the right to receive 32,183,966 shares of common stock, par value $0.01 per share, of the Company (&#8220;<span style="text-decoration:underline">Company Common Stock</span>&#8221;), and each share of <span style="white-space:nowrap">Pre-Merger</span> Innovex Common Stock held in treasury by <span style="white-space:nowrap">Pre-Merger</span> Innovex or owned directly or indirectly by the Company, Merger Sub Inc. or Merger Sub LLC was automatically cancelled and ceased to exist.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The issuance of shares of Company Common Stock pursuant to the terms of the Merger Agreement, other than shares of Company Common Stock issued to the Innovex Investors, and other shares of Company Common Stock reserved for issuance in connection with the Transactions, were registered under the Securities Act pursuant to the Company&#8217;s registration statement on Form <span style="white-space:nowrap">S-4,</span> as amended (File <span style="white-space:nowrap">No.&#160;333-279048),</span> which was declared effective by the SEC on August&#160;6, 2024. The proxy statement/prospectus (the &#8220;<span style="text-decoration:underline">Proxy Statement/Prospectus</span>&#8221;) included in the registration statement, as amended and supplemented, contains additional information about the Mergers.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The shares of Company Common Stock listed on the New York Stock Exchange (the &#8220;<span style="text-decoration:underline">NYSE</span>&#8221;), previously trading through the close of business on Friday, September&#160;6, 2024 under the ticker symbol &#8220;DRQ,&#8221; are expected to commence trading on the NYSE under the ticker symbol &#8220;INVX&#8221; effective with the open of business on Monday, September&#160;9, 2024. The Company Common Stock is represented by a new CUSIP number (457651 107).</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Immediately following the completion of the Mergers, the Company&#8217;s securityholders as of immediately prior to the Mergers owned approximately 52% of the outstanding shares of Company Common Stock on a fully diluted basis and <span style="white-space:nowrap">Pre-Merger</span> Innovex&#8217;s securityholders owned approximately 48% of the outstanding shares of the Company on a fully diluted basis.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Transactions and the Merger Agreement is a summary only, does not purport to be complete, and is subject to and qualified in its entirety by the full text of the Merger Agreement which is filed as Exhibit 2.1 hereto and incorporated herein by reference.</p></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#8201;2.03</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Creation of a Direct Financial Obligation or an Obligation under an <span style="white-space:nowrap">Off-Balance</span> Sheet Arrangement of a Registrant.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The information set forth in Item 1.01 regarding the Credit Agreement is incorporated by reference into this Item 2.03.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#8201;3.02</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Unregistered Sales of Equity Securities.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The information set forth in Item 2.01 and the Introduction above regarding the Transactions, to the extent applicable, is incorporated by reference into this Item 3.02. The issuance of 29,369,822 shares of Company Common Stock (the &#8220;<span style="text-decoration:underline">Consenting Stockholder Shares</span>&#8221;) to certain affiliates of Amberjack pursuant to the Merger Agreement was exempt from the registration requirements of the Securities Act pursuant to Section 4(a)(2) thereof. None of the Consenting Stockholder Shares nor the offering thereof have been registered under the Securities Act or any state securities laws, and the Consenting Stockholder Shares may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from the registration requirements.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#8201;3.03</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Material Modification to Rights of Security Holders.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The information set forth under Items 2.01 and 5.03 is incorporated by reference into this Item 3.03.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#8201;5.01</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Changes in Control of Registrant.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The information set forth in Item 2.01 regarding the Mergers and the information set forth in Item 5.02 regarding the Board and executive officers following the Mergers are incorporated by reference into this Item 5.01.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#8201;5.02</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Departure of Directors </span></p><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In connection with the consummation of the Mergers, Jeffrey J. Bird and Darryl K. Willis each delivered a letter effectuating his resignation as a director of the Company and, as of the Effective Time, each ceased to be a director of the Company. The resignations of Mr.&#160;Bird and Mr.&#160;Willis were not a result of any disagreements with the Company on any matter relating to the Company&#8217;s operations, policies or practices.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Appointment of Directors </span></p><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of the Effective Time, in accordance with the terms of the Merger Agreement and as approved by the Board, the Board was increased to nine members, which consists of the following members: (i)&#160;Adam Anderson, Bonnie S. Black, Patrick Connelly, Angie Sedita and Jason Turowsky, each a former member of the <span style="white-space:nowrap">Pre-Merger</span> Innovex board of directors who was appointed to the Board (each, a &#8220;<span style="text-decoration:underline">New Director</span>&#8221;); and (ii)&#160;John V. Lovoi, Terence B. Jupp, Carri A. Lockhart and Benjamin M. Fink, each a continuing director of the Board.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In connection with their appointments, each <span style="white-space:nowrap">non-employee</span> director will receive the standard annual <span style="white-space:nowrap">non-employee</span> director compensation for serving on the Board. For a description of the compensation program for the Company&#8217;s <span style="white-space:nowrap">non-employee</span> directors, see the Company&#8217;s proxy statement for its 2024 annual meeting of stockholders, filed with the SEC on March&#160;19, 2024. The description of the Indemnification Agreements between the Company and the directors set forth in Item 1.01 above is incorporated by reference into this Item 5.02.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of the Effective Time, in accordance with the terms of the Merger Agreement, the Board made the following committee appointments: (i)&#160;Mr.&#160;Lovoi was appointed to serve on the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee of the Board; (ii)&#160;Mr.&#160;Jupp was appointed to serve as Chair on the Compensation Committee of the Board; (iii)&#160;Ms.&#160;Lockhart was appointed to serve on the Audit Committee and as Chair on the Nominating and Corporate Governance Committee of the Board; (iv)&#160;Mr.&#160;Connelly was appointed to serve on the Compensation Committee of the Board; (v)&#160;Ms.&#160;Sedita was appointed to serve on the Nominating and Governance Committee of the Board; (vi)&#160;Ms.&#160;Black was appointed to serve on the Compensation Committee of the Board; and (vii)&#160;Mr.&#160;Fink was appointed to serve as Chair on the Audit Committee of the Board. Mr.&#160;Lovoi continues to serve as Chairman of the Board.</p></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">None of the New Directors are related to any officer or director of the Company. With respect to each of the New Directors, there are no arrangements or understandings between such director and any other persons pursuant to which he or she will serve as a director, other than the Merger Agreement and the Stockholders Agreement.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Officer Transition; Compensatory Plans and Arrangements </span></p><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In connection with the Mergers and pursuant to the terms and conditions of the Merger Agreement, each of the following officers: (i)&#160;Jeffrey J. Bird, the Company&#8217;s President and Chief Executive Officer, (ii)&#160;Kyle F. McClure, the Company&#8217;s Vice President and Chief Financial Officer, (iii)&#160;James C. Webster, the Company&#8217;s Vice President, General Counsel and Secretary, and (iv)&#160;Don Underwood, the Company&#8217;s Vice President of Subsea Products (each, an &#8220;Executive Officer&#8221;) were terminated without cause, effective as of the closing date of the Mergers.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Each Executive Officer will be entitled to receive severance payments and benefits contingent upon the execution and <span style="white-space:nowrap">non-revocation</span> of a separation agreement and general release of claims (the &#8220;Separation Agreements&#8221;). In consideration for a fulsome release of claims in favor of the Company and its affiliates and the applicable Executive Officer&#8217;s compliance with certain post-employment covenants, (i)&#160;Mr.&#160;Bird, Mr.&#160;McClure, and Mr.&#160;Webster will be entitled to receive severance benefits provided for with respect to a termination without cause within the change of control period under their employment agreements with the Company, effective January&#160;1, 2022, attached as Exhibits 10.3, 10.4, and 10.2, respectively, to the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> filed with the SEC on February&#160;27, 2024 and (ii)&#160;Mr.&#160;Underwood will be entitled to receive severance benefits provided for with respect to a termination without cause within the change of control period under his Employment Agreement with the Company, effective October&#160;25, 2022, attached as Exhibit 10.5 to the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> filed with the SEC on February&#160;27, 2024.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Separation Agreements is qualified in its entirety by the full text of the Separation Agreements, which are filed as Exhibits 10.8, 10.9, 10.10 and 10.11 hereto and incorporated herein by reference.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Appointment of Executive Officers </span></p><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On September&#160;6, 2024, the Board appointed Adam Anderson as the Company&#8217;s Chief Executive Officer and principal executive officer, Kendal Reed as the Chief Financial Officer and principal financial officer and principal accounting officer and Mark Reddout as the Company&#8217;s President of North America.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">There are no family relationships among any of the Company&#8217;s newly appointed principal officers. None of the Company&#8217;s newly appointed principal officers has a direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation <span style="white-space:nowrap">S-K.</span></p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Adam Anderson</span></span>. Mr.&#160;Anderson served as Chief Executive Officer of <span style="white-space:nowrap">Pre-Merger</span> Innovex and its subsidiaries since November 2016. After joining <span style="white-space:nowrap">Pre-Merger</span> Innovex, Mr.&#160;Anderson led <span style="white-space:nowrap">Pre-Merger</span> Innovex by focusing on strategic growth and acquisitions, using conventional, innovative and proprietary technologies to support upstream onshore and offshore activities worldwide. From 2002 to 2014, Mr.&#160;Anderson served in several senior management roles for Baker Hughes Company, an oilfield services company, including Vice President of the Western U.S. Division, President of Latin America, Vice President of the U.S. Completions Division, Country Manager for Saudi Arabia, overseeing more than 3,000 employees and more than $1&#160;billion in revenues, and Vice President of Investor Relations. From 2014 to 2016, Mr.&#160;Anderson served as Chief Executive Officer of Team Oil Tools, LP, a designer, manufacturer and installer of completions products for the oil and natural gas sector. Mr.&#160;Anderson holds a Master of Business Administration from Duke University and a Bachelor of Science in Petroleum Engineering from Colorado School of Mines.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Kendal Reed</span></span>. Mr.&#160;Reed joined <span style="white-space:nowrap">Pre-Merger</span> Innovex in 2016 as Vice President of Corporate Development and has been a key member of the <span style="white-space:nowrap">Pre-Merger</span> Innovex team leading mergers and acquisitions, treasury and integration. In early 2019, he took on the role of Chief Financial Officer assuming wide ranging responsibility for</p></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <span style="white-space:nowrap">Pre-Merger</span> Innovex&#8217;s financial operations. Previously, Mr.&#160;Reed served seven years as Vice President for Amberjack, where he was responsible for identifying, assessing, and managing a variety of oilfield service investments. Mr.&#160;Reed earned a Bachelor of Science in Finance and Marketing from the University of Kansas.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Mark </span></span><span style="font-weight:bold"><span style="font-style:italic">Reddout</span></span>. Since joining <span style="white-space:nowrap">Pre-Merger</span> Innovex in 2016, Mr.&#160;Reddout has held the positions of Vice President of Well Completions from October 2016 to May 2019, Chief Operations Officer from May 2019 to March 2021, and President for the North America region since March 2021. He was previously the Vice President of Operations for Team Oil Tools LP; and prior to joining <span style="white-space:nowrap">Pre-Merger</span> Innovex, Mark spent 30 years at Baker Hughes holding multiple key positions including leading the completions business in both South Texas and the Rocky Mountains.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#8201;5.03</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Amendments to Certificate of Incorporation or Bylaws; Change in Fiscal Year.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Amendment to Certificate of Incorporation </span></p><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Effective September&#160;6, 2024, the Board approved and adopted, and the Company filed, an amendment to the Restated Certificate of Incorporation of the Company to change the name of the Company from &#8220;Dril-Quip, Inc.&#8221; to &#8220;Innovex International, Inc.&#8221; The foregoing description is qualified in its entirety by the full text of the amendment, which is attached as Exhibit 3.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Amendment to Bylaws </span></p><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Effective September&#160;6, 2024, the Board approved and adopted an amendment to the Amended and Restated Bylaws (the &#8220;<span style="text-decoration:underline">Bylaws Amendment</span>&#8221;) of the Company to, among other things:</p><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provide that a single individual Amberjack Designee has the right to call meetings of the Board during the period from and after the Effective Time until the date that Amberjack ceases to have the right to nominate any designees to the Board in accordance with the provisions of the Stockholders Agreement and such Amberjack Designee will chair and preside over meetings of the Board called by such designee;</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">remove the procedures for submission of claims for indemnification and determination of the entitlement of any person and provide that the Board of directors may establish reasonable procedures for the submission of claims for indemnification, determination of the entitlement of any person to such indemnification and review of any such determination;</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provide that to the fullest extent permitted by law, the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, a federal court located within the State of Delaware) is the exclusive forum for any claims, including claims in the right of the Company: (a)&#160;that are derivative actions brought on behalf of the Company, (b)&#160;that are based upon a violation of a duty by a current or former director, officer, employee or stockholder in such capacity, (c)&#160;arising pursuant to the DGCL, the organizational documents of the Company or as to which the DGCL confers jurisdiction upon the Court of Chancery or (d)&#160;for any action asserting a claim governed by the internal affairs doctrine of the law of the State of Delaware; and</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provide that the sole and exclusive forum for any complaint asserting a cause of action arising under the Securities Act, to the fullest extent permitted by law, shall be the federal district courts of the United States.</p></td></tr></table><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The foregoing description is qualified in its entirety by the full text of the Bylaws Amendment, which is attached as Exhibit 3.2 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and incorporated herein by reference.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#8201;7.01</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On September&#160;6, 2024, the Company issued a press release announcing the closing of the Transactions. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated into this Item 7.01 by reference.</p></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The information furnished pursuant to Item 7.01, including Exhibit 99.1, shall not be deemed to be &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, shall not otherwise be subject to the liabilities of that section and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated therein by reference. The furnishing of this communication is not intended to constitute a representation that such information is required by Regulation FD or that the material it contains include material information that is not otherwise publicly available.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) Financial Statements of Business Acquired</p><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The audited consolidated balance sheets of Pre-Merger Innovex as of December 31, 2023 and December 31, 2022 and the audited consolidated statements of operations and comprehensive income, changes in stockholders&#8217; equity and cash flows of Pre-Merger Innovex for the three years ended December 31, 2023 were previously filed in the Proxy Statement/Prospectus and, pursuant to General Instruction B.3 of Form 8-K, are not required to be filed as part of this Current Report on Form 8-K.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company intends to file the unaudited financial statements of <span style="white-space:nowrap">Pre-Merger</span> Innovex as of and for the six months ended June&#160;30, 2024 under cover of Form <span style="white-space:nowrap">8-K/A</span> not later than 71 calendar days after the date this Current Report on Form <span style="white-space:nowrap">8-K</span> was required to be filed.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) Pro Forma Financial Information</p><p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The pro forma financial information required by this Item 9.01(b) as of and for the year ended December 31, 2023 was previously filed in the Proxy Statement/Prospectus under the caption &#8220;Unaudited Pro Forma Condensed Combined Financial Statements&#8221; and, pursuant to General Instruction B.3 of Form 8-K, is not required to be filed as part of this Current Report on Form 8-K. The Company intends to file pro forma financial information as of and for the period ended June 30, 2024 under cover of Form 8-K/A no later than 71 calendar days after the date this Current Report on Form 8-K was required to be filed.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits:</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;&#8199;2.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1042893/000119312524070265/d803484dex21.htm">Agreement and Plan of Merger, dated as of March&#160;18, 2024, by and among Dril-Quip, Inc., Ironman Merger Sub, Inc., DQ Merger Sub, LLC and Innovex Downhole Solutions, Inc. (incorporated by reference to Exhibit 2.1 to the Current Report on Form <span style="white-space:nowrap">8-K</span> filed by the Company on March&#160;18, 2024).</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;&#8199;3.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d802924dex31.htm">Certificate of Amendment to the Restated Certificate of Incorporation of Innovex International, Inc., dated September&#160;6, 2024. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;&#8199;3.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d802924dex32.htm">Amendment to the Amended and Restated Bylaws of Innovex International, Inc., dated September&#160;6, 2024. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;&#8199;4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d802924dex41.htm">Registration Rights Agreement, dated as of September&#160;6, 2024, by and among Innovex International, Inc., Intervale Capital Fund II, L.P., Intervale Capital Fund III, L.P., Amberjack Capital Fund II, L.P., Innovex <span style="white-space:nowrap">Co-Invest</span> Fund, L.P., Innovex <span style="white-space:nowrap">Co-Invest</span> Fund II, L.P. and Intervale Capital Fund <span style="white-space:nowrap">II-A,</span> L.P. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;&#8199;4.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d802924dex42.htm">Stockholders Agreement, dated as of September&#160;6, 2024, by and among Innovex International, Inc., Amberjack Capital Partners, L.P., Intervale Capital Fund II, L.P., Intervale Capital Fund III, L.P., Amberjack Capital Fund II, L.P., Innovex <span style="white-space:nowrap">Co-Invest</span> Fund, L.P., Innovex <span style="white-space:nowrap">Co-Invest</span> Fund II, L.P. and Intervale Capital Fund <span style="white-space:nowrap">II-A,</span> L.P. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d802924dex101.htm">Joinder Agreement, dated as of September&#160;6, 2024, by and among Innovex Downhole Solutions, Inc., Tercel Oilfield Products USA L.L.C., <span style="white-space:nowrap">Top-Co</span> Inc., Pride Energy Services, LLC, Dril-Quip, Inc., TIW Corporation, Innovex Downhole Solutions, LLC and PNC Bank, National Association. </a></td></tr></table></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001042893/000119312524127628/d773596dex101.htm">Second Amended and Restated Revolving Credit, Term Loan, Guaranty and Security Agreement, dated as of June&#160;10, 2022, among Innovex Downhole Solutions, Inc., Tercel Oilfield Products USA L.L.C., <span style="white-space:nowrap">Top-Co</span> Inc. and each party joined thereto from time to time as a borrower, as borrowers, each person joined thereto from time to time as a guarantor, as guarantors, the financial institutions from time to time party thereto, as lenders, and PNC Bank, National Association, as the agent for lenders (incorporated by reference to Exhibit 10.1 to the Registration Statement on Form <span style="white-space:nowrap">S-4</span> (File No.<span style="white-space:nowrap">&#160;333-279048)</span> declared effective on August&#160;6, 2024).</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;10.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001042893/000119312524127628/d773596dex102.htm">First Amendment to Second Amended and Restated Revolving Credit, Term Loan, Guaranty and Security Agreement, dated November&#160;28, 2022, among Innovex Downhole Solutions, Inc., Tercel Oilfield Products USA L.L.C., <span style="white-space:nowrap">Top-Co</span> Inc., Pride Energy Services, LLC and each person joined to the Credit Agreement as a borrower from time to time, as borrowers, each person joined to the Credit Agreement as guarantors, the financial institutions party to the Credit Agreement, as lenders, and PNC Bank, National Association, as the agent (incorporated by reference to Exhibit 10.2 to the Registration Statement on Form <span style="white-space:nowrap">S-4</span> (File No.<span style="white-space:nowrap">&#160;333-279048)</span> declared effective on August&#160;6, 2024).</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;10.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001042893/000119312524127628/d773596dex103.htm">Second Amendment to Second Amended and Restated Revolving Credit, Term Loan, Guaranty and Security Agreement and Limited Waiver, dated as of April&#160;3, 2023, among Innovex Downhole Solutions, Inc., Tercel Oilfield Products USA L.L.C., <span style="white-space:nowrap">Top-Co</span> Inc., Pride Energy Services, LLC and each person joined to the Credit Agreement as a borrower from time to time, as borrowers, each person joined to the Credit Agreement as a guarantor from time to time, the financial institutions from time to time party to the Credit Agreement as lenders and PNC Bank, National Association, as agent for lenders (incorporated by reference to Exhibit 10.3 to the Registration Statement on Form <span style="white-space:nowrap">S-4</span> (File No.<span style="white-space:nowrap">&#160;333-279048)</span> declared effective on August&#160;6, 2024).</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;10.5</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001042893/000119312524127628/d773596dex104.htm">Third Amendment to Second Amended and Restated Revolving Credit, Term Loan, Guaranty and Security Agreement and Limited Waiver, dated as of December&#160;15, 2023, among Innovex Downhole Solutions, Inc., Tercel Oilfield Products USA L.L.C., <span style="white-space:nowrap">Top-Co</span> Inc., Pride Energy Services, LLC and each person joined to the Credit Agreement as a borrower from time to time, as borrowers, each person joined to the Credit Agreement as a guarantor from time to time, the financial institutions from time to time party to the Credit Agreement as lenders and PNC Bank, National Association, as agent for lenders (incorporated by reference to Exhibit 10.4 to the Registration Statement on Form <span style="white-space:nowrap">S-4</span> (File No.<span style="white-space:nowrap">&#160;333-279048)</span> declared effective on August&#160;6, 2024).</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;10.6</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1042893/000119312524193373/d773596dex105.htm">Fourth Amendment to Second Amended and Restated Revolving Credit, Term Loan, Guaranty and Security Agreement and Limited Waiver, dated as of June&#160;28, 2024, among Innovex Downhole Solutions, Inc., Tercel Oilfield Products USA L.L.C., <span style="white-space:nowrap">Top-Co</span> Inc., Pride Energy Services, LLC and each person joined to the Credit Agreement as a borrower from time to time, as borrowers, each person joined to the Credit Agreement as a guarantor from time to time, the financial institutions from time to time party to the Credit Agreement as lenders and PNC Bank, National Association, as agent for lenders (incorporated by reference to Exhibit 10.5 to the Registration Statement on Form <span style="white-space:nowrap">S-4</span> (File No.<span style="white-space:nowrap">&#160;333-279048)</span> declared effective on August&#160;6, 2024).</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;10.7</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d802924dex107.htm">Form of Indemnification Agreement. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;10.8</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d802924dex108.htm">Separation Agreement and General Release of Claims, dated September&#160;6, 2024, by and between Dril-Quip, Inc. and Jeffrey J. Bird. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;10.9</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d802924dex109.htm">Separation Agreement and General Release of Claims, dated September&#160;6, 2024, by and between Dril-Quip, Inc. and Kyle F. McClure. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;10.10</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d802924dex1010.htm">Separation Agreement and General Release of Claims, dated September&#160;6, 2024, by and between Dril-Quip, Inc. and James C. Webster. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;10.11</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d802924dex1011.htm">Separation Agreement and General Release of Claims, dated September&#160;6, 2024, by and between Dril-Quip, Inc. and Donald M. Underwood. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d802924dex991.htm">Press Release, dated September&#160;6, 2024. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr></table></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:40%;border:0">
<tr>
<td style="width:7%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3">INNOVEX INTERNATIONAL, INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Anderson</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Adam Anderson</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Chief Executive Officer</td></tr></table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: September&#160;6, 2024</p></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>d802924dex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF AMENDMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO THE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RESTATED
CERTIFICATE OF INCORPORATION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DRIL-QUIP, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dril-Quip, Inc. (the &#147;Corporation&#148;), a corporation organized and existing under and by virtue of the General Corporation Law of the
State of Delaware (the &#147;DGCL&#148;), hereby certifies as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>FIRST:</B> The name of the Corporation is Dril-Quip, Inc. The
Restated Certificate of Incorporation of the Corporation was filed with the Delaware Secretary of State&#146;s Office on February&nbsp;26, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECOND: </B>The Amendment set forth in this Certificate of Amendment to the Restated Certificate of Incorporation was duly adopted in
accordance with Section&nbsp;242 of the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIRD</B>: The Restated Certificate of Incorporation of the Corporation is hereby
amended by deleting Article FIRST and replacing it with a new Article FIRST to read in its entirety as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">FIRST: The name of the
Corporation is Innovex International, Inc. (hereinafter the &#147;Corporation&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>FOURTH</B>: This Certificate of Amendment to the
Restated Certificate of Incorporation shall become effective upon the filing of this Certificate of Amendment to the Restated Certificate of Incorporation with the Secretary of State of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[The remainder of this page has been left intentionally blank.] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, this Certificate of Amendment to the Restated Certificate of
Incorporation has been executed for and on behalf of the Corporation by an officer thereunto duly authorized and attested to as of September&nbsp;6, 2024. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">DRIL-QUIP, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James C. Webster</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">James C. Webster</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President, General Counsel and Secretary</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to DRQ&#146;s Charter Amendment (Name Change)</I>] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>d802924dex32.htm
<DESCRIPTION>EX-3.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.2 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO THE
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED BYLAWS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DRIL-QUIP, INC.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Article VII, Section&nbsp;7.1 of the Amended and Restated Bylaws (the &#147;Bylaws&#148;) of Dril-Quip, Inc., a Delaware
corporation (the &#147;Corporation&#148;), the Corporation certifies that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>FIRST:</B> All references to &#147;Dril-Quip, Inc.&#148; in
the Bylaws are hereby deleted and replaced with references to &#147;Innovex International, Inc.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECOND:</B> The first sentence
of Article III, Section&nbsp;3.3(a) of the Bylaws is hereby amended and restated to read in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Subject to
(i)&nbsp;such rights of the holders of one or more outstanding series of Preferred Stock of the Corporation to elect one or more directors in case of arrearages in the payment of dividends or other defaults as shall be prescribed in the Certificate
of Incorporation or in the resolutions of the Board of Directors providing for the establishment of any such series, and (ii)&nbsp;the rights of Amberjack Capital Partners, L.P., a Delaware limited partnership (&#147;Amberjack&#148;) under the
Certificate of Incorporation and the Stockholders Agreement (as defined below), only persons who are nominated in accordance with the procedures set forth in this Section&nbsp;3.3 shall be eligible for election as, and to serve as, directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIRD:</B> Article III, Section&nbsp;3.4 of the Bylaws is hereby amended and restated to read in its entirety as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Place of Meeting; Order of Business</B>. Except as otherwise provided by law, meetings of the Board of
Directors, regular or special, may be held either within or without the State of Delaware, at whatever place is specified by the person or persons calling the meeting. In the absence of specific designation, the meetings shall be held at the
principal office of the Corporation. The Chairman of the Board will chair and preside over meetings of the Board of Directors at which he is present, except that, during the Standstill Period (as defined in the Stockholders Agreement), the Special
Amberjack Designee will chair and preside over meetings of the Board of Directors called by the Special Amberjack Designee pursuant to Section&nbsp;3.6 hereof. A majority of the directors present at any meeting of the Board of Directors from which
the Chairman of the Board or the Special Amberjack Designee, as applicable, is absent will designate one of their number as the chair of that meeting. The Secretary will act as secretary of meetings of the Board of Directors, but in his absence from
any such meeting the chair of that meeting may appoint any person to act as secretary of that meeting. At all meetings of the Board of Directors, business shall be transacted in such order as shall from time to time be determined by the Chairman of
the Board (or, with respect to meetings called by the Special Amberjack Designee, the Special Amberjack Designee), or in his absence by the President, or by resolution of the Board of Directors. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>FOURTH:</B> Article III, Section&nbsp;3.6 of the Bylaws is hereby amended and restated to read in its entirety as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Special Meetings.</B> Special meetings of the Board of Directors shall be held, whenever called by the
Chairman of the Board, the President or by a written notice signed by a majority of the members of the Board of Directors, at such place or places within or without the State of Delaware as may be stated in the notice of the meeting; provided, that
during the Standstill Period, the Special Amberjack Designee shall also be permitted to call special meetings. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>FIFTH</B>: The following Section&nbsp;3.14 shall be added immediately following Article III, Section&nbsp;3.13 of the Bylaws: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.14</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Definitions.</B> For purposes of this Article III: </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Special Amberjack Designee</I>&#148; means the Amberjack Designee
(as defined in the Stockholders Agreement) designated by Amberjack Capital Partners, L.P., a Delaware limited partnership, as the Special Amberjack Designee in connection with his nomination to the Board of Directors. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Stockholders Agreement</I>&#148; means that certain Stockholders&#146; Agreement, dated September&nbsp;6, 2024, by and
among the Corporation, Amberjack and the other stockholders party thereto (as the same may be amended, supplemented or restated from time to time). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SIXTH:</B> Article VI of the Bylaws is hereby amended and restated to read in its entirety as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VI </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INDEMNIFICATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Right to Indemnification</B>. Each person who was or is a party or is threatened to be made a party to, or
was or is otherwise involved in, any action, suit, arbitration, alternative dispute resolution mechanism, investigation, inquiry, judicial, administrative or legislative hearing, or any other threatened, pending or completed proceeding, whether
brought by or in the right of the Corporation or otherwise, including any and all appeals, whether of a civil, criminal, administrative, legislative, investigative or other nature (hereinafter a &#147;proceeding&#148;), by reason of the fact that he
or she or a person of whom he or she is the legal representative, is or was a director or an officer of the Corporation or while a director or officer of the Corporation is or was serving at the request of the Corporation, in any capacity, with any
corporation or a partnership, joint venture, trust or other enterprise, including service with respect to an employee benefit plan, whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee,
agent or in any other capacity while serving or having agreed to serve as a director, officer, employee or agent (hereinafter an &#147;indemnitee&#148;), or by reason of anything done or not done by him or her in any such capacity, shall be
indemnified and held harmless by the Corporation to the fullest extent authorized by the DGCL, as the same exists or may hereafter be amended, against all expense, liability and loss (including attorneys&#146; fees, judgments, fines, ERISA excise
taxes, penalties and amounts paid in settlement) reasonably incurred or suffered by such indemnitee in connection therewith, and such indemnification shall continue as to a person who has ceased to serve in the capacity which initially entitled such
person to indemnity hereunder and shall inure to the benefit of his or her heirs, executors and administrators, and the Corporation shall indemnify and hold harmless in such manner any person designated by the Board of Directors, or any committee
thereof, as a person subject to this indemnification provision, and who was or is made a party or is threatened to be made a party to a proceeding by reason of the fact that he, she or a person of whom he or she is the legal representative, is or
was serving at the request of the Board of Directors as a director, officer, employee or agent of another corporation or a partnership, joint venture, trust or other enterprise whether such request is made before or after the acts taken or allegedly
taken or events occurring or allegedly occurring which give rise to such proceeding, all on the terms and conditions set forth in these Bylaws; provided, however, that, except as otherwise required by law or provided in
<U>Section</U><U></U><U>&nbsp;6.3</U> with respect to suits to enforce rights under this <U>Article VI</U>, the Corporation shall indemnify any such indemnitee in connection with a proceeding, or part thereof, initiated by such indemnitee (including
claims and counterclaims, whether such counterclaims are asserted by: (i)&nbsp;such indemnitee; or (ii)&nbsp;the Corporation in a proceeding initiated by such indemnitee) only if such proceeding, or part thereof, was authorized by the Board of
Directors. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Right to Advancement of Expenses</B>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In addition to the right to indemnification conferred in Section&nbsp;6.1, an indemnitee shall also have the
right to be paid by the Corporation the expenses (including attorneys&#146; fees) incurred in defending any proceeding in advance of its final disposition (hereinafter an &#147;advancement of expenses&#148;); provided, however, that an advancement
of expenses shall be made only upon delivery to the Corporation of an undertaking (hereinafter an &#147;undertaking&#148;), by or on behalf of such indemnitee, to repay all amounts so advanced if it shall ultimately be determined that such
indemnitee is not entitled to be indemnified for such expenses under this Article VI or otherwise. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Right of Indemnitee to Bring Suit</B>. If a request for indemnification under Section&nbsp;6.1 is not paid
in full by the Corporation within 30 days, or if a request for an advancement of expenses under Section&nbsp;6.2 is not paid in full by the Corporation within 20 days, after a written request has been received by the Secretary of the Corporation,
the indemnitee may at any time thereafter bring suit against the Corporation to recover the unpaid amount of such request. If successful in whole or in part in any such suit, or in a suit brought by the Corporation to recover an advancement of
expenses pursuant to the terms of an undertaking, the indemnitee shall be entitled to be paid also the expense of prosecuting or defending such suit to the fullest extent permitted by law. In any suit brought by the indemnitee to enforce a right to
indemnification hereunder (but not in a suit brought by the indemnitee to enforce a right to an advancement of expenses) it shall be a defense that the indemnitee has not met any applicable standard of conduct for indemnification set forth in the
DGCL but the burden of proving such defense shall be on the Corporation. Neither the failure of the Corporation (including its directors who are not parties to such action, a committee of such directors, independent legal counsel or its
stockholders) to have made a determination prior to the commencement of such suit that indemnification of the indemnitee is proper in the circumstances because the indemnitee has met the applicable standard of conduct set forth in the DGCL, nor an
actual determination by the Corporation (including its directors who are not parties to such action, a committee of such directors, independent legal counsel or its stockholders) that the indemnitee has not met such applicable standard of conduct,
shall create a presumption that the indemnitee has not met the applicable standard of conduct or, in the case of such a suit brought by the indemnitee, be a defense to such suit. In any suit brought by the indemnitee to enforce a right to
indemnification or to an advancement of expenses hereunder, or brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the burden of proving that the indemnitee is not entitled to be indemnified, or
to such advancement of expenses, under applicable law, this Article VI or otherwise shall be on the Corporation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><FONT STYLE="white-space:nowrap">Non-Exclusivity</FONT> of Rights</B>. The rights to indemnification and to
the advancement of expenses conferred in this Article VI shall not be exclusive of any other right which any person may have or hereafter acquire under any law, agreement, vote of stockholders or disinterested directors, provisions of a certificate
of incorporation or bylaws, or otherwise. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Insurance</B>. The Corporation may maintain insurance, at its expense, to protect itself and any director,
officer, employee or agent of the Corporation or another corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss, whether or not the Corporation would have the power to indemnify such person against
such expense, liability or loss under the DGCL. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Indemnification of Employees and Agents of the Corporation</B>. The Corporation may, to the extent and in
the manner permitted by law, and to the extent authorized from time to time, grant rights to indemnification and to the advancement of expenses to any employee or agent of the Corporation. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Nature of Rights</B>. The rights conferred upon indemnitees in this Article VI shall be contract rights and
such rights shall continue as to an indemnitee who has ceased to be a director or officer and shall inure to the benefit of the indemnitee&#146;s heirs, executors and administrators. Any amendment, alteration or repeal of this Article VI that
adversely affects any right of an indemnitee or its successors shall be prospective only and shall not limit or eliminate any such right with respect to any proceeding involving any occurrence or alleged occurrence of any action or omission to act
that took place prior to such amendment, alteration or repeal. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.8</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Settlement of Claims</B>. Notwithstanding anything in this Article VI to the contrary, the Corporation shall
not be liable to indemnify any indemnitee under this Article VI for any amounts paid in settlement of any proceeding effected without the Corporation&#146;s written consent, which consent shall not be unreasonably withheld. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.9</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Subrogation</B>. In the event of payment under this Article VI, the Corporation shall be subrogated to the
extent of such payment to all of the rights of recovery of the indemnitee (excluding insurance obtained on the indemnitee&#146;s own behalf), and the indemnitee shall execute all papers required and shall do everything that may be necessary to
secure such rights, including the execution of such documents necessary to enable the Corporation effectively to bring suit to enforce such rights. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.10</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Procedures for Submission of Claims</B>. The Board of Directors may establish reasonable procedures for the
submission of claims for indemnification pursuant to this Article VI, determination of the entitlement of any person thereto and review of any such determination. Such procedures shall be set forth in an appendix to these Bylaws and shall be deemed
for all purposes to be a part hereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.11</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Severability</B>. If any provision or provisions of this Article VI shall be held to be invalid, illegal or
unenforceable as applied to any person or entity or circumstance for any reason whatsoever, then, to the fullest extent permitted by law: (a)&nbsp;the validity, legality and enforceability of such provision in any other circumstance and of the
remaining provisions of this Article VI (including, without limitation, all portions of any paragraph of this Article VI containing any such provision held to be invalid, illegal or unenforceable, that are not by themselves invalid, illegal or
unenforceable) and the application of such provision to other persons or entities or circumstances shall not in any way be affected or impaired thereby; and (b)&nbsp;to the fullest extent possible, the provisions of this Article VI (including,
without limitation, all portions of any paragraph of this Article VI containing any such provision held to be invalid, illegal or unenforceable, that are not themselves invalid, illegal or unenforceable) shall be construed so as to give effect to
the intent of the parties that the Corporation provide protection to the indemnitee to the fullest extent set forth in this Article VI. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SEVENTH</B>: The following Section&nbsp;7.9 shall be added immediately following Article VII, Section&nbsp;7.8 of the Bylaws: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.9</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Restrictions on Other Agreements</B>. To the fullest extent permitted by applicable law, the provisions of
the Certificate of Incorporation and of the Stockholders Agreement shall be controlling if any such provisions or the operation thereof conflict with the provisions of these Bylaws. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>EIGHTH</B>: The following Article VIII shall be added immediately following Article VII of the Bylaws: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VIII </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORUM FOR
ADJUDICATION OF DISPUTES </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Forum</B>. Unless the Corporation consents in writing to the selection of an alternative forum, (A)&nbsp;(i)
any derivative action or proceeding brought on behalf of the Corporation, (ii)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by any current or former director, officer, other employee or stockholder of the Corporation to the
Corporation or the Corporation&#146;s stockholders, (iii)&nbsp;any action asserting a claim arising pursuant to any provision of the DGCL, the Certificate of Incorporation or these Bylaws (as either may be amended or restated) or as to which the
DGCL confers jurisdiction on the Court of Chancery of the State of Delaware or (iv)&nbsp;any action asserting a claim governed by the internal affairs doctrine of the law of the State of Delaware shall, to the fullest extent permitted by law, be
exclusively brought in the Court of Chancery of the State of Delaware or, if such court does not have subject matter jurisdiction thereof, the federal district court of the State of Delaware; and (B)&nbsp;the federal district courts of the United
States shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended. Notwithstanding the foregoing, this Section&nbsp;8.1 shall not apply to claims seeking to
enforce any liability or duty created by the Securities Exchange Act of 1934, as amended. To the fullest extent permitted by law, any person or entity purchasing or otherwise acquiring or holding any interest in shares of capital stock of the
Corporation shall be deemed to have notice of and consented to the provisions of this Section&nbsp;8.1. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Enforceability</B>. If any provision of this Article VIII shall be held to be invalid, illegal or
unenforceable as applied to any person or entity or circumstance for any reason whatsoever, then, to the fullest extent permitted by law, the validity, legality and enforceability of such provision in any other circumstance and of the remaining
provisions of this Article VIII (including, without limitation, each portion of any sentence of this Article VIII containing any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or
unenforceable) and the application of such provision to other persons or entities or circumstances shall not in any way be affected or impaired thereby. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[The remainder of this page has been left intentionally blank.] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, this Amendment to the Bylaws has been executed for and on behalf
of the Corporation by an officer thereunto duly authorized and attested to as of September&nbsp;6, 2024. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">INNOVEX INTERNATIONAL, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Anderson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Adam Anderson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>4
<FILENAME>d802924dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION RIGHTS AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Registration Rights Agreement (this &#147;<B>Agreement</B>&#148;) is made and entered into as of this 6th day of September, 2024, by and
among Innovex International, Inc., a Delaware corporation (the &#147;<B>Company</B>&#148;), and each of the other parties listed on the signature pages hereto (the &#147;<B>Initial Holders</B>&#148; and, together with the Company, the
&#147;<B>Parties</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Dril-Quip, Inc., a Delaware Corporation, Ironman Merger Sub Inc., a Delaware corporation, DQ Merger
Sub, LLC, a Delaware limited liability company, and Innovex Downhole Solutions, Inc., a Delaware corporation, entered into an Agreement and Plan of Merger, dated March&nbsp;18, 2024 (as it may be amended form time to time, the &#147;<U>Merger
Agreement</U>&#148;), pursuant to which the Initial Holders have been issued shares of Common Stock (as hereinafter defined) pursuant to the Merger Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, (i)&nbsp;the Merger Agreement contemplates the execution and delivery of this Agreement and (ii)&nbsp;the Company has agreed to
provide to the Initial Holders registration rights with respect to the Registrable Securities (as hereinafter defined) as set forth in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW THEREFORE, in consideration of the mutual covenants and agreements set forth herein and for good and valuable consideration, the receipt
and sufficiency of which is hereby acknowledged by each party hereto, the Parties hereby agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.</B> <B>DEFINITIONS</B>.
As used in this Agreement, the following terms have the meanings indicated: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Action</B>&#148; means any claim, action, cause of
action, appeal, petition, plea, charge, complaint, demand, suit, litigation, arbitration, inquiry, investigation, audit, or other similar legal proceeding, whether at law or in equity, that is commenced by or before any Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Affiliate</B>&#148; means, with respect to any specified Person, any other Person directly or indirectly controlling, controlled by,
or under direct or indirect common control with such specified Person. For purposes of the foregoing, a Person shall be deemed to control a specified Person if such Person possesses, the power to direct the management and policies of such specified
Person. For purposes of this Agreement, the Holders shall not be considered Affiliates of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Agreement</B>&#148; has
the meaning set forth in the preamble. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Automatic Shelf Registration Statement</B>&#148; means an &#147;automatic shelf
registration statement&#148; as defined in Rule 405. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Blackout Period</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;3(p)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Block Trade</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Block Trade Notice</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Board</B>&#148; means the board of directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Business Day</B>&#148; means a day other than a Saturday, Sunday or other day on which commercial banks in Houston, Texas are
authorized or required to close. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Closing Date</B>&#148; has the meaning set forth in the Merger Agreement.<U> </U>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Commission</B>&#148; means the Securities and Exchange Commission or any other federal agency then administering the Securities
Act or Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Common Stock</B>&#148; means the common stock, par value $0.01 per share, of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company</B>&#148; has the meaning set forth in the preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Securities</B>&#148; means any equity interest of any class or series in the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Demand Notice</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(a)(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Demand Registration</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(a)(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Effective Date</B>&#148; means the time and date that a Registration Statement is first declared effective by the Commission or
otherwise becomes effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Effectiveness Period</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2(a)(i)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Exchange Act</B>&#148; means the Securities Exchange Act of 1934, as amended from
time to time, and the rules and regulations of the Commission promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Freely Tradeable</B>&#148; means the
Registrable Securities (i)&nbsp;are freely transferable under Rule 144 and the securities laws of any other applicable jurisdiction without limitation, or any volume,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> or other restrictions or conditions, without registration and without the requirement for the Company to be in compliance with the current public
information requirement under Rule 144(c) (or any similar rule then in force) and (ii)&nbsp;do not bear a restrictive legend relating to the Securities Act or the securities laws of any other applicable jurisdiction or a restricted CUSIP and have
been deposited (or are eligible for deposit) in the Depository Trust Company (or successor thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental
Authority</B>&#148; means any federal, state or local, tribal or foreign governmental or quasi-governmental authority, any subdivision or agency of any of the foregoing, any judicial or arbitral body or any applicable self-regulatory organization
(in each case, whether domestic or foreign). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Holder</B>&#148; means (i)&nbsp;each Initial Holder unless and until such Initial
Holder ceases to hold any Registrable Securities; and (ii)&nbsp;any holder of Registrable Securities to whom registration rights conferred by this Agreement have been transferred in compliance with <U>Section</U><U></U><U>&nbsp;8(e)</U> hereof
unless and until such subsequent Holder ceases to hold any Registrable Securities; provided that any Person referenced in <U>clause (ii)</U>&nbsp;shall be a Holder only if such Person agrees in writing to be bound by and subject to the terms set
forth in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Holder Indemnified Persons</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;6(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Holder <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period</B>&#148; has the meaning
set forth in <U>Section</U><U></U><U>&nbsp;3(r)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Holder Underwriter Registration Statement</B>&#148; has the meaning set
forth in <U>Section</U><U></U><U>&nbsp;3(t)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Initial Holder</B>&#148; has the meaning set forth in the preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Initiating Holder(s)</B>&#148; means the Holder(s) delivering the Demand Notice, Underwritten Offering Notice or Block Trade Notice,
as applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period</B>&#148; means a period of
180 days from the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Release Date</B>&#148; means the date of the
termination or expiration of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period whether by its terms or by the earlier agreement of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Losses</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;6(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Managing Underwriter</B>&#148; means, with respect to any Underwritten Offering or Block Trade, the book running lead manager or
managers of such Underwritten Offering or Block Trade. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Minimum Amount</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2(a)(i)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Notice</B>&#148; has the meaning set
forth in <U>Section</U><U></U><U>&nbsp;2(d)(v)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Parties</B>&#148; has the meaning set forth in the preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Person</B>&#148; means an individual or any, corporation, association, partnership, joint venture, limited liability company, joint
stock or other company, business trust, organization, Governmental Authority, unincorporated organization, trust, association or other entity of any kind. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Piggyback Registration</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(d)(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Piggyback Registration Notice</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(d)(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Piggyback Registration Request</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(d)(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Prospectus</B>&#148; means the prospectus included in a Registration Statement (including a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective Registration Statement in reliance upon Rule 430A, Rule 430B or Rule 430C), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any
portion of the Registrable Securities covered by such Registration Statement and all other amendments and supplements to the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by
reference in such Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Registrable Securities</B>&#148; means the Shares; provided, however, that Registrable Securities
shall not include: (i)&nbsp;any Shares that have been registered under the Securities Act and disposed of pursuant to an effective Registration Statement; (ii)&nbsp;any Shares transferred in a private transaction to a Person who is not entitled to
the registration and other rights hereunder; (iii)&nbsp;any Shares that have been sold or transferred by the Holder thereof pursuant to Rule 144 (or any similar provision then in force under the Securities Act) and the transferee thereof does not
receive &#147;restricted securities&#148; as defined in Rule 144; (iv) any Shares that cease to be outstanding (whether as a result of repurchase and cancellation, conversion or otherwise); and (v)&nbsp;after the tenth anniversary hereof, any Shares
held by a Holder at such time that are Freely Tradeable and the Holder of such Shares (together with its Affiliates) is not an affiliate of the Company (as defined in Rule 144) and does not beneficially own a number of shares of Common Stock equal
to or greater than 5% of the total number of then outstanding shares of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Registration Expenses</B>&#148; has the
meaning set forth in <U>Section</U><U></U><U>&nbsp;5</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Registration Statement</B>&#148; means a registration statement of the
Company in the form required to register under the Securities Act and other applicable law the resale of the Registrable Securities in accordance with the intended plan of distribution of each Holder of Registrable Securities included therein, and
including any Prospectus, amendments and supplements to each such registration statement or Prospectus, including <FONT STYLE="white-space:nowrap">pre-</FONT> and post-effective amendments, all exhibits thereto, and all material incorporated by
reference or deemed to be incorporated by reference in such registration statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Requested Underwritten Offering</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Requested Underwritten Offering Cap</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Requested Underwritten Offering Minimum Condition</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2(a)(iii)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rule 144</B>&#148; means Rule 144, as amended from time to time, promulgated by the
Commission pursuant to the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rule 405</B>&#148; means Rule 405, as amended from time to time, promulgated by the
Commission pursuant to the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rule 415</B>&#148; means Rule 415, as amended from time to time, promulgated by the
Commission pursuant to the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rule 424</B>&#148; means Rule 424, as amended from time to time, promulgated by the
Commission pursuant to the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rule 430A</B>&#148; means Rule 430A, as amended from time to time, promulgated by the
Commission pursuant to the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rule 430B</B>&#148; means Rule 430B, as amended from time to time, promulgated by the
Commission pursuant to the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rule 430C</B>&#148; means Rule 430C, as amended from time to time, promulgated by the
Commission pursuant to the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Securities Act</B>&#148; means the Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Selling Expenses</B>&#148; means all underwriting discounts, selling commissions and stock transfer taxes applicable to the sale of
Registrable Securities and fees and disbursements of counsel for any Holder (except as set forth in <U>Section</U><U></U><U>&nbsp;5</U>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Shares</B>&#148; means (i)&nbsp;the shares of Common Stock held by the Holders and issued pursuant to the Merger Agreement,<B>
</B>and (ii)&nbsp;any other equity interests of the Company or equity interests in any successor of the Company issued in respect of the shares of Common Stock described in clause (i)&nbsp;above by reason of or in connection with any stock dividend,
stock split, combination, reorganization, recapitalization, conversion to another type of entity or similar event involving a change in the capital structure of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Shelf Registration Statement</B>&#148; means a Registration Statement of the Company filed with the Commission on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> (or any successor form or other appropriate form under the Securities Act) for an offering to be made on a continuous or delayed basis pursuant to Rule 415 (or any similar rule that may be adopted by the
Commission) or, if the Company is not then eligible to file on Form <FONT STYLE="white-space:nowrap">S-3,</FONT> on Form <FONT STYLE="white-space:nowrap">S-1</FONT> or any other appropriate form under the Securities Act, or any successor rule that
may be adopted by the Commission, and all amendments and supplements to such Registration Statement (including post-effective amendments), covering the Registrable Securities, as applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Suspension Period</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;8(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Trading Market</B>&#148; means the principal national securities exchange on which
Registrable Securities are listed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Underwritten Offering</B>&#148; means an underwritten offering of Common Stock for cash
(whether a Requested Underwritten Offering or in connection with a public offering of Common Stock by the Company, stockholders or both), excluding an offering relating solely to an exchange offer, employee benefit plan or a dividend reinvestment
plan, an offering relating to a transaction on Form <FONT STYLE="white-space:nowrap">S-4</FONT> or Form <FONT STYLE="white-space:nowrap">S-8</FONT> or an offering on any registration statement form that does not permit secondary sales. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Underwritten Offering Limitation</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Underwritten Offering Notice</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Underwritten Offering Piggyback Notice</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(d)(ii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Underwritten Offering Piggyback Request</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(d)(ii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Underwritten Piggyback Offering</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(d)(ii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>VWAP</B>&#148; means, as of a specified date and in respect of Registrable Securities, the volume weighted average price for such
security on the Trading Market for the five trading days immediately preceding, but excluding, such date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>WKSI</B>&#148; means a
&#147;<B>well known seasoned issuer</B>&#148; as defined under Rule 405. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the context requires otherwise: (a)&nbsp;any pronoun used
in this Agreement shall include the corresponding masculine, feminine or neuter forms; (b)&nbsp;references to Sections refer to Sections of this Agreement; (c)&nbsp;the terms &#147;include,&#148; &#147;includes,&#148; &#147;including&#148; and words
of like import shall be deemed to be followed by the words &#147;without limitation&#148;; (d) the terms &#147;hereof,&#148; &#147;hereto,&#148; &#147;herein&#148; or &#147;hereunder&#148; refer to this Agreement as a whole and not to any particular
provision of this Agreement; (e)&nbsp;unless the context otherwise requires, the term &#147;or&#148; is not exclusive and shall have the inclusive meaning of &#147;and/or&#148;; (f) defined terms herein will apply equally to both the singular and
plural forms and derivative forms of defined terms will have correlative meanings; (g)&nbsp;references to any law or statute shall include all rules and regulations promulgated thereunder, and references to any law or statute shall be construed as
including any legal and statutory provisions consolidating, amending, succeeding or replacing the applicable law or statute; (h)&nbsp;references to any Person include such Person&#146;s successors and permitted assigns; and (i)&nbsp;references to
&#147;days&#148; are to calendar days unless otherwise indicated. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2. REGISTRATION. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Demand Registration</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) At any time after the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Release Date, any Holder(s) shall have the option and
right, exercisable by delivering a written notice to the Company (a &#147;<B>Demand Notice</B>&#148;), to require the Company to, pursuant to the terms of and subject to the limitations contained in this Agreement, prepare and file with the
Commission a Registration Statement registering the offering and sale of the number and type of Registrable Securities on the terms and conditions specified in the Demand Notice, which may include sales on a delayed or continuous basis pursuant to
Rule 415 pursuant to a Shelf Registration Statement (a &#147;<B>Demand Registration</B>&#148;). The Demand Notice must set forth the number of Registrable Securities that the Initiating Holder(s) intend to include in such Demand Registration and the
intended methods of disposition thereof. Notwithstanding anything to the contrary herein, in no event shall the Company be required to effectuate a Demand Registration unless the Registrable Securities of the Initiating Holder(s), their respective
Affiliates and any other Holders to be included therein have an aggregate value, based on the VWAP as of the date of the Demand Notice, of at least $30&nbsp;million (the &#147;<B>Minimum Amount</B>&#148;). In addition, as promptly as reasonably
practicable, but in no event later than 10 Business Days after the date hereof, the Company shall prepare and file with the Commission a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (which shall be an Automatic Shelf
Registration Statement if available) to permit the public resale of all of the Registrable Securities in accordance with the terms of this Agreement. The Company shall use its reasonable best efforts to cause such Registration Statement (including
such Shelf Registration Statement) to become or to be declared effective by the Commission as soon as reasonably practicable after the initial filing of such Registration Statement (or 90 days following the filing thereof if the Commission notifies
the Company that it will &#147;review&#148; the Shelf Registration Statement). Each Registration Statement (including such Shelf Registration Statement) shall provide for the resale of the Registrable Securities pursuant to any method or combination
of methods legally available to, and requested by, the Holders of any and all Registrable Securities covered by such Registration Statement. The Company shall use its reasonable best efforts to cause any Registration Statement (including such Shelf
Registration Statement) filed pursuant to this <U>Section</U><U></U><U>&nbsp;2(a)</U> to be continuously effective, supplemented and amended to the extent necessary to ensure that it is available for the resale of all Registrable Securities by the
Holders until all Registrable Securities covered by such Registration Statement have ceased to be Registrable Securities (the &#147;<B>Effectiveness Period</B>&#148;; provided, that if a Registration Statement is not a Shelf Registration Statement,
&#147;<B>Effectiveness Period</B>&#148; shall mean until all Registrable Securities covered by such Registration Statement have been sold). If such Registration Statement is filed on Form <FONT STYLE="white-space:nowrap">S-3</FONT> and has been
outstanding for at least three years, and the Registration Statement relates to offerings of securities described in Rule 415(a)(vii), (ix) or (x), at the end of the third year the Company shall refile a new Registration Statement on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> (or, if such Form is not available, Form <FONT STYLE="white-space:nowrap">S-1)</FONT> covering the Registrable Securities. For the avoidance of doubt, the Company&#146;s obligation to prepare and file such
Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> upon becoming eligible to use such form does not constitute a Demand Registration for purposes of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Within 30 days after the receipt of the Demand Notice (except if the Company is not then eligible to register for resale
the Registrable Securities on Form <FONT STYLE="white-space:nowrap">S-3,</FONT> within 45 days thereof), the Company shall, subject to the limitations of this <U>Section</U><U></U><U>&nbsp;2(a)</U>, file a Registration Statement in accordance with
the terms and conditions of, and the intended timing and method of disposition described in, the Demand Notice. The Company shall use reasonable best efforts to cause such Registration Statement to become and remain effective as soon as reasonably
practicable after the filing thereof under the Securities Act for the duration of the Effectiveness Period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) Subject
to the other limitations contained in this Agreement, the Company is not obligated hereunder to (A)&nbsp;file any Registration Statement pursuant to a Demand Registration within 90 days after the closing of any prior Requested Underwritten Offering,
unless as a result of <U>Section</U><U></U><U>&nbsp;2(e)</U>, the prior Requested Underwritten Offering included less than (the &#147;<B>Requested Underwritten Offering Minimum Condition</B>&#148;) the lesser of (i)&nbsp;Registrable Securities of
the Initiating Holder(s) having an aggregate value, based on the VWAP as of the effective date of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
related Registration Statement, of $50&nbsp;million, and (ii)&nbsp;the aggregate value, based on the VWAP as of the effective date of the related Registration Statement, of <FONT
STYLE="white-space:nowrap">two-thirds</FONT> of the number of Registrable Securities the Initiating Holder(s) set forth in the applicable Underwritten Offering Notice, or (B)&nbsp;effect a Demand Registration pursuant to a Demand Notice if a
Registration Statement covering all of the Registrable Securities held by the Initiating Holder(s) shall have become and remains effective under the Securities Act and is sufficient to permit offers and sales of the number and type of Registrable
Securities on the terms and conditions specified in the Demand Notice in accordance with the intended timing and method or methods of distribution thereof specified in the Demand Notice. No Demand Registration shall be deemed to have occurred for
purposes of this <U>Section</U><U></U><U>&nbsp;2(a)(iii)</U> if the Registration Statement relating thereto does not become effective or is not maintained effective for its entire Effectiveness Period (other than any Blackout Period pursuant to
<U>Section</U><U></U><U>&nbsp;3(p)</U>), in which case the Initiating Holder(s) shall be entitled to an additional Demand Registration in lieu thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) A Holder may withdraw all or any portion of its Registrable Securities included in a Demand Registration from such Demand
Registration at any time prior to the effectiveness of the applicable Registration Statement. Upon receipt of a notice from an Initiating Holder that such Initiating Holder is withdrawing an amount of its Registrable Securities such that the
remaining amount of Registrable Securities to be included in the Demand Registration is below the Minimum Amount, the Company shall cease all efforts to secure effectiveness of the applicable Registration Statement (it being understood that in such
event such Demand Registration shall not count towards any limits or similar restrictions under this Agreement on such Demand Registrations). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) The Company may include in any such Demand Registration or the Shelf Registration Statement referred to in
<U>Section</U><U></U><U>&nbsp;2(a)(i)</U> other Company Securities for sale for its own account or for the account of any other Person, subject to <U>Sections 2(e)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) Subject to the limitations contained in this Agreement, the Company shall effect any Demand Registration on such
appropriate registration form of the Commission (A)&nbsp;as shall be selected by the Company and (B)&nbsp;as shall permit the disposition of the Registrable Securities in accordance with the intended method or methods of disposition specified in the
Demand Notice; provided, however, that to the extent the Company is a WKSI at the time, any Initiating Holder may request that the Company file an Automatic Shelf Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (or any
equivalent or successor form under the Securities Act), in which case the Company shall file an Automatic Shelf Registration Statement which covers those Registrable Securities which are requested to be registered. The Company shall use its
reasonable best efforts to remain a WKSI (and not become an ineligible issuer (as defined in Rule 405 under the Securities Act)) during the period during which the Registrable Securities remain Registrable Securities. If the Company does not pay the
filing fee covering the Registrable Securities at the time an Automatic Shelf Registration Statement is filed, the Company agrees to pay such fee at such time or times as the Registrable Securities are to be sold. If an Automatic Shelf Registration
Statement has been outstanding for at least three years, at the end of the third year the Company shall refile a new Automatic Shelf Registration Statement covering the Registrable Securities. If at any time when the Company is required to <FONT
STYLE="white-space:nowrap">re-evaluate</FONT> its WKSI status the Company determines that it is not a WKSI, the Company shall use its reasonable best efforts to refile the Shelf Registration Statement on Form
<FONT STYLE="white-space:nowrap">S-3</FONT> and, if such form is not available, Form <FONT STYLE="white-space:nowrap">S-1</FONT> and keep such registration statement effective during the period during which such Registration Statement is required to
be kept effective hereunder. The Holders may use such Form <FONT STYLE="white-space:nowrap">S-3</FONT> to dispose of their Registrable Securities on a <FONT STYLE="white-space:nowrap">non-underwritten</FONT> basis, and may utilize such Form <FONT
STYLE="white-space:nowrap">S-3</FONT> on an underwritten basis if requested by the Initiating Holder(s). If at any time a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> is effective and a Holder provides written notice to
the Company that it intends to effect an offering of all or part of the Registrable Securities included on such Registration Statement, the Company will, subject to the terms of this Agreement, amend or supplement such Registration Statement as may
be necessary in order to enable such offering to take place. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) If the Company files any shelf registration statement for the benefit
of the holders of any of its securities other than the Holders, the Company agrees that it shall include in such registration statement such disclosures as may be required by Rule 430B under the Securities Act (referring to the unnamed selling
security holders in a generic manner by identifying the initial offering of the securities to the Holders) in order to ensure that the Holders may be added to such shelf registration statement at a later time through the filing of a prospectus
supplement rather than a post-effective amendment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) Without limiting <U>Section</U><U></U><U>&nbsp;3</U>, in
connection with any Demand Registration pursuant to and in accordance with this <U>Section</U><U></U><U>&nbsp;2(a)</U>, the Company shall (A)&nbsp;promptly prepare and file or cause to be prepared and filed (1)&nbsp;such additional forms,
amendments, supplements, prospectuses, certificates, letters, opinions and other documents, as may be necessary or advisable to register or qualify the Registrable Securities subject to such Demand Registration, including under the securities laws
of such jurisdictions as the Holders shall reasonably request; provided, however, that no such qualification shall be required in any jurisdiction where, as a result thereof, the Company would become subject to general service of process or to
taxation or qualification to do business in such jurisdiction solely as a result of registration and (2)&nbsp;such forms, amendments, supplements, prospectuses, certificates, letters, opinions and other documents as may be necessary to apply for
listing or to list the Registrable Securities subject to such Demand Registration on the Trading Market and (B)&nbsp;do any and all other acts and things that may be reasonably necessary or appropriate or reasonably requested by the Holders to
enable the Holders to consummate a public sale of such Registrable Securities in accordance with the intended timing and method or methods of distribution thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) In the event a Holder transfers Registrable Securities included on a Registration Statement, such Holder has assigned its
rights under this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8(e)</U> and such Registrable Securities remain Registrable Securities following such transfer, at the request of such Holder, the Company shall amend or supplement such
Registration Statement as may be necessary in order to enable such transferee to offer and sell such Registrable Securities pursuant to such Registration Statement; provided that in no event shall the Company be required to file a post-effective
amendment to the Registration Statement unless (A)&nbsp;such Registration Statement includes only Registrable Securities held by the Holder, Affiliates of the Holder or transferees of the Holder and securities (other than Registrable Securities) to
be offered by the Company or Persons that are not Holders or (B)&nbsp;the Company has received written consent therefor from a Person for whom Registrable Securities have been registered on (but not yet sold under) such Registration Statement, other
than the Holder, Affiliates of the Holder or transferees of the Holder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) If a Registration Statement filed pursuant to
this Agreement ceases to be effective under the Securities Act for any reason at any time during the Effectiveness Period, the Company shall use its reasonable best efforts as promptly as is reasonably practicable to cause such Registration
Statement to again become effective under the Securities Act (including obtaining the prompt withdrawal of any order suspending the effectiveness of such Registration Statement), and shall use its reasonable best efforts as promptly as is reasonably
practicable to amend such Registration Statement in a manner reasonably expected to result in the withdrawal of any order suspending the effectiveness of such Registration Statement or file an additional Registration
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Statement registering the resale from time to time by the Holders thereof of all securities that are Registrable Securities as of the time of such filing and not registered pursuant to another
Registration Statement pursuant to the Holders&#146; intended method of disposition. If any Registrable Securities required to be included under this Agreement in a Registration Statement are not included by the Company on a Registration Statement,
the Company shall, upon request by the Holders, promptly file and use its reasonable best efforts to have declared effective one or more additional Registration Statements registering the resale from time to time by the Holders thereof of all
securities that are Registrable Securities as of the time of such filing and not registered pursuant to another Registration Statement pursuant to the Holders&#146; intended method of disposition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Requested Underwritten Offering</U>. Any Initiating Holder(s) then able to effectuate a Demand Registration pursuant to the terms of
<U>Section</U><U></U><U>&nbsp;2(a)</U>, ignoring for purposes of such determination <U>Section</U><U></U><U>&nbsp;2(a)(iii)(B)</U> (or who has previously effectuated a Demand Registration pursuant to <U>Section</U><U></U><U>&nbsp;2(a)</U> but has
not engaged in an Underwritten Offering in respect of such Demand Registration), shall have the option and right, exercisable by delivering written notice to the Company of its intention to distribute Registrable Securities by means of an
Underwritten Offering (an &#147;<B>Underwritten Offering Notice</B>&#148;), to require the Company, pursuant to the terms of and subject to the limitations of this Agreement, to effectuate a distribution of any or all of its Registrable Securities
by means of an Underwritten Offering pursuant to a new Demand Registration (if the Underwritten Offering cannot be conducted pursuant to an effective Registration Statement) or pursuant to an effective Registration Statement covering such
Registrable Securities (a &#147;<B>Requested Underwritten Offering</B>&#148;); provided, that the Registrable Securities of such Holder(s) requested to be included in such Requested Underwritten Offering together with any other Holders that elect to
participate in such Requested Underwritten Offering have an aggregate value of at least equal to the Minimum Amount as of the date of such Underwritten Offering Notice. The Underwritten Offering Notice must set forth the number of Registrable
Securities that such Holder intends to include in such Requested Underwritten Offering. The Managing Underwriter and the other underwriters of a Requested Underwritten Offering shall be designated by the Initiating Holder; subject to the consent of
the Company, which consent shall not be unreasonably withheld. The Initiating Holder, in connection with any other Holder participating in such Requested Underwritten Offering, shall determine the pricing of the Registrable Securities offered
pursuant to any Requested Underwritten Offering and the applicable underwriting discounts and commissions and determine the timing of any such Requested Underwritten Offering. Notwithstanding the foregoing, the Company is not obligated to
(i)&nbsp;effect a Requested Underwritten Offering within 90 days after the closing of a Requested Underwritten Offering, unless as a result of <U>Section</U><U></U><U>&nbsp;2(e)</U>, the prior Requested Underwritten Offering failed to satisfy the
Requested Underwritten Offering Minimum Condition, in which case such prior Requested Underwritten Offering shall not be deemed to have occurred or (ii)&nbsp;conduct more than six Requested Underwritten Offerings in the aggregate or more than two
Requested Underwritten Offerings pursuant to this <U>Section</U><U></U><U>&nbsp;2(b)</U> in any twelve-month period (the &#147;<B>Requested Underwritten Offering Cap</B>&#148;); provided, that (A)&nbsp;if, prior to filing of the applicable
prospectus or prospectus supplement used for marketing such Requested Underwritten Offering, the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">majority-in-interest</FONT></FONT> of Holders participating in such Requested
Underwritten Offering withdraws from such Requested Underwritten Offering, (B)&nbsp;if the Initiating Holder has reimbursed the Company for all its Registration Expenses in connection with such Requested Underwritten Offering, or (C)&nbsp;if the
Requested Underwritten Offering Minimum Condition is not met (or, if it is met, at least 75% of the Registrable Securities included in such Requested Underwritten Offering are not sold in such Requested Underwritten Offering) then, in the case of
each of (A), (B) and (C), such Requested Underwritten Offering shall not count towards the Requested Underwritten Offering Cap ((i) and (ii)&nbsp;together, the &#147;<B>Underwritten Offering Limitation</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything contained in this<U> Section</U><U></U><U>&nbsp;2</U>, in the
event of a sale of Registrable Securities in an Underwritten Offering requiring the involvement of the Company and of the type which are commonly known as a &#147;block trade,&#148; &#147;overnight offering&#148; or &#147;bought deal&#148; (a
&#147;<B>Block </B><B>Trade</B>&#148;), the Initiating Holder shall give at least two Business Days prior notice in writing (the &#147;<B>Block Trade Notice</B>&#148;) of such transaction to the Company and identify the potential underwriter(s) in
such notice with contact information for such underwriter(s); and the Company shall cooperate with such Initiating Holder or Holders to the extent it is reasonably able to effect such Block Trade. Any Block Trade shall be for at least
$15&nbsp;million in expected gross proceeds. For the avoidance of doubt, a Block Trade shall not constitute a Requested Underwritten Offering for purposes of the Underwritten Offering Limitation. The Initiating Holder in any Block Trade shall select
the underwriter(s) to administer such Block Trade subject to the consent of the Company, which consent shall not be unreasonably withheld. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Piggyback Registration and Piggyback Underwritten Offering</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) If the Company shall at any time propose to file a registration statement under the Securities Act with respect to an
offering of Common Stock (other than a registration statement on Form <FONT STYLE="white-space:nowrap">S-4,</FONT> Form <FONT STYLE="white-space:nowrap">S-8</FONT> or any successor forms thereto or filed solely in connection with an exchange offer
or any employee benefit or dividend reinvestment plan or an offering on any registration statement form that does not permit secondary sales), whether or not for its own account, other than in connection with an Underwritten Offering subject to the
procedures of <U>Section</U><U></U><U>&nbsp;2(d)(ii)</U>, then the Company shall promptly notify all Initial Holders, Affiliates thereof and Holders holding Registrable Securities having an aggregate value, based on the VWAP as of the date prior to
the date such notification is given, of at least $1&nbsp;million (or all Holders in the case of a Demand Registration or a Shelf Registration Statement contemplated by <U>Section</U><U></U><U>&nbsp;2(a)(</U><U>i</U><U>)</U>) of such proposal
reasonably in advance of (and in any event at least 10 Business Days before) the anticipated filing date (the &#147;<B>Piggyback Registration Notice</B>&#148;). The Piggyback Registration Notice shall offer such Holders the opportunity to include
for registration in such registration statement the number of Registrable Securities as they may request in writing (a &#147;<B>Piggyback Registration</B>&#148;). The Company shall include in each such Piggyback Registration such Registrable
Securities for which the Company has received written requests for inclusion therein (&#147;<B>Piggyback Registration Request</B>&#148;) within five Business Days after sending the Piggyback Registration Notice. Each such Holder shall be permitted
to withdraw all or part of such Holder&#146;s Registrable Securities from a Piggyback Registration by giving written notice to the Company of its request to withdraw; provided that such request must be made in writing prior to the effectiveness of
such registration statement and such withdrawal shall be irrevocable and, after making such withdrawal, a Holder shall no longer have any right to include Registrable Securities in the Piggyback Registration as to which such withdrawal was made. Any
withdrawing Holder shall continue to have the right to include any Registrable Securities in any subsequent registration statement or registration statements as may be filed by the Company with respect to offerings of Common Stock, all upon the
terms and conditions set forth herein. No registration effected under this <U>Section</U><U></U><U>&nbsp;2(d)</U> shall be deemed to have been effected pursuant to <U>Section</U><U></U><U>&nbsp;2(a)</U> above or shall relieve the Company of the
Company&#146;s obligation to effect any registration upon request under <U>Section</U><U></U><U>&nbsp;2(a)</U> above. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii)
If the Company shall at any time propose to conduct an Underwritten Offering (including a Requested Underwritten Offering but excluding a Block Trade), whether or not for its own account, then the Company shall promptly notify all Initial Holders,
Affiliates thereof and Holders holding Registrable Securities having an aggregate value, based on the VWAP as of the date prior to the date such notification is given, of at least $1&nbsp;million (or all Holders in the case of a Requested
Underwritten Offering) of such proposal reasonably in advance of the commencement of the offering, which notice shall set forth the principal terms and conditions of the issuance, including the proposed offering price (or range of offering prices),
the anticipated filing date of the related registration statement (if applicable) and the number of shares of Common Stock that are proposed to be registered (the &#147;<B>Underwritten Offering Piggyback Notice</B>&#148;). Receipt of a Piggyback
Registration Notice under <U>Section</U><U></U><U>&nbsp;2(d)(</U><U>i</U><U>)</U> or any Underwritten Offering </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Piggyback Notice required to be provided in this <U>Section</U><U></U><U>&nbsp;2(d)(ii)</U> to Holders shall be kept confidential by the Holder until such proposed Underwritten Offering is
(i)&nbsp;publicly announced or (ii)&nbsp;such Holder receives notice that such proposed registration or Underwritten Offering, as the case may be, has been abandoned, which such notice shall be provided promptly by the Company to each Holder. The
Underwritten Offering Piggyback Notice shall offer such Holders the opportunity to include in such Underwritten Offering (and any related registration, if applicable) the number of Registrable Securities as they may request in writing (an
&#147;<B>Underwritten Piggyback Offering</B>&#148;); provided, however, that in the event that the Company proposes to effectuate the subject Underwritten Offering pursuant to an effective Registration Statement for offerings to be made on a
continuous or delayed basis pursuant to Rule 415 (or any similar rule that may be adopted by the Commission), regardless of whether, for purposes of this <U>Section</U><U></U><U>&nbsp;2(d)(ii)</U>, any Registrable Securities are included thereon
(other than an Automatic Shelf Registration Statement and Holders could be included in the Underwritten Offering to be effectuated pursuant to such Automatic Shelf Registration Statement without the filing of a post-effective amendment thereto,
other than a post-effective amendment that is immediately effective), only Registrable Securities of such Holders which are subject to an effective Shelf Registration Statement may be included in such Underwritten Piggyback Offering, unless the
Company is then able to file an Automatic Shelf Registration Statement and in the reasonable judgment of the Company, the filing of the same including Registrable Securities of such Holders that are not otherwise included in an effective Shelf
Registration Statement would not have a material adverse effect on the price, timing or distribution of the Common Stock in such Underwritten Piggyback Offering. The Company shall include in each such Underwritten Piggyback Offering such Registrable
Securities for which the Company has received written requests for inclusion therein (&#147;<B>Underwritten Offering Piggyback Request</B>&#148;) within three Business Days after sending the Underwritten Offering Piggyback Notice. Each Holder shall
be permitted to withdraw all or part of such Holder&#146;s Registrable Securities from an Underwritten Piggyback Offering up to and including the time of pricing of such offering, and such Holder shall continue to have the right to include any
Registrable Securities in any subsequent Underwritten Offerings, all upon the terms and conditions set forth herein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii)
The Company shall have the right to terminate or withdraw any registration initiated by it under this <U>Section</U><U></U><U>&nbsp;2(d)</U> at any time in its sole discretion whether or not any Holder has elected to include Registrable Securities
in such Registration Statement. The Registration Expenses of such withdrawn registration shall be borne by the Company in accordance with <U>Section</U><U></U><U>&nbsp;5</U> hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) Notwithstanding the foregoing, the rights afforded to Holders in this <U>Section</U><U></U><U>&nbsp;2(d)</U> shall not
apply to Block Trades. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) Notwithstanding the foregoing, any Holder may deliver written notice (an &#147;<B><FONT
STYLE="white-space:nowrap">Opt-Out</FONT> Notice</B>&#148;) to the Company requesting that such Holder not receive notice from the Company of any proposed filing of a registration statement or Underwritten Offering; provided, however, that such
Holder may later revoke any such <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Notice in writing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Priority in Underwritten
Offerings</U>. In connection with an Underwritten Offering, if the Managing Underwriter of any such Underwritten Offering advises the Company, and the Company advises the Holders in writing, that, in the reasonable opinion of the Managing
Underwriter, the total amount of Common Stock (or securities convertible into or exercisable or exchangeable for Common Stock) that the Holders and any other Persons (including the Company) intend to include in such Underwritten Offering (and any
related registration, if applicable) exceeds the number that can be included in such Underwritten Offering without being likely to have a material adverse effect on the price, timing or distribution of the Common Stock offered or the market for the
Common Stock (or securities convertible </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
into or exercisable or exchangeable for Common Stock), then the Common Stock to be included in such Underwritten Offering (in each case subject to the other terms and provisions of this
Agreement) shall include the number of shares of Common Stock that such Managing Underwriter, in its reasonable opinion, advises the Company can be sold without having such adverse effect, with such number to be allocated as follows (in each case,
with respect to such Persons that have validly requested to include shares of Common Stock in such Underwritten Offering in accordance with this Agreement or otherwise pursuant to rights of registration granted by the Company): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) if the offering was initiated for and on behalf of the Company: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(A) first, to the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(B) second, to other holders of registration rights and the Holders, pro rata based on the number of shares of Common Stock
held by such other holders and the Holders; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(C) third, to all other holders of Common Stock entitled to participate in
such Underwritten Offering, pro rata in accordance with the number of shares of Common Stock then held by such other holders; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) in the case of a Requested Underwritten Offering: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(A) first, to the Holders, pro rata based on the relative number of Registrable Securities then held by each such Holder; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(B) second, any remaining Holders, pro rata based on the relative number of Registrable Securities then held by each such
Holder, in the case that an Initiating Holder withdraws its participation in the Requested Underwritten Offering; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(C)
third, to the Company; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(D) fourth, pro rata among all other holders of Common Stock entitled to participate in such
Underwritten Offering, pro rata in accordance with the number of shares of Common Stock then held by such other holders; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) if the offering was not initiated for and on behalf of the Company and was initiated for and on behalf of any holder of
registration rights (other than any Holder): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(A) first, to such other holders and the Holders, pro rata based on the
number of shares of Common Stock held by such other holders and the Holders; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(B) second, to the Company; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(C) third, pro rata among all other holders of Common Stock proposed to be included in such offering based on the number of
shares of Common Stock held by such other holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if (i)&nbsp;an offering was initiated by the Holders,
(ii)&nbsp;the Holders are unable to include in the offering all of the shares of Common Stock including in the Underwritten Offering Piggyback Request and (iii)&nbsp;the underwriters in such offering exercise their option to purchase up to an
additional 15% of the shares sold in such offering, the shares to be included in such option closing shall be allocated (x)&nbsp;first, to the Holders, pro rata in accordance with the number of Registrable Securities then held by each such Holder
until all shares included in the Underwritten Offering Piggyback Request are sold, and (y)&nbsp;second, to the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3. REGISTRATION AND UNDERWRITTEN OFFERING PROCEDURES. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The procedures to be followed by the Company and each Holder electing to sell Registrable Securities in a Registration Statement pursuant to
this Agreement, and the respective rights and obligations of the Company and such Holders, with respect to the preparation, filing and effectiveness of such Registration Statement and the effectuation of any Underwritten Offering, are as follows:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In connection with a Demand Registration and the Shelf Registration Statement referred to in
<U>Section</U><U></U><U>&nbsp;2(a)(i)</U>, the Company will, at least five Business Days prior to the anticipated filing of the Registration Statement and any related Prospectus or any amendment or supplement thereto (other than any filing made
under the Exchange Act that is incorporated by reference into the Registration Statement), (i) offer to provide and, if requested, furnish to such Holders and counsel selected by such Holders copies of all such documents prior to filing and
(ii)&nbsp;use reasonable best efforts to address in each such document when so filed with the Commission such comments as such Holders reasonably shall propose prior to the filing thereof, and the Company shall not file any such Registration
Statement or any related Prospectus or any amendment or supplement thereto to which the Holders of a majority of the Registrable Securities covered by such Registration Statement, any Managing Underwriter or any of their respective counsel shall
reasonably object in writing on a timely basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In connection with a Piggyback Registration, an Underwritten Piggyback Offering or a
Requested Underwritten Offering, the Company will, at least three Business Days prior to the anticipated filing of any initial Registration Statement that identifies the Holders and any related Prospectus or any amendment or supplement thereto
(other than amendments and supplements that do not materially alter the previous disclosure or do nothing more than name Holders and provide information with respect thereto that in each case such Holders have previously consented to in writing or
provided for inclusion therein), as applicable, (i)&nbsp;furnish to such Holders and counsel selected by such Holders copies of any such Registration Statement or related Prospectus or amendment or supplement thereto that identify the Holders and
any related Prospectus or any amendment or supplement thereto (other than amendments and supplements that do not materially alter the previous disclosure or do nothing more than name Holders and provide information with respect thereto) prior to
filing and (ii)&nbsp;use reasonable best efforts to address in each such document when so filed with the Commission such comments as such Holders reasonably shall propose prior to the filing thereof, and the Company shall not file any such
Registration Statement or any related Prospectus or any amendment or supplement thereto to which the Holders of a majority of the Registrable Securities covered by such Registration Statement, any Managing Underwriter or any of their respective
counsel shall reasonably object in writing on a timely basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In connection with a Demand Registration, the Company will, promptly
prior to the filing of any document which is to be incorporated by reference into the Registration Statement or the Prospectus (after the initial filing of such Registration Statement), and prior to the filing of any free writing prospectus, provide
copies of such document to counsel for each Holder whose Registrable Securities are included therein and to each Managing Underwriter, if any, and will make the Company&#146;s representatives reasonably available for discussion of such document and
make such changes in such document concerning the Holders prior to the filing thereof as counsel for the Holders or Managing Underwriters may reasonably request. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company will use reasonable best efforts to as promptly as reasonably practicable
(i)&nbsp;prepare and file with the Commission such amendments, including post-effective amendments, and supplements to each Registration Statement and the Prospectus used in connection therewith as may be necessary under applicable law to keep such
Registration Statement continuously effective with respect to the disposition of all Registrable Securities covered thereby for its Effectiveness Period and, subject to the limitations contained in this Agreement, prepare and file with the
Commission such additional Registration Statements in order to register for resale under the Securities Act all of the Registrable Securities held by the Holders; (ii)&nbsp;cause the related Prospectus to be amended or supplemented by any required
prospectus supplement, and as so supplemented or amended to be filed pursuant to Rule 424; (iii) if a prospectus supplement will be used in connection with the marketing of an Underwritten Offering and the Managing Underwriter at any time shall
notify the Holders that, in the reasonable judgment of such Managing Underwriter, inclusion of detailed information to be used in such prospectus supplement is of material importance to the success of the Underwritten Offering, or if such
information is required by applicable law (including the rules and regulation of the Commission), include such information in a prospectus supplement; and (iv)&nbsp;respond to any comments received from the Commission with respect to each
Registration Statement or any amendment thereto and, as promptly as reasonably practicable provide such Holders true and complete copies of all correspondence from and to the Commission relating to such Registration Statement that pertains to such
Holders as selling stockholders but not any comments that would result in the disclosure to such Holders of material and <FONT STYLE="white-space:nowrap">non-public</FONT> information concerning the Company unless requested by such Holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company will comply in all material respects with the provisions of the Securities Act and the Exchange Act with respect to the
Registration Statements and the disposition of all Registrable Securities covered by each Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Company will
notify such Holders who are included in a Registration Statement as promptly as reasonably practicable: (i)&nbsp;(A) when a Prospectus or any prospectus supplement or post-effective amendment to a Registration Statement in which such Holder is
included has been filed; (B)&nbsp;when the Commission notifies the Company whether there will be a &#147;review&#148; of the applicable Registration Statement and whenever the Commission comments in writing on such Registration Statement (in which
case the Company shall provide true and complete copies thereof and all written responses thereto to each of such Holders that pertain to such Holders as selling stockholders but not any comments or responses that would result in the disclosure to
such Holders of material and <FONT STYLE="white-space:nowrap">non-public</FONT> information concerning the Company unless requested by such Holders); and (C)&nbsp;with respect to each applicable Registration Statement or any post-effective amendment
thereto, when the same has been declared effective; (ii)&nbsp;of any request by the Commission or any other federal or state governmental authority for amendments or supplements to such Registration Statement or Prospectus or for additional
information that pertains to such Holders as sellers of Registrable Securities; (iii)&nbsp;of the issuance by the Commission of any stop order suspending the effectiveness of such Registration Statement covering any or all of the Registrable
Securities or the initiation of any Actions for that purpose; (iv)&nbsp;of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for
sale in any jurisdiction, or the initiation or threatening of any Action for such purpose; and (v)&nbsp;of the occurrence (but not the details unless requested by such Holders) of any event or passage of time that makes any statement made in such
Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to such Registration Statement, Prospectus or other documents so that,
in the case of such Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading (provided, however, that no notice by the Company shall be required pursuant to this <U>clause </U><U>(v)</U>&nbsp;in the event that the Company either promptly
files a prospectus supplement to update the Prospectus or a Form <FONT STYLE="white-space:nowrap">8-K</FONT> or other appropriate Exchange Act report that is incorporated by reference into the Registration Statement, which in either case, contains
the requisite information that results in such Registration Statement no longer containing any untrue statement of material fact or omitting to state a material fact necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Company will use reasonable best efforts to avoid the issuance of or, if issued,
obtain the withdrawal of (i)&nbsp;any order suspending the effectiveness of a Registration Statement, or (ii)&nbsp;any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any
jurisdiction, as promptly as reasonably practicable, or if any such order or suspension is made effective during any Blackout Period or Suspension Period, as promptly as reasonably practicable after such Blackout Period or Suspension Period is over.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) During the Effectiveness Period, the Company will furnish to each such Holder, without charge, at least one conformed copy of each
Registration Statement and each amendment thereto and all exhibits to the extent requested by such Holder (including those incorporated by reference) promptly after the filing of such documents with the Commission; provided, that the Company will
not have any obligation to provide any document pursuant to this clause that is available on the Commission&#146;s EDGAR system. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The
Company will promptly deliver to each Holder, without charge, as many copies of each Prospectus or Prospectuses (including each form of prospectus) authorized by the Company for use and each amendment or supplement thereto as such Holder may
reasonably request during the Effectiveness Period. Subject to the terms of this Agreement, including <U>Section</U><U></U><U>&nbsp;8(b)</U>, the Company consents to the use of such Prospectus and each amendment or supplement thereto by each of the
selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) The Company will cooperate with such Holders to facilitate the timely preparation and delivery of certificates representing Registrable
Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free of all restrictive legends indicating that the Registrable Securities are unregistered or unqualified for resale under the Securities
Act, Exchange Act or other applicable securities laws, and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holder may request in writing. In connection therewith, if required by the
Company&#146;s transfer agent, the Company will promptly, after the Effective Date of the Registration Statement, use reasonable best efforts to cause an opinion of counsel as to the effectiveness of the Registration Statement to be delivered to and
maintained with its transfer agent, together with any other authorizations, certificates and directions required by the transfer agent which authorize and direct the transfer agent to issue such Registrable Securities without any such legend upon
sale by the Holder of such Registrable Securities under the Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Upon the occurrence of any event contemplated by
<U>Section</U><U></U><U>&nbsp;3(f)(v)</U>, as promptly as reasonably practicable, the Company will prepare a supplement or amendment, including a post-effective amendment, if required by applicable law, to the affected Registration Statement or a
supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter delivered, no Registration Statement nor any Prospectus will contain an
untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) With respect to Underwritten Offerings, subject to the right of a Holder to withdraw
such Holder&#146;s Registrable Securities from an Underwritten Offering in accordance with the terms of this Agreement, (i)&nbsp;the right of any Holder to include such Holder&#146;s Registrable Securities in an Underwritten Offering shall be
conditioned upon such Holder&#146;s participation in such underwriting and the inclusion of such Holder&#146;s Registrable Securities in the underwriting to the extent provided herein, (ii)&nbsp;each Holder participating in such Underwritten
Offering severally agrees to enter into an underwriting agreement in customary form and sell such Holder&#146;s Registrable Securities on the basis provided in any underwriting arrangements approved by the Persons entitled to select the Managing
Underwriter hereunder and (iii)&nbsp;each Holder participating in such Underwritten Offering severally agrees to complete and execute all questionnaires, powers of attorney, indemnities, underwriting agreements and other documents customarily and
reasonably required under the terms of such underwriting arrangements. The Company hereby agrees with each Holder that, in connection with any Underwritten Offering in accordance with the terms hereof, it will negotiate in good faith and execute all
indemnities, underwriting agreements and other documents reasonably required under the terms of such underwriting arrangements, including using all reasonable best efforts to procure customary legal opinions and auditor &#147;comfort&#148; letters.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) For a reasonable period prior to the filing of any Registration Statement and throughout the Effectiveness Period, the Company will
make available, upon reasonable notice at the Company&#146;s principal place of business or such other reasonable place, for inspection during normal business hours by a representative or representatives of the selling Holders, the Managing
Underwriter and any attorneys or accountants retained by such selling Holders or underwriters, all such financial and other information and books and records of the Company, and cause the officers, employees, counsel and independent certified public
accountants of the Company to respond to such inquiries, as shall be reasonably necessary (and in the case of counsel, not violate an attorney-client privilege in such counsel&#146;s reasonable belief) to conduct a reasonable investigation within
the meaning of Section&nbsp;11 of the Securities Act; provided, however, that any information that is not generally publicly available at the time of delivery of such information shall be kept confidential by such Persons unless disclosure of such
information is required by court or administrative order or, in the opinion of counsel to such Person, law, in which case, such Person shall be required to give the Company written notice of the proposed disclosure prior to such disclosure and, if
requested by the Company, assist the Company in seeking to prevent or limit the proposed disclosure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) Enter into customary agreements
and take such other actions as are reasonably requested by the Holders or the Managing Underwriters, if any, in order to expedite or facilitate the disposition of such Registrable Securities and entry of such Registrable Securities in book-entry
with The Depository Trust Company, and in connection with any Demand Registration or Requested Underwritten Offering, the Company will use reasonable best efforts to take such actions as the Holders and underwriters reasonably request with respect
to all road shows, ratings agency presentations and marketing activities or in order to expedite or facilitate the disposition of the Registrable Securities subject to such Demand Registration or Requested Underwritten Offering and to cause
appropriate officers and employees to be available, on a customary basis and upon reasonable notice, to meet with prospective investors and others relevant parties in presentations, meetings, ratings agency presentations and other marketing efforts
and otherwise provide reasonable assistance to the underwriters (taking into account the needs of the Company&#146;s businesses and the requirements of the marketing process) in marketing the Registrable Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) Each Holder agrees to furnish to the Company any other information regarding such Holder and the distribution of such securities as the
Company reasonably determines is required to be included in any Registration Statement or any Prospectus or prospectus supplement relating to inclusion in a Registration Statement or an Underwritten Offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) Notwithstanding any other provision of this Agreement, the Company shall not be required
to file a Registration Statement (or any amendment thereto) or effect a Requested Underwritten Offering (or, if the Company has filed a Shelf Registration Statement and has included Registrable Securities therein, the Company shall be entitled to
suspend the offer and sale of Registrable Securities pursuant to such Registration Statement) for a period of up to 60 days if (i)&nbsp;the Board determines in good faith that a postponement is in the best interest of the Company and its
stockholders generally due to a pending transaction involving the Company (including a pending securities offering by the Company), (ii) the Board determines in good faith such registration or offering would render the Company unable to comply with
applicable securities laws, or (iii)&nbsp;the Board determines in good faith such registration or offering would require disclosure of material information that the Company has a bona fide business purpose for preserving as confidential (any such
period, a &#147;<B>Blackout Period</B>&#148;); provided that the Company shall not delay filing any demanded Registration Statement or effecting any Requested Underwritten Offering more than twice in any consecutive
<FONT STYLE="white-space:nowrap">12-month</FONT> period and for no more than 60 days on each such occasion. Notwithstanding anything to the contrary in this Agreement, in no event shall any Blackout Periods, any Suspension Periods and any Holder <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Periods collectively continue for more than 120 days in the aggregate during any consecutive <FONT STYLE="white-space:nowrap">12-month</FONT> period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) In connection with an Underwritten Offering, the Company shall use reasonable best efforts to provide to each Holder named as a selling
securityholder in any Registration Statement a copy of any auditor &#147;comfort&#148; letters and customary legal opinions, in each case that have been provided to the Managing Underwriter in connection with the Underwritten Offering, not later
than the Business Day prior to the effective date of such Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) In connection with any Underwritten Offering other
than a Block Trade or, with respect to the Initial Holders, an Underwritten Offering where the Initiating Holders are not the Initial Holders or Affiliates thereof (other than one such occasion subject to the other provisions of this Agreement), any
Holder that together with its Affiliates owns 10% or more of the outstanding Common Stock, shall execute a customary <FONT STYLE="white-space:nowrap">&#147;lock-up&#148;</FONT> agreement with the underwriters of such Underwritten Offering containing
a <FONT STYLE="white-space:nowrap">lock-up</FONT> period equal to the shorter of (A)&nbsp;the shortest number of days that a director of the Company, &#147;executive officer&#148; (as defined under Section&nbsp;16 of the Exchange Act) of the Company
or any stockholder of the Company (other than a Holder or director or employee of, or consultant to, the Company) who owns 10% or more of the outstanding Common Stock contractually agrees to with the underwriters of such Underwritten Offering not to
sell any securities of the Company following such Underwritten Offering and (B) 60 days from the date of the execution of the underwriting agreement with respect to such Underwritten Offering or such shorter period as agreed to by the Managing
Underwriter (each such period, a &#147;<B>Holder <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period</B>&#148;); provided, that, each such Holder shall receive the benefit of any shorter Holder <FONT STYLE="white-space:nowrap">Lock-Up</FONT>
Period or permitted exceptions (on a pro rata basis) agreed to by the Managing Underwriter with respect to any Holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) In connection
with an Underwritten Offering, the Company will provide and cause to be maintained a transfer agent and registrar for all Registrable Securities covered by such Registration Statement from and after a date not later than the effective date of such
Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) If any Holder could reasonably be deemed to be an &#147;underwriter,&#148; as defined in
Section&nbsp;2(a)(11) of the Securities Act, in connection with the Registration Statement or any other registration statement contemplated by this Agreement and any amendment or supplement thereof (a &#147;<B>Holder Underwriter Registration
Statement</B>&#148;), then the Company will reasonably cooperate with such Holder in allowing such Holder to conduct customary &#147;underwriter&#146;s due diligence&#148; with respect to the Company and satisfy its obligations in respect thereof.
In addition, at any Holder&#146;s request, the Company will furnish to such Holder, on the date of the effectiveness of the Holder Underwriter Registration Statement and thereafter from time to time on such dates as such Holder may reasonably
request (provided that such request shall not be more frequently than on an annual basis unless such Holder is offering Registrable Securities pursuant to an Underwritten Offering), (i) a &#147;comfort letter&#148;, dated such date, from the
Company&#146;s independent certified public accountants in form and substance as has been customarily given by independent certified public accountants to underwriters in Underwritten Offerings of securities
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by the Company, addressed to such Holder, (ii)&nbsp;an opinion, dated as of such date, of counsel representing the Company for purposes of the Holder Underwriter Registration Statement, in form,
scope and substance as has been customarily given in Underwritten Offerings of securities by the Company, including standard <FONT STYLE="white-space:nowrap">&#147;10b-5&#148;</FONT> negative assurance for such offerings, addressed to such Holder
and (iii)&nbsp;a standard officer&#146;s certificate from the chief executive officer or chief financial officer, or other officers serving such functions, of the Company addressed to the Holder, as has been customarily given by such officers in
Underwritten Offerings of securities by the Company. The Company will also use its reasonable best efforts to provide legal counsel to such Holder with an opportunity to review and comment upon any such Holder Underwriter Registration Statement, and
any amendments and supplements thereto, prior to its filing with the Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary in this
<U>Section</U><U></U><U>&nbsp;3(t)</U>, the Company will not name a Holder as an underwriter (as defined in Section&nbsp;2(a)(11) of the Securities Act) in any Registration Statement without such Holder&#146;s consent. If the staff of the Commission
requires the Company to name any Holder as an underwriter (as defined in Section&nbsp;2(a)(11) of the Securities Act), and such Holder does not consent thereto, then such Holder&#146;s Registrable Securities shall not be included on the applicable
Registration Statement, and the Company shall have no further obligations hereunder with respect to Registrable Securities held by such Holder with respect to such Registration Statement, unless such Holder has not had an opportunity to conduct
customary underwriter&#146;s due diligence as set forth in <U>subsection (m)</U>&nbsp;of this <U>Section</U><U></U><U>&nbsp;3</U> with respect to the Company at the time such Holder&#146;s consent is sought. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u) In connection with a Demand Registration or Underwritten Offering, the Company will cause its senior management, officers and employees to
participate in, and the Company will otherwise facilitate and cooperate with the preparation of the Registration Statement and Prospectus and any amendments or supplements thereto (including participating in meetings, drafting sessions, due
diligence sessions and rating agency presentations) taking into account the Company&#146;s reasonable business needs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) The Company
will take no direct or indirect action prohibited by Regulation M under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.</B> <B>NO INCONSISTENT AGREEMENTS;
ADDITIONAL RIGHTS</B>. The Company shall not hereafter enter into, and is not currently a party to, any agreement with respect to its securities that is superior to or inconsistent with or that in any way violates or subordinates rights granted to
the Holders by this Agreement and any such agreement shall be considered void <I>ab initio</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.</B> <B>REGISTRATION EXPENSES</B>.
All Registration Expenses incident to the Parties&#146; performance of or compliance with their respective obligations under this Agreement or otherwise in connection with any Demand Registration, Requested Underwritten Offering, Piggyback
Registration or Underwritten Piggyback Offering (in each case, excluding any Selling Expenses) shall be borne by the Company, whether or not any Registrable Securities are sold pursuant to a Registration Statement. &#147;<B>Registration
Expenses</B>&#148; shall include, without limitation, all (i)&nbsp;registration and filing fees (including fees and expenses (A)&nbsp;with respect to filings required to be made with the Trading Market, (B)&nbsp;in compliance with applicable state
securities or &#147;<B>Blue Sky</B>&#148; laws and (C)&nbsp;with respect to filings with FINRA), (ii) printing expenses (including expenses of printing certificates for Company Securities and of printing Prospectuses if the printing of Prospectuses
is reasonably requested by a Holder of Registrable Securities included in the Registration Statement), (iii) messenger, telephone and delivery expenses, (iv)&nbsp;fees and disbursements of counsel, auditors and accountants for the Company,
(v)&nbsp;Securities Act liability insurance, if the Company so desires such insurance, (vi)&nbsp;fees and expenses of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement,
(vii)&nbsp;the fees and expenses of one law firm of national standing selected by the Holders owning the majority of the Registrable Securities to be included in any such registration or offering and (viii)&nbsp;all expenses relating to marketing
the sale of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Registrable Securities, including expenses related to conducting a &#147;road show.&#148; In addition, the Company shall be responsible for all of its expenses incurred in connection with the
consummation of the transactions contemplated by this Agreement (including expenses payable to third parties and including all salaries and expenses of their officers and employees performing legal or accounting duties), the expense of any annual
audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on the Trading Market. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.
INDEMNIFICATION. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall indemnify and hold harmless each Holder, its Affiliates and each of their respective officers
and directors and any agent thereof (collectively, &#147;<B>Holder Indemnified Persons</B>&#148;), to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, joint or several, costs
(including reasonable costs of preparation and reasonable attorneys&#146; fees) and expenses, judgments, fines, penalties, interest, settlements or other amounts arising from any and all claims, demands, actions, suits or proceedings, whether civil,
criminal, administrative or investigative, in which any Holder Indemnified Person may be involved, or is threatened to be involved, as a party or otherwise, under the Securities Act or otherwise (collectively, &#147;<B>Losses</B>&#148;), as
incurred, arising out of or relating to any untrue or alleged untrue statement of a material fact contained in any Registration Statement under which any Registrable Securities were registered, in any preliminary prospectus (if the Company
authorized the use of such preliminary prospectus prior to the Effective Date), or in any summary or final prospectus or free writing prospectus (if such free writing prospectus was authorized for use by the Company) or in any amendment or
supplement thereto (if used during the period the Company is required to keep the Registration Statement current), or arising out of, based upon or resulting from the omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements made therein not misleading, in the case of the Registration Statement, or arising out of or based upon the omission to state a material fact necessary in order to make the statements therein, in
the light of the circumstances in which they were made, not misleading, in the case of any preliminary prospectus (if the Company authorized the use of such preliminary prospectus prior to the Effective Date), or in any summary or final prospectus
or free writing prospectus (if such free writing prospectus was authorized for use by the Company) or in any amendment or supplement thereto (if used during the period the Company is required to keep the Registration Statement current); provided,
however, that the Company shall not be liable to any Holder Indemnified Person to the extent that any such claim arises out of, is based upon or results from an untrue or alleged untrue statement or omission or alleged omission made in such
Registration Statement, such preliminary, summary or final prospectus or free writing prospectus or such amendment or supplement, in reliance upon and in conformity with written information furnished to the Company by or on behalf of such Holder
Indemnified Person specifically for use in the preparation thereof. The Company shall notify the Holders promptly of the institution, threat or assertion of any Action of which the Company is aware in connection with the transactions contemplated by
this Agreement. This indemnity shall be in addition to any liability the Company may otherwise have and shall remain in full force and effect regardless of any investigation made by or on behalf of such Holder Indemnified Person or any indemnified
party and shall survive the transfer of such securities by such Holder. Notwithstanding anything to the contrary herein, this <U>Section</U><U></U><U>&nbsp;6</U> shall survive any termination or expiration of this Agreement indefinitely. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In connection with any Registration Statement in which a Holder participates, such Holder shall, severally and not jointly, indemnify and
hold harmless the Company, its Affiliates and each of their respective officers, directors and any agent thereof, to the fullest extent permitted by applicable law, from and against any and all Losses as incurred, arising out of or relating to any
untrue or alleged untrue statement of a material fact contained in any such Registration Statement, in any preliminary prospectus (if used prior to the Effective Date of such Registration Statement), or in any summary or final prospectus or free
writing prospectus or in any amendment or supplement thereto (if used during the period </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Company is required to keep the Registration Statement current), or arising out of, based upon or resulting from the omission or alleged omission to state therein a material fact required to
be stated therein or necessary to make the statements made therein not misleading, in the case of the Registration Statement, or arising out of or based upon the omission to state a material fact necessary in order to make the statements therein, in
the light of the circumstances in which they were made, not misleading in the case of any preliminary prospectus (if used prior to the Effective Date of such Registration Statement), or in any summary or final prospectus or free writing prospectus
(if such free writing prospectus was authorized for use by the Company) or in any amendment or supplement thereto (if used during the period the Company is required to keep the Registration Statement current), but only to the extent that the same
are made in reliance and in conformity with information relating to the Holder furnished in writing to the Company by such Holder expressly for use therein. This indemnity shall be in addition to any liability such Holder may otherwise have and
shall remain in full force and effect regardless of any investigation made by or on behalf of the Company or any indemnified party. In no event shall the liability of any selling Holder hereunder be greater in amount than the dollar amount of the
proceeds received by such Holder from the sale of the Registrable Securities giving rise to such indemnification obligation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Any
Person entitled to indemnification hereunder shall (i)&nbsp;give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification and (ii)&nbsp;unless in such indemnified party&#146;s reasonable judgment a
conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim or there may be reasonable defenses available to the indemnified party that are different from or additional to those available to the
indemnifying party, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any
settlement made by the indemnified party without its consent (but such consent will not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees
and expenses of more than one counsel (in addition to any local counsel) for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party there may be one or more legal or
equitable defenses available to such indemnified party that are in addition to or may conflict with those available to another indemnified party with respect to such claim. Failure to give prompt written notice shall not release the indemnifying
party from its obligations hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If the indemnification provided for in this <U>Section</U><U></U><U>&nbsp;6</U> is held by a
court of competent jurisdiction to be unavailable to an indemnified party with respect to any Losses referred to herein, the indemnifying party, in lieu of indemnifying such indemnified party thereunder, shall to the extent permitted by applicable
law contribute to the amount paid or payable by such indemnified party as a result of such Losses in such proportion as is appropriate to reflect the relative fault of the indemnifying party, on the one hand, and of the indemnified party, on the
other, in connection with the untrue or alleged untrue statement of a material fact or the omission to state a material fact that resulted in such Losses, as well as any other relevant equitable considerations. The relative fault of the indemnifying
party and of the indemnified party shall be determined by a court of law by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied
by the indemnifying party or by the indemnified party and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission; provided, that in no event shall any contribution by a
Holder hereunder exceed the net proceeds from the offering received by such Holder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7. FACILITATION OF SALES PURSUANT TO RULE 144; REMOVAL OF LEGEND. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall timely file the reports required to be filed by it under the Exchange Act or the Securities Act (including the reports
under Sections 13 and 15(d) of the Exchange Act referred to in subparagraph (c)(1) of Rule 144), and shall take such further action as any Holder may reasonably request, all to the extent required from time to time to enable the Holders to sell
Registrable Securities without registration under the Securities Act within the limitations of the exemption provided by Rule 144. Upon the request of any Holder in connection with that Holder&#146;s sale pursuant to Rule 144, the Company shall
deliver to such Holder a written statement as to whether it has complied with such requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In connection with a sale of the
Registrable Securities by a Holder in reliance on Rule 144, the applicable Holder or its broker shall, if required by the Company or its transfer agent, deliver to the Company a broker and seller representation letter, as appropriate, including
information required under Rule 144 for the Company to determine that the sale of such shares is made in compliance with Rule 144. Upon receipt of such representation letter or letters, the Company shall, in connection with such sale, promptly
remove (or cause to be removed) the notation of the securities laws restrictive legend on such Holder&#146;s certificates representing such shares or the book-entry account maintained by the Company and the Company shall bear all costs associated
therewith. At such time as (i)&nbsp;such shares referred to above have been sold pursuant to an effective Registration Statement or (ii)&nbsp;a Holder has a &#147;holding period&#148; with respect to such securities under Rule 144(d) of more than 12
months and such Holder is not, and has not been in the preceding three months, an affiliate of the Company (as defined in Rule 144), if certificates representing such shares or the book-entry account of such shares still bears a notation of a
securities laws restrictive legend, the Company agrees, upon request of such Holder or permitted assignee, to take all steps reasonably necessary to promptly effect the removal of such legend from such shares, and the Company shall bear all costs
associated therewith, regardless of whether the request is made in connection with a sale or otherwise, so long as such Holder or its permitted assigns provide to the Company any information the Company deems reasonably necessary to determine (in
the case of clause (ii)&nbsp;above) that the legend is no longer required. The Company shall cooperate with each Holder to effect the removal of a Securities Act restrictive legend at any time such legend is no longer appropriate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8. MISCELLANEOUS. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
<U>Remedies</U>. In the event of actual or potential breach by the Company of any of its obligations under this Agreement, each Holder, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery
of damages, will be entitled to specific performance of its rights under this Agreement. The Company agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions of
this Agreement and further agrees that, in the event of any action for specific performance in respect of such breach, it shall waive the defense that a remedy at law would be adequate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Discontinued Disposition</U>. Subject to the last sentence of <U>Section</U><U></U><U>&nbsp;3(p)</U>, each Holder agrees that, upon
receipt of a notice from the Company of the occurrence of any event of the kind described in <U>clauses </U><U>(ii)</U>&nbsp;through <U>(v)</U> of <U>Section</U><U></U><U>&nbsp;3(f)</U>, such Holder will forthwith discontinue disposition of such
Registrable Securities under the Registration Statement until such Holder&#146;s receipt of the copies of the supplemental Prospectus or amended Registration Statement as contemplated by <U>Section</U><U></U><U>&nbsp;3(k)</U> or until it is advised
in writing by the Company that the use of the applicable Prospectus may be resumed, and, in either case, has received copies of any additional or supplemental filings that are incorporated or deemed to be incorporated by reference in such Prospectus
or Registration Statement (a &#147;<B>Suspension Period</B>&#148;). The Company may provide appropriate stop orders to enforce the provisions of this <U>Section</U><U></U><U>&nbsp;8(b)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Amendments and Waivers</U>. No provision of this Agreement may be waived or amended
except in a written instrument signed by the Company and Holders that hold a majority of the Registrable Securities as of the date of such waiver or amendment; provided, that any waiver or amendment that would have a disproportionate adverse effect
on a Holder relative to the other Holders shall require the consent of such Holder. The Company shall provide prior notice to all Holders of any proposed waiver or amendment. No waiver of any default with respect to any provision, condition or
requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any Party to exercise
any right hereunder in any manner impair the exercise of any such right. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Notices</U>. Any and all notices or other communications
or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (i)&nbsp;the date of transmission, if such notice or communication is delivered via electronic mail as
specified in this <U>Section</U><U></U><U>&nbsp;8(d)</U> prior to 5:00 p.m. Central Time on a Business Day, (ii)&nbsp;the Business Day after the date of transmission, if such notice or communication is delivered via electronic mail as specified in
this Agreement later than 5:00 p.m. Central Time on any date and earlier than 11:59 p.m. Central Time on such date, (iii)&nbsp;the Business Day following the date of mailing, if sent by nationally recognized overnight courier service, or
(iv)&nbsp;upon actual receipt by the Party to whom such notice is required to be given. The address for such notices and communications shall be as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="93%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">If to the Company:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Innovex International, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">19120 Kenswick
Drive</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Humble, Texas 77338</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: Kendal Reed</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Email: <FONT STYLE="white-space:nowrap">kendal.reed@innovex-inc.com</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">If to any Person who is then the registered Holder:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">To the address of such Holder as it appears in the applicable register for the Registrable Securities or such other address as may be designated in writing by such Holder (including on the signature pages hereto).</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the
Parties hereto and their respective heirs, executors, administrators, successors, legal representatives and permitted assigns. Except as provided in this <U>Section</U><U></U><U>&nbsp;8(e)</U>, this Agreement, and any rights or obligations
hereunder, may not be assigned without the prior written consent of the Company (acting through the Board) and the Holders. Notwithstanding anything in the foregoing to the contrary, the rights of a Holder pursuant to this Agreement with respect to
all or any portion of its Registrable Securities may be assigned without such consent (but only with all related obligations) with respect to such Registrable Securities (and any Registrable Securities issued as a dividend or other distribution with
respect to, in exchange for or in replacement of such Registrable Securities) by such Holder to a transferee of such Registrable Securities; provided (i)&nbsp;the Company is, within a reasonable time after such transfer, furnished with written
notice of the name and address of such transferee or assignee and the Registrable Securities with respect to which such registration rights are being assigned (and, if applicable, if the transferor or assignor is an Affiliate of an Initial Holder)
and (ii)&nbsp;such transferee or assignee agrees in writing to be bound by and subject to the terms set forth in this Agreement. The Company may not assign its rights or obligations hereunder without the prior written consent of the Holders holding
a majority of the Registrable Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>No Third Party Beneficiaries</U>. Nothing in this Agreement, whether express or implied,
shall be construed to give any Person, other than the parties hereto or their respective successors and permitted assigns, any legal or equitable right, remedy, claim or benefit under or in respect of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Execution and Counterparts</U>. This Agreement may be executed in any number of
counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same Agreement. In the event that any signature is delivered by facsimile or electronic mail transmission,
such signature shall create a valid binding obligation of the Party executing (or on whose behalf such signature is executed) the same with the same force and effect as if such signature delivered by facsimile or electronic mail transmission were
the original thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Governing Law; Consent to Jurisdiction; Waiver of Jury Trial</U>. This Agreement shall be governed by, and
construed in accordance with, the internal laws of the State of Delaware. Each of the Parties irrevocably submits to the exclusive jurisdiction of United States District Court for the District of Delaware or in the Court of Chancery of the State of
Delaware (or, if such courts lack subject-matter jurisdiction, in the Superior Court of the State of Delaware) for the purpose of any suit, action, proceeding or judgment relating to or arising out of this Agreement and the transactions contemplated
hereby. Service of process in connection with any such suit, action or proceeding may be served on each Party anywhere in the world by the same methods as are specified for the giving of notices under this Agreement. Each of the Parties irrevocably
waives any objection to the laying of venue of any such suit, action or proceeding brought in such courts and irrevocably waives any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum.
<B>EACH OF THE PARTIES HEREBY WAIVES ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY LITIGATION WITH RESPECT TO THIS AGREEMENT AND REPRESENTS THAT COUNSEL HAS BEEN CONSULTED SPECIFICALLY AS TO THIS WAIVER.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Cumulative Remedies</U>. The remedies provided herein are cumulative and not exclusive of any remedies provided by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be
invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the Parties shall use
their reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of
the Parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>Entire Agreement</U>. This Agreement constitutes the entire agreement among the Parties with respect to the subject matter hereof and
supersedes all prior contracts or agreements with respect to the subject matter hereof and the matters addressed or governed hereby, whether oral or written. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>Termination</U>. Except for <U>Section</U><U></U><U>&nbsp;6</U>, this Agreement shall terminate as to any Holder, when all Registrable
Securities held by such Holder no longer constitute Registrable Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) <U>Recapitalizations, Etc</U>. The provisions of this
Agreement shall apply to the full extent set forth herein with respect to any and all stock or other securities of the Company or any successor or assign of the Company (whether by merger, consolidation, sale of assets or otherwise), which may be
issued in respect of, in exchange for or in substitution of, the Registrable Securities, and shall be appropriately adjusted for combinations, stock splits, recapitalizations, pro rata distributions of stock and the like occurring after the date of
this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) <U>Change of Control</U>. The Company shall not merge, consolidate or combine with any
other Person, or reorganize or convert into another entity or form of entity, or sell all or substantially all of its assets (on a consolidated basis or otherwise), or engage in any similar transaction unless the agreement, plan of conversion and/or
other governing instrument providing for such merger, consolidation or combination, or reorganization, conversion, sale or similar transaction, expressly provides for the continuation of the rights specified in this Agreement with respect to the
Registrable Securities or other equity securities issued pursuant to such merger, consolidation or combination or reorganization, conversion, sale or similar transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) <U>Obligations Limited to Parties to Agreement</U>. Each of the parties hereto covenants, agrees and acknowledges that no Person other
than the Holders (and their transferees or assignees) and the Company shall have any obligation hereunder and that notwithstanding that a Holder is a limited liability company or other entity, no recourse under this Agreement shall be had against
any former, current or future director, officer, employee, agent, general or limited partner, manager, member, stockholder or Affiliate of the Holders or any former, current or future director, officer, employee, agent, general or limited partner,
manager, member, stockholder or Affiliate of any of the foregoing, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any applicable law, it being expressly agreed and acknowledged that no personal
liability whatsoever shall attach to, be imposed on or otherwise be incurred by any former, current or future director, officer, employee, agent, general or limited partner, manager, member, stockholder or Affiliate of the Holders or any former,
current or future director, officer, employee, agent, general or limited partner, manager, member, stockholder or Affiliate of any of the foregoing, as such, for any obligations of the Holders under this Agreement or for any claim based on, in
respect of or by reason of such obligation or its creation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) <U>Independent Nature of Holder&#146;s Obligations</U>. The obligations
of each Holder under this Agreement are several and not joint with the obligations of any other Holder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder under this Agreement. Nothing contained
herein, and no action taken by any Holder pursuant thereto, shall be deemed to constitute the Holder as a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that a Holder is in any way acting
in concert or as a group with respect to such obligations or the transactions contemplated by this Agreement. Each Holder shall be entitled to independently protect and enforce its rights, including, the rights arising out of this Agreement, and it
shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[THIS SPACE LEFT BLANK
INTENTIONALLY] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written
above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>COMPANY:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Innovex International, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Anderson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Adam Anderson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Chief Executive Officer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page to Registration Rights Agreement </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INTERVALE CAPITAL FUND II, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Intervale Capital GP II, L.P., its general partner</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Intervale Capital Associates II, LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ W. Patrick Connelly</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: W. Patrick Connelly</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INTERVALE CAPITAL FUND <FONT STYLE="white-space:nowrap">II-A,</FONT> L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Intervale Capital GP II, L.P., its general partner</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Intervale Capital Associates II, LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ W. Patrick Connelly</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: W. Patrick Connelly</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INTERVALE CAPITAL FUND III, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Intervale Capital GP III, L.P., its general partner</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Intervale Capital Associates III, LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ W. Patrick Connelly</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: W. Patrick Connelly</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Partner</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page to Registration Rights Agreement </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>AMBERJACK CAPITAL FUND II, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Amberjack Capital GP II, L.P., its general partner</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Amberjack Capital Associates II, LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ W. Patrick Connelly</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: W. Patrick Connelly</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INNOVEX <FONT STYLE="white-space:nowrap">CO-INVEST</FONT> FUND, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Innovex <FONT STYLE="white-space:nowrap">Co-Invest</FONT> Fund GP, L.P., its general partner</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Innovex <FONT STYLE="white-space:nowrap">Co-Invest</FONT> Associates, LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ W. Patrick Connelly</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: W. Patrick Connelly</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INNOVEX <FONT STYLE="white-space:nowrap">CO-INVEST</FONT> FUND II, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Innovex <FONT STYLE="white-space:nowrap">Co-Invest</FONT> Fund II, GP, L.P., its general partner</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Innovex <FONT STYLE="white-space:nowrap">Co-Invest</FONT> Associates, LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ W. Patrick Connelly</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: W. Patrick Connelly</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Partner</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page to Registration Rights Agreement </I></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>5
<FILENAME>d802924dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCKHOLDERS&#146; AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>of </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INNOVEX
INTERNATIONAL, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dated as of September&nbsp;6, 2024 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">Page</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE I DEFINITIONS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 1.1.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 1.2.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Construction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE II CORPORATE GOVERNANCE</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 2.1.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Board of Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 2.2.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Permitted Disclosure</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;2.3.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Information Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 2.4.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Corporate Opportunity Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE III STANDSTILL; VOTING</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 3.1.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Standstill Restrictions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 3.2.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Attendance at Meetings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE IV TRANSFER RESTRICTIONS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.1.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Transfer Restrictions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.2.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Legends on Stockholder Shares; Securities Act Compliance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE V MISCELLANEOUS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.1.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.2.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Amendments and Waivers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.3.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Successors, Assigns and Transferees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.4.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Rights of Third Parties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.5.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.6.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Further Assurances</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.7.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Entire Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.8.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Restrictions on Other Agreements; Bylaws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.9.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Delays or Omissions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.10.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governing Law; Jurisdiction; Waiver of Jury Trial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.11.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.12.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Enforcement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.13.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Titles and Subtitles</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.14.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Recourse</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.15.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Counterparts; Electronic Signatures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.16.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effectiveness</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Exhibits </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit A &#150; Assignment and Assumption Agreement </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule
A &#150; Certain Affiliates of Amberjack </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule B &#150; Competitors </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>STOCKHOLDERS&#146; AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS STOCKHOLDERS&#146; AGREEMENT (as the same may be amended from time to time in accordance with its terms, the
&#147;<U>Agreement</U>&#148;) is entered into as of September&nbsp;6, 2024, by and among Innovex International, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), Amberjack Capital Partners, L.P., a Delaware limited partnership
(&#147;<U>Amberjack</U>&#148;) and the Principal Stockholders (as defined below). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company, Ironman Merger Sub, Inc., a Delaware corporation (&#147;<U>Merger Sub</U>&#148;), DQ Merger Sub, LLC, a Delaware limited
liability company (&#147;<U>LLC Sub</U>&#148;), Innovex Downhole Solutions, Inc., a Delaware corporation (&#147;<U>Innovex</U>&#148;), entered into that certain Agreement and Plan of Merger, dated March&nbsp;18, 2024 (as it may be amended from time
to time, the &#147;<U>Merger Agreement</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, pursuant to the Merger Agreement, (i)&nbsp;Merger Sub shall merge with and
into Innovex, with Innovex continuing as the surviving entity and a wholly owned subsidiary of the Company (the &#147;<U>First Merger</U>&#148;) and (ii)&nbsp;immediately following the First Merger, Innovex will merge with and into LLC Sub (the
&#147;<U>Second Merger</U>&#148; and, together with the First Merger, the &#147;<U>Mergers</U>&#148;), with LLC Sub surviving the Second Merger as a wholly owned subsidiary of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, in connection with the First Merger, each share of common stock of Innovex<B> </B>issued and outstanding as of immediately prior to
the Effective Time of the First Merger will be exchanged into the right to receive shares of Common Stock (as defined below) as set forth in the Merger Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, in connection with, and effective upon, the date of completion of the Mergers (the &#147;<U>Closing Date</U>&#148;), the parties
hereto desire to enter into this Agreement to govern certain of Amberjack&#146;s and the Principal Stockholders&#146; rights, duties and obligations with respect to its ownership of Common Stock after consummation of the Mergers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties to this Agreement hereby agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;1.1. Definitions. Capitalized terms used herein shall have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; shall mean, (i)&nbsp;with respect to any Person (other than Amberjack), an &#147;affiliate&#148; as defined in
Rule 405 of the regulations promulgated under the Securities Act, and (ii)&nbsp;with respect to Amberjack, an &#147;affiliate&#148; as defined in Rule 405 of the regulations promulgated under the Securities Act, and any investment fund, vehicle or
holding company of which Amberjack or an Affiliate of Amberjack serves as the general partner, managing member </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or discretionary manager or advisor. For purposes of this Agreement (i)&nbsp;the Company and its Subsidiaries shall not be Affiliates of Amberjack and (ii)&nbsp;Amberjack shall not be an
Affiliate of the Company or its Subsidiaries. For the avoidance of doubt (and without limitation as to any future Affiliates), each Person listed on <U>Schedule A</U> shall constitute an Affiliate of Amberjack for purposes of this Agreement as of
the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Agreement</U>&#148; shall have the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Amberjack Designee</U>&#148; shall mean any Director designated by Amberjack pursuant to <U>Section</U><U></U><U>&nbsp;2.1</U> of
this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Applicable Law</U>&#148; means any applicable statute, law, regulation, ordinance, rule, judgment, rule of law
(including common law), decree, permit, requirement, or other governmental restriction or any similar form of decision of, or any provision or condition issued under any of the foregoing by, or any determination by any Governmental Authority having
or asserting jurisdiction over the matter or matters in question, whether now or hereafter in effect and in each case as amended (including all of the terms and provisions of the common law of such Governmental Authority), as interpreted and
enforced at the time in question. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Applicable Stock Exchange</U>&#148; means the NYSE or such other stock exchange or such other
securities exchange or interdealer quotation system designated as the primary market on which the Common Stock is then listed or quoted for trading. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>beneficial owner</U>&#148; means, with respect to any security, any Person who directly or indirectly, through any contract,
arrangement, understanding, relationship or otherwise, has or shares (a)&nbsp;voting power, which includes the power to vote, or to direct the voting of, such security or (b)&nbsp;investment power, which includes the power to dispose, or to direct
the disposition of, such security. The terms &#147;<U>beneficially own</U>&#148; and &#147;<U>beneficial ownership</U>&#148; shall have correlative meanings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Board</U>&#148; shall mean the board of directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means Monday through Friday of each week, except that a legal holiday recognized as such by the government of
the United States of America or where federal banks are closed in the States of Delaware, Texas or New York shall not be regarded as a Business Day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Bylaws</U>&#148; shall mean the Amended and Restated Bylaws of the Company, as in effect on the date hereof and as the same may be
amended, supplemented or otherwise modified from time to time in accordance with the terms thereof, the terms of the Charter and the terms of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Opportunity</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.4</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>CEO Director</U>&#148; shall mean the person who is then serving as the Chief Executive Officer of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Charter</U>&#148; shall mean the Restated Certificate of Incorporation of the
Company, as in effect on the date hereof and as the same may be amended, supplemented or otherwise modified from time to time in accordance with the terms thereof and the terms of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing</U>&#148; shall mean the closing of the Mergers and the transactions contemplated by the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Date</U>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Common Stock</U>&#148; shall mean the common stock, par value $0.01 per share, of the Company and any securities issued in respect
thereof, or in substitution therefor, in connection with any stock split, dividend or combination, or any reclassification, recapitalization, merger, consolidation, exchange or other similar reorganization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company</U>&#148; shall have the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Competitor</U>&#148; shall mean (i)&nbsp;each Person listed on <U>Schedule B</U>, (ii)&nbsp;any successor (by merger or otherwise) to
any Person listed on <U>Schedule B</U> or a substantial portion of such Person&#146;s operations, assets or businesses or (iii)&nbsp;any subsequent successor to a successor specified in <U>clause (ii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>control</U>&#148; (including the terms &#147;<U>controlling</U>&#148;, &#147;<U>controlled by</U>&#148; and &#147;<U>under common
control with</U>&#148;), with respect to the relationship between or among two or more Persons, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the affairs or management of a Person, whether
through the ownership of voting securities, as trustee or executor, by contract or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Covered Person</U>&#148; means
(ii)&nbsp;any director of the Company or any of its Subsidiaries, or officer of the Company or any of its Subsidiaries (so long as such individual is not also an employee of the Company or any of its Subsidiaries) who is also a director, officer,
employee, managing director, equity holder, representative or Affiliate of Amberjack or any Principal Stockholder and (ii)&nbsp;Amberjack and each Principal Stockholder and any Affiliate of Amberjack or a Principal Stockholder (other than the
Company and its Subsidiaries). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>DGCL</U>&#148; mean the Delaware General Corporation Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Director</U>&#148; shall mean any member of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Effective Time</U>&#148; shall mean the effective time of the First Merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Equity Securities</U>&#148; shall mean any and all shares of (i)&nbsp;Common Stock, (ii)&nbsp;preferred stock of the Company, and
(iii)&nbsp;any equity securities (including, without limitation, preferred stock) of the Company convertible into, or exchangeable or exercisable for, any of the foregoing shares, and options, warrants or other rights to acquire any of the foregoing
shares or other securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Act</U>&#148; shall mean the Securities Exchange Act of 1934, as amended from time to time,
and the rules and regulations promulgated pursuant thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Governmental Authority</U>&#148; means any applicable multinational, foreign,
federal, state, local or other governmental statutory or administrative authority, regulatory body or commission, or any court, tribunal or judicial or arbitral authority which has any jurisdiction over a matter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Group</U>&#148; shall mean two or more Persons acting together, pursuant to any agreement, arrangement or understanding, for the
purpose of acquiring, holding, voting or disposing of securities as contemplated by Rule <FONT STYLE="white-space:nowrap">13d-5(b)</FONT> of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Guest Attendee</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.1(g)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Independent</U>&#148; means, with respect to members of the Board, &#147;independent&#148; within the meaning of the rules or listing
standards of the Applicable Stock Exchange and any applicable rules of the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>LLC Sub</U>&#148; shall have the meaning set
forth in the Recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period</U>&#148; means a period of 180 days from the
Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Mergers</U>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Merger Agreement</U>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Merger Sub</U>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>NYSE</U>&#148; shall mean the New York Stock Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Organizational Documents</U>&#148; shall mean the Charter and the Bylaws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Transfer</U>&#148; shall mean, with respect to any Stockholder, a Transfer in accordance with the terms hereof to any
Person that is (i)&nbsp;an Affiliate of such Stockholder, or (ii)&nbsp;a director, officer or employee of such Stockholder or any Affiliate of such Stockholder (or any subsequent Transfer in accordance with the terms hereof of such Stockholder
Shares by the transferee to another Permitted Transferee). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Transferee</U>&#148; shall mean any Person who acquires
Stockholder Shares pursuant to a Permitted Transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; shall mean any individual, corporation, partnership,
trust, joint stock company, business trust, unincorporated association, joint venture or other entity of any nature whatsoever. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Principal Stockholders</U>&#148; shall mean collectively, Intervale Capital Fund II, L.P., a Delaware limited partnership, Intervale
Capital Fund III, L.P., a Delaware limited partnership, Amberjack Capital Fund II, L.P., a Delaware limited partnership, Innovex <FONT STYLE="white-space:nowrap">Co-Invest</FONT> Fund, L.P., a Delaware limited partnership, Innovex <FONT
STYLE="white-space:nowrap">Co-Invest</FONT> Fund II, L.P., a Delaware limited partnership, Intervale Capital Fund <FONT STYLE="white-space:nowrap">II-A,</FONT> L.P., a Delaware limited partnership, and any of their respective Permitted Transferees.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Registration Rights Agreement</U>&#148; shall mean the Registration Rights
Agreement, dated as of September&nbsp;6, 2024, by and among the Company and the holders party thereto, as the same may be amended from time to time in accordance with its terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sales Process</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.1(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>SEC</U>&#148; shall mean the United States Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities Act</U>&#148; shall mean the Securities Act of 1933, as amended from time to time, and the rules and regulations
promulgated pursuant thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Standstill Level</U>&#148; means the greater of (i)&nbsp;a number of shares of Common Stock or any
other Voting Securities of the Company that provides ordinary voting power equivalent to that provided by 29,369,822 shares of Common Stock (as adjusted from time to time to reflect the effect of any stock split, reverse stock split, stock dividend,
reorganization, recapitalization, reclassification, combination, exchange of shares or other like change with respect to Common Stock or such other Voting Securities with a record date occurring on or after the date of this Agreement) and
(ii)&nbsp;a number of shares of Common Stock and other Voting Securities of the Company that provides 43% of the ordinary voting power of the outstanding Voting Securities of the Company as of the date of determination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Stockholder</U>&#148; or &#147;<U>Stockholders</U>&#148; shall mean Amberjack, its Permitted Transferees and the Principal
Stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Stockholder Shares</U>&#148; shall mean (i)&nbsp;all Voting Securities beneficially owned by the Stockholders on
the Closing Date or issued to the Principal Stockholders pursuant to the Merger Agreement and the First Merger, immediately after giving effect to the Closing and (ii)&nbsp;all Voting Securities issued to the Stockholders in respect of any such
securities or into which any such securities shall be converted or exchanged in connection with stock splits, reverse stock splits, stock dividends or distributions, combinations or any similar recapitalizations, reclassifications or capital
reorganizations occurring after the date of this Agreement. For the avoidance of doubt, Stockholder Shares shall include any of the foregoing Voting Securities specified in clause (i)&nbsp;or (ii) of the immediately preceding sentence that are
beneficially owned by a Permitted Transferee following the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary</U>&#148; shall mean, with respect to an
entity, (i)&nbsp;any corporation of which a majority of the securities entitled to vote generally in the election of directors thereof, at the time as of which any determination is being made, are owned by such entity, either directly or indirectly,
and (ii)&nbsp;any joint venture, general or limited partnership, limited liability company or other legal entity in which the entity is the record or beneficial owner, directly or indirectly, of a majority of the voting interests or the general
partner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transfer</U>&#148; shall mean, directly or indirectly, by operation of law, contract or otherwise, to sell, transfer,
assign, encumber, hypothecate or similarly dispose of, either voluntarily or involuntarily, or to enter into any contract, option or other arrangement or understanding with respect to the sale, transfer, assignment, encumbrance, hypothecation or
similar disposition of, any shares of Equity Securities beneficially owned by a Person or any interest in any shares of Equity Securities beneficially owned by a Person, including derivative or similar transactions or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
arrangements whereby the voting or economic interest therein are transferred to another Person; <U>provided</U>, <U>however</U>, that (i)&nbsp;the grant of a proxy to officers or directors of the
Company at the request of the Board or a committee thereof in connection with actions to be taken at a general or special meeting of stockholders shall not be considered a &#147;Transfer&#148; and (ii) &#147;Transfer&#148; shall be deemed to exclude
any assignment, transfer, sale, pledge, alienation, hypothecation or other disposition or encumbrance of equity securities in Amberjack or any Stockholder, <U>provided</U> that in the case of this clause (ii), such entity&#146;s principal asset is
not Equity Securities of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Voting Securities</U>&#148; shall mean any Equity Securities that are entitled to vote
generally in the election of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;1.2. <U>Construction</U>. Whenever the context requires, the gender of all words
used in this Agreement includes the masculine, feminine and neuter forms and the singular form of words shall include the plural and vice versa. All references to Articles and Sections refer to articles and sections of this Agreement. Whenever the
words &#147;include,&#148; &#147;includes&#148; or &#147;including&#148; are used in this Agreement, they shall be deemed to be followed by the words &#147;without limitation.&#148; This Agreement shall be construed without regard to any presumption
or rule requiring construction or interpretation against the party drafting or causing any instrument to be drafted. Any percentage set forth herein (or the number of shares used to calculate any percentage set forth herein) shall be deemed to be
automatically adjusted without any action on the part of any party hereto to take into account any stock split, stock dividend or similar transaction occurring after the date of this Agreement so that the rights provided to the Stockholders shall
continue to apply to the same extent such rights would have applied absent such stock split, stock dividend or similar transaction. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CORPORATE
GOVERNANCE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;2.1. <U>Board of Directors</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Amberjack Designees</U>. Following the Closing Date, Amberjack shall have the right, but not the obligation, to designate for
nomination by the Company to the Board a number of designees equal to: (i)&nbsp;four Directors, so long as the Stockholders collectively beneficially own 40% or more of the number of shares of Common Stock outstanding as of the Effective Time;
(ii)&nbsp;three Directors, in the event that the Stockholders collectively beneficially own less than 40% but at least 30% of the number of shares of Common Stock outstanding as of the Effective Time; (iii)&nbsp;two Directors in the event that the
Stockholders collectively beneficially own less than 30% but at least 20% of the number of shares of Common Stock outstanding as of the Effective Time; and (iv)&nbsp;one Director in the event that the Stockholders collectively beneficially own less
than 20% but at least 10% of the number of shares of Common Stock outstanding as of the Effective Time; <U>provided,</U> that as long as Amberjack has the right to nominate three or more Directors, (A)&nbsp;at least one of the Directors nominated
pursuant to this provision shall be Independent and (B)&nbsp;at least two of the Directors nominated pursuant to this provision shall not be employees or Affiliates of Amberjack. Amberjack shall permanently, and despite any later increase in their
beneficial ownership, no longer be entitled to designate a Director nominee at such time as the Stockholders collectively beneficially own Common Stock </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
representing less than 10% of the number of shares of Common Stock outstanding as of the Effective Time. For the avoidance of doubt, each Amberjack Designee, regardless of whether up for election
at the relevant meeting of stockholders, will be included in determining Amberjack&#146;s nomination rights under this Section<U></U><U>&nbsp;2.1(a)</U>. For purposes of this <U>Agreement</U>, the number of shares of Common Stock outstanding as of
the Effective Time assumes and gives effect to the issuance of all of the shares of Common Stock issuable pursuant to the First Merger in accordance with the terms of the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Necessary Action to Elect Amberjack Designees</U>. For so long as Amberjack has the right to designate at least one Amberjack Designee
to the Board of Directors, the Company agrees, to the fullest extent permitted by Applicable Law (including with respect to fiduciary duties under Delaware law), to take, or cause to be taken, all necessary action, and, if applicable, the
Stockholders agree to vote their respective shares, to cause the election of the CEO Director and each Amberjack Designee to the Board, which such necessary action shall include, without limitation, (i)&nbsp;nominating the CEO Director and each
Amberjack Designee to be elected as a director and included in the slate of nominees to be elected or appointed to the Board at the next (and each applicable subsequent) annual or special meeting of stockholders, (ii)&nbsp;including the CEO Director
and each of the Amberjack Designees in the proxy statement and on the proxy card, (iii)&nbsp;executing any necessary agreements and instruments, (iv)&nbsp;making or causing to be made, with any Governmental Authority, all filings, registrations or
similar actions that are required to achieve such results, and (v)&nbsp;without limiting the foregoing, otherwise using its best efforts to cause such nominees who are Amberjack Designees and the CEO Director to be elected to the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Board Composition</U>. The Board shall be divided into three classes of directors, with each class serving staggered three-year terms
in accordance with the Charter and, unless otherwise requested by Amberjack, each Amberjack Designee, if any, shall be assigned (or continue to be assigned) to the classes specified in the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Other Directors</U>. To the extent that Amberjack no longer has the right to nominate and designate for election such Amberjack
Designees, such Directors shall be nominated and elected in accordance with Applicable Law, the Company&#146;s Organizational Documents and its related guidelines and any corporate governance guidelines and the rules of the Applicable Stock
Exchange, as applicable and as then in effect. Upon such time as Amberjack is no longer entitled to nominate and designate for election to the Board an Amberjack Designee, Amberjack and the Principal Stockholders shall take all necessary action to,
at the request of either a majority of the Directors then in office who are not Amberjack Designees or the Chairman of the Nominating and Corporate Governance Committee (or equivalent), cause such individual to resign immediately or, if no such
request is made, such individual shall continue to serve until his or her successor is elected and appointed or until his or her earlier death, resignation, retirement, disqualification or removal. Following such resignation, the Directors remaining
in office shall be entitled, in their discretion, to decrease the size of the Board to eliminate such vacancy or to select a replacement Director to fill such vacancy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Nomination Procedures</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) With respect to any Director to be nominated and designated for election by Amberjack other than the initial Amberjack
Designees listed in the Merger Agreement, Amberjack shall nominate and designate an Amberjack Designee by delivering to the Company a written statement identifying such individual(s), which in the case of the Company&#146;s annual meeting must be
delivered no less than 90 days prior to the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the preceding annual meeting nominating and designating for election such Amberjack Designee or Amberjack Designees; <U>provided</U>, that if
Amberjack shall fail to deliver such written notice, Amberjack shall be deemed to have nominated and designated for election the Amberjack Designee(s) previously nominated and designated (or designated pursuant the Merger Agreement) who is/are
currently serving on the Board and are then up for election at the relevant meeting or action by written consent; <U>provided</U>, <U>further</U>, that such notice period shall not apply in the event Amberjack is required to select a substitute
individual under <U>Section</U><U></U><U>&nbsp;2.1(e)(iii)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Each Amberjack Designee, as a condition to his or her
initial nomination, appointment or election to the Board and any <FONT STYLE="white-space:nowrap">re-nomination</FONT> for election to the Board, must be willing to be interviewed by the nominating and corporate governance committee on the same
basis as any other new or returning, as applicable, candidate for appointment or election to the Board. Amberjack, in its capacity as a stockholder of the Company, and each Amberjack Designee, shall deliver such questionnaires and otherwise provide
such information as are reasonably requested by the Company in connection with assessing qualification, independence and other criteria applicable to Directors, or required to be provided by Directors, candidates for Director, and their Affiliates
and representatives for inclusion in a proxy statement or other filing required by Applicable Law and the rules of the Applicable Stock Exchange, in each case to the same extent requested or required of other candidates for appointment or election
to the Board. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) An individual nominated and designated by Amberjack for election (including pursuant to
<U>Section</U><U></U><U>&nbsp;2.1(e)(</U><U>i</U><U>)</U> and <U>Section</U><U></U><U>&nbsp;2.1(a)</U>) as a Director shall comply with Applicable Law. Notwithstanding anything to the contrary in this <U>Article II</U>, in the event that the Board
determines in good faith, after consultation with outside legal counsel, that the election of a particular Amberjack Designee pursuant to this <U>Section</U><U></U><U>&nbsp;2.1</U> would constitute a breach of its fiduciary duties to the
Company&#146;s stockholders or does not otherwise comply with Applicable Law (provided that any such determination with respect to any Amberjack Designee pursuant to this <U>Section</U><U></U><U>&nbsp;2.1</U> shall be made no later than fifteen days
after such individual&#146;s nomination and designation and in any event with reasonably sufficient time for Amberjack to nominate and designate a substitute individual for inclusion in the Company&#146;s proxy or other solicitation materials), the
Board shall inform Amberjack of such determination in writing and explain in reasonable detail the basis for such determination and Amberjack shall nominate and designate another individual for election to the Board (subject in each case to this
<U>Section</U><U></U><U>&nbsp;2.1(e)(iii)</U>), and the Board and the Company shall take all of the actions required by this <U>Article II</U> with respect to the election of such substitute </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
individual. It is hereby acknowledged and agreed that (A)&nbsp;the initial Amberjack Designees designated pursuant to the Merger Agreement&nbsp;would not constitute such a breach, comply with
such requirements and otherwise shall be deemed to have satisfied the conditions set forth in <U>Section</U><U></U><U>&nbsp;2.1(e)(ii)</U> and <U>Section</U><U></U><U>&nbsp;2.1(e)(iii)</U> and (B)&nbsp;the fact that a particular Amberjack Designee
is an Affiliate, director, professional, partner, member, manager, employee or agent of Amberjack, any Principal Stockholder or any Affiliate of Amberjack or any Principal Stockholder or is not Independent shall not in and of itself constitute an
acceptable basis for such determination by the Board; <U>provided</U>, that in the case of clause (B)&nbsp;above, such Amberjack Designee must still satisfy the conditions set forth in <U>Section</U><U></U><U>&nbsp;2.1(a)</U>,
<U>Section</U><U></U><U>&nbsp;2.1(e)(ii)</U> and <U>Section</U><U></U><U>&nbsp;2.1(e)(iii)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) In the absence of any
nomination and designation (or deemed nominated and designation) from Amberjack, the nominating and corporate governance committee, or the Board or such other committee of the Board as is fulfilling such function, shall nominate a candidate to
serve. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Compensation; No Employment</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Compensation of Directors</U>. The Company, Amberjack and each Principal Stockholder acknowledge and agree that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">a) each Director shall be reimbursed by the Company for his or her reasonable travel and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred in the performance of his or her duties as a Director, including attendance in person at meetings of the Board or the board of any Company Subsidiary (or any committees
thereof), pursuant to such policies as from time to time established by the Board. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">b) Nothing contained in this
<U>Section</U><U></U><U>&nbsp;2.1(f)</U> shall be construed to preclude any Director from serving the Company or any Company Subsidiary in any other capacity and receiving reasonable compensation for such services. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <U>No Right of Employment Conferred</U>. This Agreement does not, and is not intended to, confer upon any Director any
rights with respect to continued employment by the Company, and nothing herein should be construed to have created any employment agreement with any Director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Guest Attendee</U>. Until the end of the Standstill Period, Amberjack shall have the right to request that a representative of
Amberjack (a &#147;<U>Guest Attendee</U>&#148;) attend meetings of the Board (and any committee of which an Amberjack Designee is a member, to the extent consistent with Applicable Law) from time to time, subject to the approval of the Chairman of
the Board, and the Guest Attendee shall in such event be entitled to attend and observe and shall receive (at the same time as the Directors to the extent practicable) all notices, invitations, communications and other information pertaining to such
meetings (unless Amberjack notifies the Company in writing that such Guest Attendee has opted out of receiving such information); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<U>provided</U>, <U>however</U>, that such Guest Attendee shall not (i)&nbsp;participate in or vote on any discussions conducted at Board or applicable committee meetings, (ii)&nbsp;be counted
for purposes of determining whether a quorum is present at any meeting of the Board or any applicable committee and (iii)&nbsp;be entitled to any other rights or powers of directors under the Organizational Documents, the DGCL, Applicable Law or any
other agreement to which the Company is a party. Notwithstanding any of the foregoing, the Company shall not be obligated to provide such Guest Attendee with access to any information, materials or meetings (or portions thereof) if a majority of the
members of the Board who are not Amberjack Designees determine reasonably that the exclusion of such Guest Attendee is reasonably necessary to (A)&nbsp;preserve attorney-client privilege or (B)&nbsp;avoid a conflict of interest between the Company
and Amberjack or any of its Affiliates or breach of <FONT STYLE="white-space:nowrap">pre-existing</FONT> contractual or other legal obligations. Amberjack shall cause the Guest Attendee to (1)&nbsp;keep all information received pursuant to the
rights granted by this Agreement confidential and, at the Company&#146;s request, execute an attendee agreement and/or confidentiality agreement in the form reasonably acceptable to the Company and Amberjack and (2)&nbsp;not use such information in
any way or for any purpose other than to assist Amberjack in monitoring, evaluating and managing its investment in the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;2.2. <U>Permitted Disclosure</U>. Each Amberjack Designee is permitted to disclose to the Stockholders information that he or she
receives as a result of being a Director. Each of the Stockholders severally agrees that it will, and will cause its respective Affiliates to, keep confidential and not disclose, divulge or use for any purpose, other than to monitor and make voting
and investment decisions with respect to its investment in the Company and its Subsidiaries and to the extent necessary for the enforcement of any of its rights under this Agreement, any confidential information of the Company (including, for the
avoidance of doubt, confidential information obtained pursuant to this <U>Section</U><U></U><U>&nbsp;2.2</U> and <U>Section</U><U></U><U>&nbsp;2.3</U>), unless such confidential information is known or becomes known to the public in general (other
than as a result of a breach of this <U>Section</U><U></U><U>&nbsp;2.2</U> by the Stockholders or their respective Affiliates), is or has been independently developed or conceived by the Stockholders without use of, reliance on or reference to the
Company&#146;s confidential information or is or has been made known or disclosed to the Stockholders by a third party (other than an Amberjack Designee or an Affiliate of a Stockholder) without a breach of any obligation of confidentiality such
third party may have to the Company that is known to the Stockholders; <U>provided</U>, <U>however</U>, that the Stockholders may disclose confidential information (x)&nbsp;to its Affiliates, and its and their respective attorneys, accountants,
consultants, and other professionals to the extent necessary to obtain their services in connection with monitoring and making voting and investment decisions with respect to its or its Affiliate&#146;s investment in the Company or to any potential
transferees of Equity Securities (directly or indirectly, including a merger or other business combination) held by the Stockholders (provided such potential transferee has executed a confidentiality agreement with terms substantially similar to
this <U>Section</U><U></U><U>&nbsp;2.2</U>) or (y)&nbsp;as may otherwise be required by Applicable Law or legal, judicial or regulatory process, <U>provided</U> that the Stockholders shall take reasonable steps to minimize the extent of any required
disclosure described in this clause (y); and <U>provided</U>, <U>further</U>, that the acts and omissions of any Person to whom the Stockholders may disclose confidential information pursuant to clause (x)&nbsp;of the preceding proviso will be
attributable to the Stockholders for purposes of determining such Stockholder&#146;s compliance with this <U>Section</U><U></U><U>&nbsp;2.2</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;2.3. <U>Information Rights</U>. Until the end of the Standstill Period, the
Company shall provide Amberjack or its authorized representatives, at reasonable times and upon reasonable prior notice to the Company, with (i)&nbsp;reasonable access to the books and records of the Company or any of its material Subsidiaries and
(ii)&nbsp;the right to discuss the Company&#146;s or its material Subsidiaries&#146; affairs, finances and condition with its and their officers, subject in each case to the confidentiality obligations set forth in
<U>Section</U><U></U><U>&nbsp;2.2</U>. Notwithstanding any of the foregoing, the Company shall not be obligated to provide Amberjack with access to any information or materials (or portions thereof) if a majority of the members of the Board who are
not Amberjack Designees determine reasonably that the withholding of such information or materials (or portions thereof) is reasonably necessary to (A)&nbsp;preserve attorney-client privilege or (B)&nbsp;avoid a conflict of interest between the
Company and Amberjack or any of its Affiliates or breach of <FONT STYLE="white-space:nowrap">pre-existing</FONT> contractual or other legal obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;2.4. <U>Corporate Opportunity Waiver</U>. To the fullest extent permitted by the DGCL and subject to applicable legal
requirements and any express agreement that may from time to time be in effect after the date hereof, the Company agrees that the Covered Persons may, and shall have no duty not to, (i)&nbsp;invest in, carry on and conduct, whether directly, or as a
partner in any partnership, or as a joint venturer in any joint venture, or as an officer, director, stockholder, equityholder or investor in any Person, or as a participant in any syndicate, pool, trust or association, any business of any kind,
nature or description, whether or not such business is competitive with or in the same or similar lines of business as the Company or any of its Subsidiaries, (ii)&nbsp;do business with any client, customer, vendor or lessor of any of the Company or
its Affiliates, and/or (iii)&nbsp;make investments in any kind of property in which the Company or its Subsidiaries may make investments. To the fullest extent permitted by Section&nbsp;122(17) of the DGCL or any other Applicable Law in the event
that the applicable entity is not incorporated, formed or organized as a corporation in the State of Delaware, the Company (for itself and on behalf of each of its Subsidiaries and controlled Affiliates) hereby renounces any interest or expectancy
to participate in any business, business opportunity, transaction, investment or other matter (each, a &#147;<U>Business Opportunity</U>&#148;) of any Covered Person as currently conducted or as may be conducted in the future (or in which a Covered
Person engages or seeks to engage), and waives any claim against a Covered Person and shall indemnify a Covered Person against any claim that such Covered Person is liable to the Company or its stockholders for breach of any fiduciary duty or
otherwise solely by reason of such Person&#146;s participation in, or failure to offer or communicate to the Company, its Subsidiaries or any controlled Affiliates any information regarding, any such Business Opportunity. In the event that a Covered
Person acquires knowledge of a potential Business Opportunity which may constitute a corporate opportunity for both (x)&nbsp;the Covered Person and (y)&nbsp;the Company or any of its Subsidiaries or controlled Affiliates, the Covered Person shall
not have any duty to offer or communicate information regarding such corporate opportunity to the Company or any of its Subsidiaries or controlled Affiliates. To the fullest extent permitted by Section&nbsp;122(17) of the DGCL or any other
Applicable Law in the event that the applicable entity is not incorporated, formed or organized as a corporation in the State of Delaware, the Company (for itself and on behalf of each of its Subsidiaries and controlled Affiliates) hereby renounces
any interest or expectancy in any potential Business Opportunity of which the Covered Person acquires knowledge (or engages in or seeks to engage or with respect to which takes any of the actions specified in clause (A)&nbsp;or (B) below), except
for any corporate opportunity which is expressly offered in writing to such Covered Person solely in his or her capacity as a director or, if applicable, officer of the Company, and waives any claim against each Covered Person and shall indemnify a
Covered Person against any claim, that such Covered Person is liable to the Company or its stockholders </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(or any Subsidiary or controlled Affiliate) for breach of any fiduciary duty or otherwise solely by reason of the fact that such Covered Person (A)&nbsp;pursues or acquires any corporate
opportunity for its own account or the account of any Affiliate or other Person, (B)&nbsp;directs, recommends, sells, assigns or otherwise transfers such corporate opportunity to another Person or (C)&nbsp;does not communicate information regarding
such corporate opportunity or offer such corporate opportunity to the Company, its Subsidiaries or any controlled Affiliate. The Company shall pay in advance any expenses incurred in defense of such claim as provided in this provision, except to the
extent that a Covered Person is determined by a final, <FONT STYLE="white-space:nowrap">non-appealable</FONT> order of a Delaware court having competent jurisdiction (or any other judgment which is not appealed in the applicable time) to have
breached this <U>Section</U><U></U><U>&nbsp;2.4</U>, in which case any such advanced expenses shall be promptly reimbursed to the Company. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STANDSTILL;
VOTING </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.1. <U>Standstill Restrictions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) From and after the Closing Date until the date that Amberjack ceases to have the right to nominate any designees to the Board pursuant to
<U>Section</U><U></U><U>&nbsp;2.1</U> (the &#147;<U>Standstill</U><U> Period</U>&#148;), the Stockholders shall not, and the Stockholders shall cause each of their respective Affiliates not to, directly or indirectly, alone or in concert with any
other Person, except as expressly set forth in this <U>Section</U><U></U><U>&nbsp;3.1</U>: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) acquire, offer to acquire,
or agree to acquire, directly or indirectly (whether beneficially, constructively or synthetically through any derivative, hedging or trading position or otherwise) any shares of Common Stock or other Voting Securities, unless (A)&nbsp;as a result
of any stock split, stock dividend or distribution, subdivision, reorganization, reclassification, merger or similar capital transaction involving Equity Securities of the Company, (B)&nbsp;approved by Directors representing 80% of the entire Board
(rounded down to the nearest whole number) or (C)&nbsp;after such acquisition the beneficial or record ownership of shares of Common Stock or any other Voting Securities of the Company by the Stockholders does not exceed the Standstill Level;
<I>provided</I>&nbsp;that no Stockholder shall be in breach of this<U>&nbsp;Section 3.1(a)(</U><U>i</U><U>)</U> as a result of the acquisition by any Amberjack Designee of any Equity Securities of the Company pursuant to (x)&nbsp;the grant or
vesting of any equity compensation awards granted by the Company to any Amberjack Designee, or (y)&nbsp;the exercise of any stock options, restricted stock units, or similar awards relating to any Equity Securities of the Company granted by the
Company to any Amberjack Designee; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) make, or in any way participate in, directly or indirectly, any
&#147;solicitation&#148; of &#147;proxies&#148; (as such terms are used in the rules of the SEC promulgated under Section&nbsp;14 of the Exchange Act) to vote, or seek to advise or influence any Person with respect to the voting of, any Voting
Securities of the Company, in each case other than in a manner that is consistent with the Board&#146;s recommendation or Amberjack&#146;s nomination rights under this Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) deposit any Voting Securities into a voting trust or subject any
Voting Securities to any voting agreement, pooling arrangement or similar arrangement, form or join in a partnership, limited partnership, syndicate or other group (including a Group), with respect to Voting Securities or grant any proxy with
respect to any Voting Securities other than to a Person designated by the Board or by and among Amberjack, the Principal Stockholders and their Permitted Transferees; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) make any public announcement with respect to, or submit a proposal for, or otherwise act alone or in concert with others
to seek any change to management of the Company or the Board or propose, alone or in concert with others, any nominees for election to the Board other than pursuant to its rights under <U>Section</U><U></U><U>&nbsp;2.1(a)</U> or
<U>Section</U><U></U><U>&nbsp;2.1(e)</U>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) make any public announcement with respect to, or submit a proposal for, or
offer of (with or without conditions) or ask or request any other person to make such a proposal or offer of, or in any other way support, any merger, consolidation, business combination, tender or exchange offer, restructuring, recapitalization or
other extraordinary transaction of or involving the Company or any of its Subsidiaries or their securities or assets (unless such transaction is approved or affirmatively recommended by the Board); or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) take any action that would reasonably be expected to cause or require the Company to make a public announcement regarding
any actions prohibited by this <U>Section</U><U></U><U>&nbsp;3.1(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This <U>Section</U><U></U><U>&nbsp;3.1</U> shall not, in any
way, prevent, restrict, encumber or limit (i)&nbsp;the Stockholders from (A)&nbsp;if the Board has previously authorized or approved the solicitation by the Company of bids or indications of interest in the potential acquisition of the Company or
any of its assets or operations by auction or other sales process (each, a &#147;<U>Sales Process</U>&#148;), participating in such Sales Process in accordance with any procedures established by the Company therefor and, if selected as the
successful bidder by the Company, completing the acquisition contemplated thereby, <U>provided</U> that the Stockholders shall otherwise remain subject to the provisions of this <U>Section</U><U></U><U>&nbsp;3.1</U> in all respects during the
completion of the Sales Process, (B)&nbsp;engaging in confidential discussions with the Board or any of its members regarding any of the matters described in this <U>Section</U><U></U><U>&nbsp;3.1</U>, <U>provided</U> that the Stockholders will not
pursue (or except as permitted by clause (C)&nbsp;below publicly disclose the existence of such discussions regarding) any such matters, or (C)&nbsp;taking any action necessary to comply with any Applicable Law or any action required by any
Governmental Authority or any requirement of the Applicable Stock Exchange, (ii)&nbsp;any Amberjack Designee then serving as a Director from acting as a Director or exercising and performing his or her duties (fiduciary and otherwise) as a Director
in accordance with Applicable Law, the Company&#146;s Organizational Documents and its related guidelines and any corporate governance guidelines and the rules of the Applicable Stock Exchange, as applicable and as then in effect, or (iii)&nbsp;any
Transfer otherwise permitted by <U>Section</U><U></U><U>&nbsp;4.1</U>. Notwithstanding anything to the contrary herein, the Standstill Period shall terminate if (i)&nbsp;a third party commences a tender offer (within the meaning of Rule <FONT
STYLE="white-space:nowrap">14d-2</FONT> under the Exchange Act) for at least 50% of the outstanding capital stock of the Company or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
commences a proxy contest with respect to the election of any directors of the Company and either (A)&nbsp;the Board of Directors of the Company does not, within 10 business days after the
commencement of such offer or proxy contest, recommend against, as applicable, stockholders of the Company tendering their shares in such offer or voting for directors proposed in such proxy contest or (B)&nbsp;at the time of commencement of such
tender offer or proxy contest, there are fewer than three Amberjack Designees serving on the Board of Directors of the Company, or (ii)&nbsp;a third party enters into an agreement with the Company contemplating the acquisition (by way of merger,
tender offer or otherwise) of at least 50% of the outstanding capital stock of the Company or all or substantially all of the Company&#146;s assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.2. <U>Attendance at Meetings</U>. During the Standstill Period, the Stockholders shall cause all Voting Securities then owned
by the Stockholders to be present, in person or by proxy, at any meeting of the stockholders of the Company occurring at which an election of Directors is to be held, so that all such Voting Securities shall be counted for the purpose of determining
the presence of a quorum at such meeting. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TRANSFER RESTRICTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.1. <U>Transfer Restrictions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The right of the Stockholders to Transfer any Stockholder Shares is subject to the restrictions set forth in this <U>Article IV</U>. No
Transfer of Stockholder Shares by the Stockholders may be effected except in compliance with the restrictions set forth in this <U>Article IV</U> and with the requirements of the Securities Act and any other Applicable Laws. Any attempted Transfer
in violation of this Agreement shall be of no effect and null and void, regardless of whether the purported transferee has any actual or constructive knowledge of the Transfer restrictions set forth in this Agreement, and shall not be recorded on
the stock transfer books of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) During the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, the Stockholders shall
not Transfer any Stockholder Shares without the prior written consent of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Following the end of the <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Period the Stockholders may Transfer the Stockholder Shares, in whole at any time or in part from time to time, without the prior consent of the Company and without restriction; <U>provided</U>,
<U>however</U>, that in connection with any Transfer of Stockholder Shares that is effected (A)&nbsp;pursuant to a Registration Statement (as defined in the Registration Rights Agreement) or a privately-negotiated transaction not subject to the
registration requirements of the Securities Act, in each case in which the Stockholders (or any of their respective representatives) negotiate the terms of such Transfer directly with the third party purchaser (other than any underwriter, placement
agent or initial purchaser thereof) of such Stockholder Shares or (B)&nbsp;in accordance with Rule 144 under the Securities Act but not pursuant to the manner of sale provisions specified in Rule 144(f), in each case the Stockholder shall not
knowingly Transfer Stockholder Shares to any Person or Group (whether such Person or Group is purchasing Stockholder Shares for its or their own account(s) or as fiduciary on behalf of one or more accounts) who (x)&nbsp;is a Competitor or
(y)&nbsp;at the time of such Transfer is, or following such Transfer would become, a beneficial owner of Common Stock in excess of 5% of the voting power of the outstanding shares of Common Stock (provided, that the restrictions in clause
(y)&nbsp;shall only apply during the Standstill Period). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding anything to the contrary set forth in <U>Article III</U> or this
<U>Article IV</U>, the Stockholders may, at any time, (i)&nbsp;Transfer some or all of the Stockholder Shares pursuant to a Permitted Transfer; <U>provided</U> that, prior to any such Transfer, such Permitted Transferee executes and delivers to the
Company an Assignment and Assumption Agreement in the form attached hereto as <U>Exhibit A</U>; (ii)&nbsp;Transfer the Stockholder Shares, in whole or in part, to the Company or any Subsidiary of the Company, including pursuant to any redemption,
share repurchase program, self-tender offer or otherwise; (iii)&nbsp;Transfer the Stockholder Shares, in whole or in part, to a direct or indirect member or general or limited partner of such Stockholder pursuant to a distribution of Stockholder
Shares by such Stockholder; <U>provided</U> that, prior to any such Transfer during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, such direct or indirect member or general or limited partner of such Stockholder executes and delivers to
the Company an Assignment and Assumption Agreement in the form attached hereto as <U>Exhibit A</U>; or (iv)&nbsp;Transfer the Stockholder Shares, in whole or in part, pursuant to any (A)&nbsp;recapitalization, reclassification, consolidation,
merger, share exchange or other business combination transaction involving the Company, or (B)&nbsp;tender offer for all Voting Securities of a class that is commenced by any Person or Group. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.2. <U>Legends on Stockholder Shares; Securities Act Compliance</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each share certificate representing Stockholder Shares shall bear the following legends (and a comparable notation or other arrangement
will be made with respect to any uncertificated Stockholder Shares): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR
INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED. SUCH SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS THE ISSUER RECEIVES AN OPINION OF COUNSEL REASONABLY ACCEPTABLE
TO IT STATING THAT SUCH SALE OR TRANSFER IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF SAID ACT.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;THE SECURITIES
REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE PROVISIONS OF A STOCKHOLDERS&#146; AGREEMENT, DATED AS OF SEPTEMBER&nbsp;6, 2024, AMONG THE ISSUER AND THE OTHER PARTIES THERETO, A COPY OF WHICH MAY BE INSPECTED AT THE PRINCIPAL OFFICE OF THE
ISSUER OR OBTAINED FROM THE ISSUER WITHOUT CHARGE.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Stockholders agree that they will, if requested by the Company, deliver
at their expense to the Company an opinion of reputable U.S. counsel selected by the Stockholder and reasonably acceptable to the Company, in form and substance reasonably satisfactory to the Company and counsel for the Company, that any Transfer
made, other than in connection with an <FONT STYLE="white-space:nowrap">SEC-registered</FONT> offering by the Company or pursuant to Rule 144 under the Securities Act, does not require registration under the Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.1. <U>Termination</U>. Subject to the early termination of any provision as a result of an amendment to this Agreement agreed
to by the Board and the Stockholders as provided under <U>Section</U><U></U><U>&nbsp;5.2</U>, (i) the provisions of <U>Article II</U>, <U>Article III</U> and <U>Article IV</U> shall, with respect to each Stockholder, terminate as provided in the
applicable Section of <U>Article II</U>, <U>Article III</U> and <U>Article IV</U>, as the case may be, and (ii)&nbsp;this <U>Article V</U> shall not terminate. Nothing herein shall relieve any party from any liability for the breach of any of the
agreements set forth in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.2. <U>Amendments and Waivers</U>. Except as otherwise provided herein, no
modification, amendment, restatement, amendment and restatement, or waiver of any provision of this Agreement shall be effective without the approval of the Board, Amberjack and the Stockholders holding a majority of the Stockholder Shares;
<U>provided</U>, <U>however</U>, that any Stockholder may waive (in writing) the benefit of any provision of this Agreement with respect to itself for any purpose; <U>provided</U>, <U>further</U>, that any such modification, amendment, restatement,
amendment and restatement or waiver that would disproportionately and adversely affect the rights of any Stockholder hereunder (in its capacity as a Stockholder) without similarly affecting the rights hereunder of all Stockholders (in their
capacities as Stockholders) having the same rights or obligations under this Agreement to which such modification, amendment, restatement, amendment and restatement or waiver relates, as the case may be, shall not be effective as to such Stockholder
without such Stockholder&#146;s prior written consent. Any written amendment, restatement, amendment and restatement, or waiver to this Agreement that receives the vote or consent of the Stockholders provided herein need not be signed by all
Stockholders, but shall be effective in accordance with its terms and shall be binding upon all Stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.3.
<U>Successors, Assigns and Transferees</U>. This Agreement shall bind and inure to the benefit of and be enforceable by the parties hereto and their respective successors and permitted assigns. This Agreement may not be assigned without the express
prior written consent of the other parties hereto, and any attempted assignment, without such consents, will be null and void; <U>provided</U>, <U>however</U>, that the Stockholders shall be entitled to assign, in whole or in part, any of their
rights hereunder to any of their respective Permitted Transferees without such prior written consent; <U>provided</U> <U>further</U>, <U>however</U>, that any such assignment shall not relieve such transferring Stockholder from, and who shall remain
responsible for, any of its obligations hereunder (unless and to the extent actually performed in full by such Permitted Transferee). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.4. <U>Rights of Third Parties</U>. The rights of the Stockholders pursuant to this Agreement are personal to the Stockholders
and shall not be exercised by any Person. Except as may otherwise be expressly provided in this Agreement, this Agreement does not create any rights, claims or benefits inuring to any person that is not a party hereto nor create or establish any
third party beneficiary hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.5. <U>Notices</U>. All notices and other communications required or permitted
under this Agreement shall be in writing and shall be deemed effectively given: (a)&nbsp;when delivered personally by hand to the party to be notified (with written confirmation of receipt), (b) when sent by
<FONT STYLE="white-space:nowrap">e-mail</FONT> (with written confirmation of transmission or if no failure to deliver message is generated), (c) when received or rejected by the addressee if sent by registered or certified mail, postage prepaid,
return receipt requested, or (d)&nbsp;one Business Day following the day sent by reputable overnight courier (with written confirmation of receipt), in each case at the following addresses (or to such other address as a party may have specified by
notice given to the other party pursuant to this provision): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to the Company, to: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Innovex International, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">19120 Kenswick Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Humble,
Texas 77338 </P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="91%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Attention:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Adam Anderson</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Kendal Reed</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Email:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap">adam.anderson@innovex-inc.com</FONT></U></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap">kendal.reed@innovex-inc.com</FONT></U></P></TD></TR>
</TABLE></DIV> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to the Stockholders, to: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Amberjack Capital Partners, L.P. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">1021 Main Street, Suite 1100 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Houston, Texas 77002 </P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="91%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Attention:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">W. Patrick Connelly</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Melissa Rocco</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Will Donnell</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Email:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>patrick@amberjackcapital.com</U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>melissa@amberjackcapital.com</U></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U>will@amberjackcapital.com</U></P></TD></TR>
</TABLE></DIV> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">With copies (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Akin, Gump, Strauss, Hauer&nbsp;&amp; Feld LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">1111 Louisiana St., 44<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Houston, Texas 77002 </P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="91%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Email:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Matthew Kapinos</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">mkapinos@akingump.com</P></TD></TR>
</TABLE></DIV> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.6. <U>Further
Assurances</U>. At any time or from time to time after the date hereof, the parties agree to cooperate with each other, and at the request of any other party, to execute and deliver any further instruments or documents and to take all such further
action as the other party may reasonably request in order to evidence or effectuate the consummation of the transactions contemplated hereby and to otherwise carry out the intent of the parties hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.7. <U>Entire Agreement</U>. This Agreement sets forth the entire
understanding of the parties hereto with respect to the subject matter hereof. There are no agreements, representations, warranties, covenants or understandings with respect to the subject matter hereof or thereof other than those expressly set
forth herein and therein. This Agreement supersedes all other prior agreements and understandings between the parties with respect to such subject matter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.8. <U>Restrictions on Other Agreements; Bylaws</U>. To the fullest extent permitted by Applicable Law, the provisions of this
Agreement shall be controlling if any such provisions or the operation thereof conflict with the provisions of the Company&#146;s Bylaws. Each of the Stockholders covenants and agrees to vote their Equity Securities and to take any other action
reasonably requested by the Company or any other Stockholder to amend the Company&#146;s Bylaws so as to avoid any conflict with the provisions hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.9. <U>Delays or Omissions</U>. It is agreed that no delay or omission to exercise any right, power or remedy accruing to any
party, upon any breach, default or noncompliance by another party under this Agreement, shall impair any such right, power or remedy, nor shall it be construed to be a waiver of any such breach, default or noncompliance, or any acquiescence therein,
or of or in any similar breach, default or noncompliance thereafter occurring. It is further agreed that any waiver, permit, consent or approval of any kind or character on the part of any party hereto of any breach, default or noncompliance under
this Agreement or any waiver on such party&#146;s part of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement,
by law, or otherwise afforded to any party, shall be cumulative and not alternative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.10. <U>Governing Law; Jurisdiction;
Waiver of Jury Trial</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement and any dispute, controversy or claim arising out of or relating to this Agreement shall be
governed by, and construed and enforced in accordance with, the laws of the State of Delaware, applicable to contracts executed in and to be performed entirely within that State, without giving effect to principles or rules of conflict of laws that
would result in the application of the laws of a different jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In any judicial proceeding involving any dispute,
controversy or claim arising out of or relating to this Agreement, each of the parties unconditionally accepts the jurisdiction and venue of the Delaware Court of Chancery or, if the Delaware Court of Chancery does not have subject matter
jurisdiction over this matter, the Superior Court of the State of Delaware (Complex Commercial Division) or, if jurisdiction over the matter is vested exclusively in federal courts, the United States District Court for the District of Delaware, and
the appellate courts to which orders and judgments thereof may be appealed. In any such judicial proceeding, the parties agree that in addition to any method for the service of process permitted or required by such courts, to the fullest extent
permitted by Applicable Law, service of process may be made by delivery provided pursuant to the directions in <U>Section</U><U></U><U>&nbsp;5.5</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) EACH OF THE PARTIES HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW TRIAL BY JURY IN ANY JUDICIAL PROCEEDING INVOLVING ANY
DISPUTE, CONTROVERSY OR CLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.11. <U>Severability</U>. Whenever possible, each provision of this Agreement
shall be interpreted in such manner as to be effective and valid under Applicable Law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any Applicable Law in any jurisdiction, such
invalidity, illegality or unenforceability shall not affect any other provision or any other jurisdiction, but this Agreement shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had
never been contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.12. <U>Enforcement</U>. Each party hereto acknowledges that money damages would not be an
adequate remedy in the event that any of the covenants or agreements in this Agreement are not performed in accordance with its terms, and it is therefore agreed that in addition to and without limiting any other remedy or right it may have, the <FONT
STYLE="white-space:nowrap">non-breaching</FONT> party will have the right to an injunction, temporary restraining order or other equitable relief in any court of competent jurisdiction enjoining any such breach and enforcing specifically the terms
and provisions hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.13. <U>Titles and Subtitles</U>. The titles of the sections and subsections of this Agreement are
for convenience of reference only and are not to be considered in construing this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.14. <U>No Recourse</U>. This
Agreement may only be enforced against, and any claims or cause of action that may be based upon, arise out of or relate to this Agreement, or the negotiation, execution or performance of this Agreement, may be made only against the entities that
are expressly identified as parties hereto, and no past, present or future Affiliate, director, officer, employee, incorporator, member, manager, partner, stockholder, agent, attorney or representative of any party hereto shall have any liability
for any obligations or liabilities of the parties to this Agreement or for any claim based on, in respect of, or by reason of the transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.15. <U>Counterparts; Electronic Signatures</U>.<B> </B>This Agreement may be executed in any number of counterparts, each of
which shall be an original, but all of which together shall constitute one instrument. The words &#147;execution,&#148; &#147;signed,&#148; &#147;signature,&#148; &#147;delivery,&#148; and words of like import in or relating to this Agreement or any
document to be signed in connection with this Agreement shall be deemed to include electronic signatures, deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a
manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, and the parties hereto consent to conduct the transactions contemplated hereunder by electronic means. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.16. <U>Effectiveness</U>. This Agreement shall become effective at the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of Page Intentionally Left Blank; Signatures follow</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have executed this Stockholders&#146; Agreement as of
the date set forth in the first paragraph hereof. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INNOVEX INTERNATIONAL, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Anderson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Adam Anderson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to Innovex International, Inc. Stockholders&#146; Agreement] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>AMBERJACK CAPITAL PARTNERS, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Amberjack Management, LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ W. Patrick Connelly</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: W. Patrick Connelly</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INTERVALE CAPITAL FUND II, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Intervale Capital GP II, L.P., its general partner</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Intervale Capital Associates II, LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ W. Patrick Connelly</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: W. Patrick Connelly</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INTERVALE CAPITAL FUND <FONT STYLE="white-space:nowrap">II-A,</FONT> L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Intervale Capital GP II, L.P., its general partner</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Intervale Capital Associates II, LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ W. Patrick Connelly</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: W. Patrick Connelly</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INTERVALE CAPITAL FUND III, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Intervale Capital GP III, L.P., its general partner</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Intervale Capital Associates III, LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ W. Patrick Connelly</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: W. Patrick Connelly</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Partner</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to Innovex International, Inc. Stockholders&#146; Agreement] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>AMBERJACK CAPITAL FUND II, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Amberjack Capital GP II, L.P., its general</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">partner</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Amberjack Capital Associates II, LLC, its</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ W. Patrick Connelly</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: W. Patrick Connelly</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INNOVEX <FONT STYLE="white-space:nowrap">CO-INVEST</FONT> FUND, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Innovex <FONT STYLE="white-space:nowrap">Co-Invest</FONT> Fund GP, L.P., its general partner</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Innovex <FONT STYLE="white-space:nowrap">Co-Invest</FONT> Associates, LLC, its general</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ W. Patrick Connelly</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: W. Patrick Connelly</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INNOVEX <FONT STYLE="white-space:nowrap">CO-INVEST</FONT> FUND II, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Innovex <FONT STYLE="white-space:nowrap">Co-Invest</FONT> Fund II, GP, L.P., its general</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">partner</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Innovex <FONT STYLE="white-space:nowrap">Co-Invest</FONT> Associates, LLC, its general</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ W. Patrick Connelly</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: W. Patrick Connelly</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Partner</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to Innovex International, Inc. Stockholders&#146; Agreement] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><U>Exhibit A </U></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Assignment and Assumption Agreement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Stockholders&#146; Agreement, dated as of September&nbsp;6, 2024 (the &#147;<U>Stockholders&#146; Agreement</U>&#148;), among
Innovex International, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), Amberjack Capital Partners, L.P., a Delaware limited partnership, and the Principal Stockholders (as defined in the Stockholders&#146; Agreement), _________, (the
&#147;<U>Transferor</U>&#148;) hereby assigns to the undersigned the rights that may be assigned thereunder, and the undersigned hereby agrees that, having acquired Equity Securities as permitted by the terms of the Stockholders&#146; Agreement, the
undersigned hereby assumes and agrees to perform the covenants and obligations of the Transferor under the Stockholders&#146; Agreement. Capitalized terms used but not defined herein shall have the meanings assigned to them in the Stockholders&#146;
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Listed below is information regarding the Equity Securities: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Number of Shares of </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Common
Stock </U></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of Page Intentionally Left Blank</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Exhibit A &#150;
Assignment and Assumption Agreement </I></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned has executed this Assumption Agreement as of __________
___, ________. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">[NAME OF TRANSFEROR]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">[NAME OF TRANSFEREE]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Acknowledged by: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">INNOVEX
INTERNATIONAL, INC. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to Assignment and Assumption Agreement] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Certain Affiliates of Amberjack </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.
Intervale Capital Fund II, L.P., a Delaware limited partnership </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. Intervale Capital Fund III, L.P., a Delaware limited partnership </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. Amberjack Capital Fund II, L.P., a Delaware limited partnership </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. Innovex <FONT STYLE="white-space:nowrap">Co-Invest</FONT> Fund, L.P., a Delaware limited partnership </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. Innovex <FONT STYLE="white-space:nowrap">Co-Invest</FONT> Fund II, L.P., a Delaware limited partnership </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. Intervale Capital Fund <FONT STYLE="white-space:nowrap">II-A,</FONT> L.P., a Delaware limited partnership </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Competitors of the Company </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Baker Hughes
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Halliburton </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schlumberger (SLB), including OneSubsea </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Weatherford International </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TechnipFMC </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>6
<FILENAME>d802924dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>JOINDER AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS JOINDER AGREEMENT (this &#147;<U>Agreement</U>&#148;), dated as of September&nbsp;6, 2024 (the &#147;<U>Joinder Date</U>&#148;), is by
and among Tercel Oilfield Products USA L.L.C., a Texas limited liability company (&#147;<U>Tercel</U>&#148;), Pride Energy Services, LLC, a Texas limited liability company (&#147;<U>Pride</U>&#148;), <FONT STYLE="white-space:nowrap">Top-Co</FONT>
Inc., an Alberta corporation (&#147;<U><FONT STYLE="white-space:nowrap">Top-Co</FONT></U>&#148; and, together with Tercel and Pride, each an &#147;<U>Existing Borrower</U>&#148; and collectively, the &#147;<U>Existing Borrowers</U>&#148;), Innovex
Downhole Solutions, LLC, a Delaware limited liability company formerly known as DQ Merger Sub, LLC (&#147;<U>Merger Sub</U>&#148;), Innovex International, Inc., a Delaware corporation formerly known as Dril-Quip, Inc.
(&#147;<U>International</U>&#148;), and TIW Corporation, a Texas corporation (&#147;<U>TIW</U>&#148;, and together with Merger Sub and International, collectively the &#147;<U>New Borrowers</U>&#148; and each a &#147;<U>New Borrower</U>&#148;), the
financial institutions which are now or which hereafter become a party to the Credit Agreement (as defined below) (collectively, the &#147;<U>Lenders</U>&#148; and each individually, a &#147;<U>Lender</U>&#148;) and PNC BANK, NATIONAL ASSOCIATION
(&#147;<U>PNC</U>&#148;), as agent for the Lenders (PNC, together with its successors and assigns in such capacity, &#147;<U>Agent</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, Innovex Downhole Solutions, Inc., a Delaware corporation (&#147;<U>Innovex</U>&#148;), the Existing Borrowers, the Agent and
the Lenders are parties to that certain Second Amended and Restated Revolving Credit, Term Loan, Guaranty and Security Agreement, dated June&nbsp;10, 2022, as amended by that certain First Amendment to Second Amended and Restated Revolving Credit,
Term Loan, Guaranty and Security Agreement dated November&nbsp;28, 2022, that certain Second Amendment to Second Amended and Restated Revolving Credit, Term Loan, Guaranty and Security Agreement and Limited Waiver dated April&nbsp;3, 2023, that
certain Third Amendment to Second Amended and Restated Revolving Credit, Term Loan, Guaranty and Security Agreement and Limited Consent dated as of December&nbsp;15, 2023 and that certain Fourth Amendment to Second Amended and Restated Revolving
Credit, Term Loan, Guaranty and Security Agreement and Limited Waiver dated as of June&nbsp;28, 2024 (as may be further amended, amended and restated, joined, extended, supplemented or otherwise modified from time to time, the &#147;<U>Credit
Agreement</U>&#148;; capitalized terms used herein but not defined herein shall have the meanings ascribed to them in the Credit Agreement); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS, </B>prior to the consummation of the Dril-Quip Merger, Dril-Quip, Inc, a Delaware corporation, changed its name to Innovex
International, Inc., a Delaware corporation, pursuant to a Certificate of Amendment to the Restated Certificate of Incorporation filed with the Delaware Secretary of State; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, pursuant to the terms of the Dril-Quip Merger, Innovex has merged with and into DQ Merger Sub, LLC, a Delaware limited
liability company, with DQ Merger Sub, LLC, a Delaware limited liability company, as the surviving entity and a wholly owned subsidiary of International and DQ Merger Sub, LLC, a Delaware limited liability company, changed its name to Innovex
Downhole Solutions, LLC, a Delaware limited liability company pursuant to a Certificate of Merger filed with the Delaware Secretary of State; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, each of the New Borrowers desires to become a &#147;Borrower&#148; or &#147;Pledgor&#148;, as applicable, pursuant to the
terms of the Credit Agreement and each of the Other Documents specified on <U>Annex A</U> hereto (collectively, the &#147;<U>Other Specified Documents</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW THEREFORE</B>, the New Borrowers and the Existing Borrowers hereby agree, jointly and severally, with the Agent and Lenders as follows:
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. Each New Borrower hereby jointly and severally, as a &#147;Borrower&#148; or
&#147;Pledgor&#148;, as applicable, (i)&nbsp;joins in, becomes a party to, and agrees to comply with and be bound by the terms and conditions of the Credit Agreement and each Other Specified Document (including, without limitation, as a
&#147;Pledgor&#148; under that certain Second Amended and Restated Pledge Agreement, dated as of June&nbsp;10, 2022, by and between the Existing Borrowers and the Agent (the &#147;<U>Pledge Agreement</U>&#148;)) to the same extent as if each New
Borrower were an original signatory to the Credit Agreement and such Other Specified Documents (and as if the Credit Agreement and Other Specified Documents were executed and delivered on the Joinder Date), as applicable, with all of the rights,
obligations, liabilities and duties of a &#147;Borrower&#148; or &#147;Pledgor&#148;, as applicable, under the Credit Agreement and the Other Specified Documents to which the New Borrowers are a party; (ii)&nbsp;makes on and as of the Joinder Date
all of the representations and warranties set forth in the Credit Agreement and such Other Specified Documents; (iii)&nbsp;grants, assigns and pledges to Agent, for the benefit of itself and the Lenders, pursuant to the terms and provisions of
Section&nbsp;4 of the Credit Agreement, a continuing security interest in and Lien on all of its Collateral, free and clear of all Liens (other than Permitted Encumbrances); (iv) grants to Agent, for the benefit of itself and the Lenders, pursuant
to the terms and provisions of Section&nbsp;1 of the Pledge Agreement, a continuing security interest in and Lien on all of its &#147;Collateral&#148; (as defined therein), free and clear of all Liens (other than the Permitted Encumbrances);<SUP
STYLE="font-size:75%; vertical-align:top"> </SUP>and (v)&nbsp;agrees that it is a direct obligor (and not a surety) under the Credit Agreement and the Other Specified Documents to which such New Borrower is a party. Without limiting the foregoing,
each New Borrower agrees that it shall be jointly and severally liable with the Existing Borrowers for all liabilities and obligations, regardless of when they first arose under the Credit Agreement or any such Other Specified Document, and each New
Borrower acknowledges and confirms that it has received a copy of the Credit Agreement, including the exhibits, schedules and other attachments thereto, and each Other Specified Document. For the avoidance of doubt, each New Borrower shall not be
joined to (or become a party to or agree to comply with or be bound by) any Canadian Transaction Document. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. The Schedules to the Credit
Agreement are amended and restated and replaced in their entirety as set forth on the attached <U>Exhibit A</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. Existing Borrowers
acknowledge and confirm (i)&nbsp;the joinder by New Borrowers to the Credit Agreement and the Other Specified Documents, (ii)&nbsp;that all of their respective obligations under the Credit Agreement and the Other Documents are, and, upon the New
Borrowers becoming a &#147;Borrower&#148; or &#147;Pledgor&#148;, as applicable, under the Credit Agreement or otherwise becoming party to any Other Specified Document pursuant to the terms hereof, shall continue to be, in full force and effect,
(iii)&nbsp;that the execution of this Agreement shall in no manner vitiate, impair or affect the Liens and security interests created and evidenced by the Credit Agreement and the Other Documents in effect as of the date of the Credit Agreement or
otherwise created prior to the date hereof, (iv)&nbsp;that as of the date hereof, the term &#147;Obligations,&#148; as used in the Credit Agreement, shall include all Obligations of the New Borrowers under the Credit Agreement and each Other
Specified Document, (v)&nbsp;each and every term and condition set forth in the Credit Agreement and the Other Specified Documents effective as of the date hereof and (vi)&nbsp;that upon and after the effectiveness of this Agreement, (a)&nbsp;each
reference in the Credit Agreement to &#147;this Agreement&#148;, &#147;hereunder&#148;, &#147;herein&#148;, &#147;hereof&#148; or words of like import referring to the Credit Agreement, and each reference in the Other Documents to &#147;the Credit
Agreement&#148;, &#147;thereunder&#148;, &#147;therein&#148;, &#147;thereof&#148; or words of like import referring to the Credit Agreement, shall mean and be a reference to the Credit Agreement as supplemented hereby; and (b)&nbsp;each reference in
any Other Specified Document to &#147;this Agreement&#148;, &#147;hereunder&#148;, &#147;herein&#148;, &#147;hereof&#148; or words </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of like import referring to such Other Specified Document, and each reference in the Credit Agreement or any Other Document to any Other Specified Document, &#147;thereunder&#148;,
&#147;therein&#148;, &#147;thereof&#148; or words of like import referring to such Other Specified Document, shall mean and be a reference to such Other Specified Document as supplemented hereby. This Agreement shall be an Other Document for all
purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">D. In furtherance of the foregoing, each New Borrower shall deliver to Agent on the date hereof, in form and substance
reasonably satisfactory to Agent and its legal counsel, (i)&nbsp;a certificate certified by an Authorized Officer of the applicable New Borrower dated as of the date hereof including, as applicable, (A)&nbsp;its certificate of formation, operating
agreement or other organizational documents, (B)&nbsp;the names of its officers, directors or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> that are authorized to sign this Agreement and the Other
Documents to which the applicable New Borrower is or will be a party to, together with specimen signatures and/or powers of attorney, as applicable, of such officers, directors or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact,</FONT></FONT> (C)&nbsp;evidence that the applicable New Borrower&#146;s applicable governing body has duly adopted resolutions which authorize the execution,
delivery and performance by the applicable New Borrower of this Agreement, the Credit Agreement and any Other Document to which it is or will be a party and (D)&nbsp;certificates of good standing (or equivalent documents) issued by the State of
Texas or Delaware, as applicable, as of a recent date, and (ii)&nbsp;such other documentation as Agent may reasonably request, including, without limitation, any legal opinions or Other Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">E. The New Borrowers and Existing Borrowers shall satisfy each of the following post-closing covenants, in each case by no later than the date
set forth below (or such later day as agreed to by Agent in its sole discretion): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) On or before five (5)&nbsp;Business
Days after the Joinder Date, New Borrowers and Existing Borrowers shall deliver to the Agent (i)&nbsp;the original stock certificate no. 22 with respect to the Equity Interests of TIW Corporation, together with the original related undated stock
power executed in blank and (ii)&nbsp;the original stock certificate with respect to the Equity Interests of Dril-Quip International LLC, together with the original related undated stock power executed in blank. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) On or before ten (10)&nbsp;days after the Joinder Date, New Borrowers shall deliver to the Agent all insurance
certificates in respect of the insurance policies of New Borrowers required to be delivered pursuant to Section&nbsp;6.6 of the Credit Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) On or before thirty (30)&nbsp;days after the Joinder Date, New Borrowers shall deliver to the Agent all insurance
endorsements in respect of the insurance policies of New Borrowers required to be delivered pursuant to Section&nbsp;6.6 of the Credit Agreement, including additional insured endorsements, lenders loss payable endorsements and notice of cancellation
endorsements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) On or before thirty (30)&nbsp;days after the Joinder Date, New Borrowers and Existing Borrowers shall
provide evidence to Agent that New Borrowers and Existing Borrowers and their respective Subsidiaries have filed all appropriate assignments or name changes, as applicable, to the applicable New Borrower or Existing Borrower or Subsidiary with the
United States Patent and Trademark Office with respect to all registered Intellectual Property. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) On or before forty-five (45)&nbsp;days after the Joinder Date, the
applicable New Borrowers and Existing Borrowers shall deliver a duly executed Intellectual Property Security Agreement with respect to the Intellectual Property subject to clause (iv)&nbsp;of this paragraph E to be properly filed with the United
States Patent and Trademark Office. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) On or before sixty-five (65)&nbsp;days after the Joinder Date, New Borrowers and
Existing Borrowers shall have delivered to Agent either (i)&nbsp;evidence that New Borrowers have closed all existing accounts listed on Schedule 4.8(j) other than accounts maintained with PNC or (ii)&nbsp;deposit account control agreements for the
existing accounts of New Borrowers listed on Schedule 4.8(j), other than accounts constituting Excluded Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">F. This Agreement may
be executed in one or more counterparts (which taken together, as applicable, shall constitute one and the same instrument) and by facsimile or other electronic transmission, which signatures shall be considered original executed counterparts. Each
party to this Agreement agrees that it will be bound by its own signature and that it accepts the signature of each other party, in each case as executed by electronic transmission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">G. THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER, SHALL BE CONSTRUED IN ACCORDANCE WITH AND BE GOVERNED BY THE LAWS
OF THE STATE OF NEW YORK. THE TERMS OF SECTION 12.3 AND 17.1 OF THE CREDIT AGREEMENT WITH RESPECT TO WAIVER OF JURY TRIAL, SUBMISSION TO JURISDICTION AND VENUE ARE INCORPORATED HEREIN BY REFERENCE, <I>MUTATIS MUTANDIS</I>, AND THE PARTIES HERETO
AGREE TO SUCH TERMS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[The remainder of this page has been intentionally left blank; signature pages follow.] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the Existing Borrowers, the New Borrowers and the Agent have
caused this Agreement to be duly executed and delivered by its authorized officer as of the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">EXISTING BORROWERS:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>TERCEL OILFIELD PRODUCTS USA L.L.C.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Anderson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Adam Anderson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><FONT STYLE="white-space:nowrap">TOP-CO</FONT> INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Anderson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Adam Anderson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>PRIDE ENERGY SERVICES, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Anderson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Adam Anderson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Joinder Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">NEW BORROWERS:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INNOVEX DOWNHOLE SOLUTIONS, LLC (FORMERLY KNOWN AS DQ MERGER SUB, LLC)</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Anderson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Adam Anderson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INNOVEX INTERNATIONAL, INC. </B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>(FORMERLY KNOWN AS DRIL-QUIP, INC.)</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Anderson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Adam Anderson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>TIW CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Anderson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Adam Anderson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Joinder Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AGENT: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PNC BANK, NATIONAL ASSOCIATION </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ron Zeiber</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Ron Zeiber</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Senior Vice President</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Joinder Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ANNEX A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Other Specified Documents </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Fourth Amended and Restated Revolving Credit Note, dated as of April&nbsp;3, 2023, executed by Innovex and
the Existing Borrowers in favor of PNC </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Amended and Restated Revolving Credit Note, dated as of April&nbsp;3, 2023, executed by Innovex and the
Existing Borrowers in favor of U.S. Bank National Association </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Third Amended and Restated Term Note, dated as of June&nbsp;10, 2022, executed by Innovex, Tercel, and <FONT
STYLE="white-space:nowrap">Top-Co</FONT> in favor of PNC </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Term Note, dated as of June&nbsp;10, 2022, executed by Innovex, Tercel, and
<FONT STYLE="white-space:nowrap">Top-Co</FONT> in favor of U.S. Bank National Association </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Second Amended and Restated Swing Loan Note, dated as of April&nbsp;3, 2023, executed by Innovex and the
Existing Borrowers in favor of PNC </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Third Amended and Restated Pledge Agreement, dated as of September&nbsp;6, 2024, among the Existing
Borrowers and the New Borrowers. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Second Amended and Restated Fee Letter, dated as of May&nbsp;9, 2022, among the Innovex, Tercel, and <FONT
STYLE="white-space:nowrap">Top-Co,</FONT> Agent and PNC Capital Markets LLC </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Second Amended and Restated Trademark and Patent Security Agreement, dated as June&nbsp;10, 2022, executed
by the Existing Borrowers in favor of the Agent </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Fee Letter, dated as of June&nbsp;28, 2024, among the Existing Borrowers and PNC </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Amended and Restated Schedules to Credit Agreement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Intentionally Omitted. </I></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>7
<FILENAME>d802924dex107.htm
<DESCRIPTION>EX-10.7
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.7</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.7 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF INDEMNIFICATION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS INDEMNIFICATION AGREEMENT (this &#147;<B><I>Agreement</I></B>&#148;) is made and entered into as of September&nbsp;6, 2024, by and
between Innovex International, Inc., a Delaware corporation (the&nbsp;&#147;<B><I>Company</I></B>&#148;), and [________] (&#147;<B><I>Indemnitee</I></B>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WITNESSETH THAT: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, highly competent persons have become more reluctant to serve corporations as directors, officers or in other capacities unless they
are provided with adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions against them arising out of their service to and activities on behalf of the corporation; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board of Directors of the Company (the&nbsp;&#147;<B><I>Board</I></B>&#148;) has determined that, in order to attract and retain
qualified individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its subsidiaries from certain liabilities. Although the furnishing of such insurance
has been a customary and widespread practice among United States-based corporations and other business enterprises, the Company believes that, given current market conditions and trends, such insurance may be available to it in the future only at
higher premiums and with more exclusions. At the same time, directors, officers and other persons in service to corporations or business enterprises are being increasingly subjected to expensive and time-consuming litigation relating to, among other
things, matters that traditionally would have been brought only against the corporation or business enterprise itself. The Amended and Restated Bylaws of the Company (as amended and/or restated from time to time,
the&nbsp;&#147;<B><I>Bylaws</I></B>&#148;) require indemnification of the officers and directors of the Company. Indemnitee may also be entitled to indemnification pursuant to the General Corporation Law of the State of Delaware (the
&#147;<B><I>DGCL</I></B>&#148;). The Bylaws and the DGCL expressly provide that the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts may be entered into between the Company and members of the
Board, officers and other persons with respect to indemnification; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the uncertainties relating to such insurance and to
indemnification have increased the difficulty of attracting and retaining such persons; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board has determined that the
increased difficulty in attracting and retaining such persons is detrimental to the best interests of the Company&#146;s stockholders and that the Company should act to assure such persons that there will be increased certainty of such protection in
the future; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, and to
advance expenses on behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company free from undue concern that they will not be so indemnified; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, this Agreement is a supplement to and in furtherance of the Bylaws and any resolutions adopted pursuant thereto, and shall not be
deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Indemnitee does not regard the protection available under the Bylaws and insurance
as adequate in the present circumstances, and may not be willing to serve as an officer or director without adequate protection, and the Company desires Indemnitee to serve in such capacity; and Indemnitee is willing to serve, continue to serve and
to take on additional service for or on behalf of the Company on the condition that Indemnitee be so indemnified; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, this
Agreement supersedes all prior indemnification agreements between the Company and Indemnitee, and each such prior indemnification agreement is hereby terminated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of Indemnitee&#146;s agreement to serve or continue to serve as an officer or director of the Company and in
any other capacity with respect to the Company as the Company may request, as the case may be, from and after the date hereof, the parties hereto agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1. <U>Services by the Indemnitee</U>. Indemnitee shall serve or continue to serve as a director or officer of the Company faithfully and to
the best of Indemnitee&#146;s ability so long as Indemnitee is duly elected or appointed. Indemnitee may at any time and for any reason resign from such position (subject to any other contractual obligation or any obligation imposed by operation of
law), in which event the Company will have no obligation under this Agreement to continue Indemnitee in such position. This Agreement will not be construed as giving Indemnitee any right to be retained in such position or in the employ of the
Company (or any other Enterprise (as hereinafter defined)) generally. By entering into this Agreement, Indemnitee is deemed to be serving at the request of the Company, and the Company is deemed to be requesting such service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2. <U>Indemnification</U>. The Company hereby agrees to indemnify and hold harmless Indemnitee to the fullest extent permitted by law, as such
may be amended from time to time. For purposes of this Agreement, the meaning of the phrase &#147;<B><I>to the fullest extent permitted by law</I></B>&#148; will include to the fullest extent permitted by Section&nbsp;145 of the DGCL or any
amendments to or replacements of the DGCL that increase the extent to which a corporation may indemnify or provide advancement to its officers and directors. In furtherance of the foregoing indemnification, and without limiting the generality
thereof: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Proceedings Other than Proceedings by or in the Right of the Company</U>. Indemnitee shall be entitled to the rights of
indemnification provided in this <U>Section</U><U></U><U>&nbsp;2(a)</U> if, by reason of such Indemnitee&#146;s Corporate Status (as hereinafter defined), the Indemnitee was, is, or is threatened to be made, a party to or participant in any
Proceeding (as hereinafter defined) other than a Proceeding by or in the right of the Company and/or its subsidiaries. Pursuant to this <U>Section</U><U></U><U>&nbsp;2(a)</U>, Indemnitee shall be indemnified against all Expenses (as hereinafter
defined), judgments, penalties, fines and amounts paid in settlement actually and reasonably incurred by Indemnitee in connection with such Proceeding or any claim, issue or matter therein, if the Indemnitee acted in good faith and in a manner the
Indemnitee reasonably believed to be in or not opposed to the best interests of the Company, and with respect to any criminal Proceeding, had no reasonable cause to believe the Indemnitee&#146;s conduct was unlawful. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Proceedings by or in the Right of the Company</U>. Indemnitee shall be entitled to
the rights of indemnification provided in this <U>Section</U><U></U><U>&nbsp;2(b)</U> if, by reason of such Indemnitee&#146;s Corporate Status, the Indemnitee was, is, or is threatened to be made, a party to or participant in any Proceeding brought
by or in the right of the Company and/or its subsidiaries. Pursuant to this <U>Section</U><U></U><U>&nbsp;2(b)</U>, Indemnitee shall be indemnified against all Expenses actually and reasonably incurred by the Indemnitee, or on the Indemnitee&#146;s
behalf, in connection with such Proceeding if the Indemnitee acted in good faith and in a manner the Indemnitee reasonably believed to be in or not opposed to the best interests of the Company; provided, however, if applicable law so provides, no
indemnification against such Expenses shall be made in respect of any claim, issue or matter in such Proceeding as to which Indemnitee shall have been adjudged to be liable to the Company unless and to the extent that the Court of Chancery of the
State of Delaware (the &#147;<B><I>Delaware Court</I></B>&#148;) or the court in which such Proceeding was brought shall determine that such indemnification may be made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Indemnification for Expenses of a Party Who is Wholly or Partly Successful</U>. Notwithstanding any other provision of this Agreement,
to the extent that Indemnitee is, by reason of such Indemnitee&#146;s Corporate Status, a party to and is successful, on the merits or otherwise, in any Proceeding, Indemnitee shall be indemnified to the maximum extent permitted by law, as such may
be amended from time to time, against all Expenses actually and reasonably incurred by Indemnitee or on such Indemnitee&#146;s behalf in connection therewith. If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits
or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on such Indemnitee&#146;s behalf in
connection with each successfully resolved claim, issue or matter. For purposes of this <U>Section</U><U></U><U>&nbsp;2(c)</U> and without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without
prejudice, shall be deemed to be a successful result as to such claim, issue or matter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3. <U>Additional Indemnity</U>. In addition to,
and without regard to any limitations on, the indemnification provided for in <U>Section</U><U></U><U>&nbsp;2</U> hereof, the Company shall and hereby does indemnify and hold harmless Indemnitee against all Expenses, judgments, penalties, fines and
amounts paid in settlement actually and reasonably incurred by Indemnitee or on such Indemnitee&#146;s behalf if, by reason of Indemnitee&#146;s Corporate Status, Indemnitee is, or is threatened to be made, a party to or participant in any
Proceeding (including a Proceeding by or in the right of the Company), including, without limitation, all liability arising out of the negligence or active or passive wrongdoing of Indemnitee. The only limitation that shall exist upon the
Company&#146;s obligations pursuant to this Agreement shall be that the Company shall not be obligated to make any payment to Indemnitee that is finally determined (under the procedures, and subject to the presumptions, set forth in
<U>Sections</U><U></U><U>&nbsp;7</U> and <U>8</U> hereof) to be unlawful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4. <U>Contribution</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Whether or not the indemnification provided in <U>Sections</U><U></U><U>&nbsp;2</U> and <U>3</U> hereof is available, in respect of any
threatened, pending or completed Proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such Proceeding), the Company shall pay, in the first instance, the entire amount of any judgment or settlement of such
Proceeding without requiring Indemnitee to contribute to such payment and the Company hereby waives and relinquishes any right of contribution it may have against Indemnitee. The Company shall not enter into any settlement of any Proceeding in which
the Company is jointly liable with Indemnitee (or would be if joined in such Proceeding) unless such settlement provides for a full and final release of all claims asserted against Indemnitee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Without diminishing or impairing the obligations of the Company set forth in the
preceding subparagraph, if, for any reason, Indemnitee shall elect or be required to pay all or any portion of any judgment or settlement in any threatened, pending or completed Proceeding in which the Company is jointly liable with Indemnitee (or
would be if joined in such Proceeding), the Company shall contribute to the amount of Expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred and paid or payable by Indemnitee in proportion to the relative benefits
received by the Company and all officers, directors or employees of the Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such Proceeding), on the one hand, and Indemnitee, on the other hand, from the
transaction or events from which such Proceeding arose; provided, however, that the proportion determined on the basis of relative benefit may, to the extent necessary to conform to law, be further adjusted by reference to the relative fault of the
Company and all officers, directors or employees of the Company other than Indemnitee who are jointly liable with Indemnitee (or would be if joined in such Proceeding), on the one hand, and Indemnitee, on the other hand, in connection with the
transaction or events that resulted in such expenses, judgments, fines or settlement amounts, as well as any other equitable considerations which applicable law may require to be considered. The relative fault of the Company and all officers,
directors or employees of the Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such Proceeding), on the one hand, and Indemnitee, on the other hand, shall be determined by reference to, among other
things, the degree to which their actions were motivated by intent to gain personal profit or advantage, the degree to which their liability is primary or secondary and the degree to which their conduct is active or passive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) The Company hereby agrees to fully indemnify and hold Indemnitee harmless from any claims of contribution which may be brought by
officers, directors or employees of the Company, other than Indemnitee, who may be jointly liable with Indemnitee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) To the fullest
extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by
Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed
fair and reasonable in light of all of the circumstances of such Proceeding in order to reflect (i)&nbsp;the relative benefits received by the Company and Indemnitee as a result of the event(s) and/or transaction(s) giving cause to such Proceeding,
and/or (ii)&nbsp;the relative fault of the Company (and its directors, officers, employees and agents) and Indemnitee in connection with such event(s) and/or transaction(s). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5. <U>Indemnification for Expenses of a Witness</U>. Notwithstanding any other provision of this Agreement, to the maximum extent permitted by
the DGCL, to the extent that Indemnitee is, by reason of such Indemnitee&#146;s Corporate Status, a witness or otherwise incurs legal expenses in any Proceeding to which Indemnitee is not, nor is threatened to be made, a party, Indemnitee shall be
entitled to indemnification against all Expenses actually and reasonably incurred by Indemnitee or on such Indemnitee&#146;s behalf in connection therewith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6. <U>Advancement of Expenses</U>. Notwithstanding any other provision of this Agreement,
the Company shall advance all Expenses incurred by or on behalf of Indemnitee in connection with any Proceeding by reason of Indemnitee&#146;s Corporate Status within 30 days after the receipt by the Company of a statement or statements from
Indemnitee requesting such advance or advances from time to time, whether prior to or after final disposition of such Proceeding. Such statement or statements shall reasonably evidence the Expenses incurred by Indemnitee. The Indemnitee shall
qualify for advances upon the execution and delivery to the Company of this Agreement, which shall constitute an undertaking by Indemnitee to repay any Expenses advanced if it shall ultimately be determined that Indemnitee is not entitled to be
indemnified against such Expenses. Any advances and undertakings to repay pursuant to this <U>Section</U><U></U><U>&nbsp;6</U> shall be unsecured and interest free. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7. <U>Procedures and Presumptions for Determination of Entitlement to Indemnification</U>. It is the intent of this Agreement to secure for
Indemnitee rights of indemnity that are as favorable as may be permitted under the DGCL and public policy of the State of Delaware. Accordingly, the parties agree that the following procedures and presumptions shall apply in the event of any
question as to whether Indemnitee is entitled to indemnification under this Agreement: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) To obtain indemnification under this
Agreement, Indemnitee shall submit to the Company a written request, including therein or therewith such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent
Indemnitee is entitled to indemnification. The Secretary of the Company shall, promptly upon receipt of such a request for indemnification, advise the Board in writing that Indemnitee has requested indemnification. Notwithstanding the foregoing, any
failure of Indemnitee to provide such a request to the Company, or to provide such a request in a timely fashion, shall not relieve the Company of any liability that it may have to Indemnitee unless, and to the extent that, such failure actually and
materially prejudices the interests of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Upon written request by Indemnitee for indemnification pursuant to the first
sentence of <U>Section</U><U></U><U>&nbsp;7(a)</U> hereof, a determination with respect to Indemnitee&#146;s entitlement thereto shall be made in the specific case by one of the following four methods, which shall be at the election of the Board:
(1)&nbsp;by a majority vote of the Disinterested Directors (as hereinafter defined), even though less than a quorum, (2)&nbsp;by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less
than a quorum, (3)&nbsp;if there are no Disinterested Directors or if the Disinterested Directors so direct, by Independent Counsel (as hereinafter defined) in a written opinion to the Board, a copy of which shall be delivered to the Indemnitee or
(4)&nbsp;if so directed by the Board, by the stockholders of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) If the determination of entitlement to indemnification is
to be made by Independent Counsel pursuant to <U>Section</U><U></U><U>&nbsp;7(b)</U> hereof, the Independent Counsel shall be selected as provided in this <U>Section</U><U></U><U>&nbsp;7(c)</U>. The Independent Counsel shall be selected by the
Board. Indemnitee may, within 10 days after such written notice of selection shall have been given, deliver to the Company a written objection to such selection; provided, however, that such objection may be asserted only on the ground that the
Independent Counsel so selected does not meet the requirements of &#147;<B><I>Independent Counsel</I></B>,&#148; and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the
person so selected shall </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
act as Independent Counsel. If a written objection is made and substantiated, the Independent Counsel selected may not serve as Independent Counsel unless and until such objection is withdrawn or
a court of competent jurisdiction has determined that such objection is without merit. If, within 20 days after submission by Indemnitee of a written request for indemnification pursuant to <U>Section</U><U></U><U>&nbsp;7(a)</U> hereof, no
Independent Counsel shall have been selected or shall have been selected and objected to, either the Company or Indemnitee may petition the Delaware Court or other court of competent jurisdiction for resolution of any objection which shall have been
made by the Indemnitee to the Company&#146;s selection of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by the court or by such other person as the court shall designate, and the person with respect to
whom all objections are so resolved or the person so appointed shall act as Independent Counsel under <U>Section</U><U></U><U>&nbsp;7(b)</U> hereof. The Company shall pay any and all reasonable fees and expenses of Independent Counsel incurred by
such Independent Counsel in connection with acting pursuant to <U>Section</U><U></U><U>&nbsp;7(b)</U> hereof, and the Company shall pay all reasonable fees and expenses incident to the procedures of this <U>Section</U><U></U><U>&nbsp;7(c)</U>,
regardless of the manner in which such Independent Counsel was selected or appointed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) In making a determination with respect to
entitlement to indemnification hereunder, the person or persons or entity making such determination shall presume that Indemnitee is entitled to indemnification under this Agreement. Anyone seeking to overcome this presumption shall have the burden
of proof and the burden of persuasion by clear and convincing evidence. Neither the failure of the Company (including by its directors or Independent Counsel) to have made a determination prior to the commencement of any action pursuant to this
Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Company (including by its directors or Independent Counsel) that Indemnitee has not met
such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) Indemnitee shall be deemed to have acted in good faith if Indemnitee&#146;s action is based on the records or books of account of the
Enterprise, including financial statements, or on information supplied to Indemnitee by the officers of the Enterprise in the course of their duties, or on the advice of legal counsel for the Enterprise or on information or records given or reports
made to the Enterprise by an independent certified public accountant or by an appraiser or other expert selected with reasonable care by the Enterprise. In addition, the knowledge and/or actions, or failure to act, of any director, officer, agent or
employee of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement. Whether or not the foregoing provisions of this <U>Section</U><U></U><U>&nbsp;7(e)</U> are satisfied, it
shall in any event be presumed that Indemnitee has at all times acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company. Anyone seeking to overcome this presumption shall have
the burden of proof and the burden of persuasion by clear and convincing evidence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) If the person, persons or entity empowered or
selected under this <U>Section</U><U></U><U>&nbsp;7</U> to determine whether Indemnitee is entitled to indemnification shall not have made a determination within 60 days after receipt by the Company of the request therefor, the requisite
determination of entitlement to indemnification shall be deemed to have been made and Indemnitee shall be entitled to such indemnification absent (i)&nbsp;a misstatement by Indemnitee of a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
material fact, or an omission of a material fact necessary to make Indemnitee&#146;s statement not materially misleading, in connection with the request for indemnification, or (ii)&nbsp;a
prohibition of such indemnification under applicable law; provided, however, that such <FONT STYLE="white-space:nowrap">60-day</FONT> period may be extended for a reasonable time, not to exceed an additional 30 days, if the person, persons or entity
making such determination with respect to entitlement to indemnification in good faith requires such additional time to obtain or evaluate documentation and/or information relating thereto; and provided, further, that the foregoing provisions of
this <U>Section</U><U></U><U>&nbsp;7(f)</U> shall not apply if the determination of entitlement to indemnification is to be made by the stockholders pursuant to <U>Section</U><U></U><U>&nbsp;7(b)</U> hereof and if (A)&nbsp;within 15 days after
receipt by the Company of the request for such determination, the Board or the Disinterested Directors, if appropriate, resolve to submit such determination to the stockholders for their consideration at an annual meeting thereof to be held within
75 days after such receipt and such determination is made thereat, or (B)&nbsp;a special meeting of stockholders is called within 15 days after such receipt for the purpose of making such determination, such meeting is held for such purpose within
60 days after having been so called and such determination is made thereat. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) Indemnitee shall cooperate with the person, persons or
entity making such determination with respect to Indemnitee&#146;s entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged or
otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination. Any Independent Counsel, member of the Board or stockholder of the Company shall act reasonably and in good faith in
making a determination regarding the Indemnitee&#146;s entitlement to indemnification under this Agreement. Any costs or expenses (including attorneys&#146; fees and disbursements) incurred by Indemnitee in so cooperating with the person, persons or
entity making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee&#146;s entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) The Company acknowledges that a settlement or other disposition short of final judgment may be successful if it permits a party to avoid
expense, delay, distraction, disruption and uncertainty. In the event that any action, claim or proceeding to which Indemnitee is a party is resolved in any manner other than by adverse judgment against Indemnitee (including, without limitation,
settlement of such action, claim or proceeding with or without payment of money or other consideration) it shall be presumed that Indemnitee has been successful on the merits or otherwise in such Proceeding. Anyone seeking to overcome this
presumption shall have the burden of proof and the burden of persuasion by clear and convincing evidence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The termination of any
Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of <I>nolo contendere</I> or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely
affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any
criminal Proceeding, that Indemnitee had reasonable cause to believe that his conduct was unlawful. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8. <U>Remedies of Indemnitee</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) In the event that (i)&nbsp;a determination is made pursuant to <U>Section</U><U></U><U>&nbsp;7</U> hereof that Indemnitee is not entitled
to indemnification under this Agreement, (ii)&nbsp;advancement of Expenses is not timely made pursuant to <U>Section</U><U></U><U>&nbsp;6</U> hereof, (iii)&nbsp;no determination of entitlement to indemnification is made pursuant to
<U>Section</U><U></U><U>&nbsp;7(b)</U> hereof within 90 days after receipt by the Company of the request for indemnification, (iv)&nbsp;payment of indemnification is not made pursuant to this Agreement within 10 days after receipt by the Company of
a written request therefor or (v)&nbsp;payment of indemnification is not made within 10 days after a determination has been made that Indemnitee is entitled to indemnification or such determination is deemed to have been made pursuant to
<U>Section</U><U></U><U>&nbsp;7</U> hereof, Indemnitee shall be entitled to an adjudication in an appropriate court of the State of Delaware, or in any other court of competent jurisdiction, of Indemnitee&#146;s entitlement to such indemnification.
Indemnitee shall commence such proceeding seeking an adjudication within 180 days following the date on which Indemnitee first has the right to commence such proceeding pursuant to this <U>Section</U><U></U><U>&nbsp;8(a)</U>. The Company shall not
oppose Indemnitee&#146;s right to seek any such adjudication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) In the event that a determination shall have been made pursuant to
<U>Section</U><U></U><U>&nbsp;7(b)</U> hereof that Indemnitee is not entitled to indemnification, any judicial proceeding commenced pursuant to this <U>Section</U><U></U><U>&nbsp;8</U> shall be conducted in all respects as a de novo trial on the
merits, and Indemnitee shall not be prejudiced by reason of the adverse determination under <U>Section</U><U></U><U>&nbsp;7(b)</U> hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) If a determination shall have been made pursuant to <U>Section</U><U></U><U>&nbsp;7(b)</U> hereof that Indemnitee is entitled to
indemnification, the Company shall be bound by such determination in any judicial proceeding commenced pursuant to this <U>Section</U><U></U><U>&nbsp;8</U>, absent (i)&nbsp;a misstatement by Indemnitee of a material fact, or an omission of a
material fact necessary to make Indemnitee&#146;s misstatement not materially misleading in connection with the application for indemnification, or (ii)&nbsp;a prohibition of such indemnification under applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) In the event that Indemnitee, pursuant to this <U>Section</U><U></U><U>&nbsp;8</U>, seeks a judicial adjudication of such
Indemnitee&#146;s rights under, or to recover damages for breach of, this Agreement, or to recover under any directors&#146; and officers&#146; liability insurance policies maintained by the Company, the Company shall pay on such Indemnitee&#146;s
behalf, in advance, any and all expenses (of the types described in the definition of Expenses in <U>Section</U><U></U><U>&nbsp;14</U> of this Agreement) actually and reasonably incurred by Indemnitee in such judicial adjudication, regardless of
whether Indemnitee ultimately is determined to be entitled to such indemnification, advancement of expenses or insurance recovery. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e)
The Company shall be precluded from asserting in any judicial proceeding commenced pursuant to this <U>Section</U><U></U><U>&nbsp;8</U> that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate
in any such court that the Company is bound by all the provisions of this Agreement. The Company shall indemnify Indemnitee against any and all Expenses and, if requested by Indemnitee, shall (within 10 days after receipt by the Company of a written
request therefor) advance, to the extent not prohibited by law, such expenses to Indemnitee, which are incurred by Indemnitee in connection with any action brought by Indemnitee for indemnification or advance of Expenses from the Company under this
Agreement or under any directors&#146; and officers&#146; liability insurance policies maintained by the Company, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification, advancement of Expenses or insurance
recovery, as the case may be. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) Notwithstanding anything in this Agreement to the contrary, no determination as to
entitlement to indemnification under this Agreement shall be required to be made prior to the final disposition of the Proceeding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.
<U>Defense of Proceedings</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Subject to <U>Section</U><U></U><U>&nbsp;9(c)</U> below, in the event the Company is obligated to pay
in advance the Expenses of any Proceeding pursuant to <U>Section</U><U></U><U>&nbsp;6</U>, the Company will be entitled, by written notice to Indemnitee, to assume the defense of such Proceeding, with counsel reasonably satisfactory to Indemnitee.
The Company will identify the counsel it proposes to employ in connection with such defense as part of the written notice sent to Indemnitee notifying Indemnitee of the Company&#146;s election to assume such defense, and Indemnitee will be required,
within 10 days following Indemnitee&#146;s receipt of such notice, to inform the Company of its approval of such counsel or, if it has objections, the reasons therefor. If such objections cannot be resolved by the parties, the Company will identify
alternative counsel, which counsel will also be subject to approval by Indemnitee in accordance with the procedure described in the prior sentence. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Following approval of counsel by Indemnitee pursuant to <U>Section</U><U></U><U>&nbsp;9(a)</U> and retention of such counsel by the
Company, the Company will not be liable to Indemnitee under this Agreement for any fees and expenses of counsel subsequently incurred by Indemnitee with respect to the same Proceeding; provided, however, that (i)&nbsp;Indemnitee has the right to
employ counsel in any such Proceeding at Indemnitee&#146;s expense and (ii)&nbsp;the Company will be required to pay the fees and expenses of Indemnitee&#146;s counsel if (x)&nbsp;the employment of counsel by Indemnitee has been previously
authorized by the Company, (y)&nbsp;Indemnitee reasonably concludes that there is an actual or potential conflict between the Company (or any other person or persons included in a joint defense) and Indemnitee in the conduct of such defense or
representation by such counsel retained by the Company or (z)&nbsp;the Company does not continue to retain the counsel approved by Indemnitee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding <U>Section</U><U></U><U>&nbsp;9(a)</U>, the Company will not be entitled to assume the defense of any Proceeding brought
by or on behalf of the Company or any Proceeding as to which Indemnitee has reasonably made the conclusion provided for in <U>Section</U><U></U><U>&nbsp;9(b)(y)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10. <U><FONT STYLE="white-space:nowrap">Non-Exclusivity;</FONT> Survival of Rights; Insurance; Primacy of Indemnification; Subrogation</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The rights of indemnification and to the advancement of Expenses as provided by this Agreement shall not be deemed exclusive of any
other rights to which Indemnitee may at any time be entitled under applicable law, the Restated Certificate of Incorporation of the Company (as amended and/or restated from time to time, the &#147;<B><I>Certificate of Incorporation</I></B>&#148;),
the Bylaws, any agreement, a vote of stockholders or Disinterested Directors, a resolution of the Board, or otherwise. No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee
under this Agreement in respect of any action taken or omitted by such Indemnitee in such Indemnitee&#146;s Corporate Status prior to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such amendment, alteration or repeal. To the extent that a change in the DGCL, whether by statute or judicial decision, permits greater indemnification than would be afforded currently under the
Certificate of Incorporation, the Bylaws or this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change. No right or remedy herein conferred is intended to be
exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment
of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers,
employees, or agents or fiduciaries of the Company or of any other Enterprise, Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any director, officer,
employee, agent or fiduciary under such policy or policies. If, at the time of the receipt of a notice of a claim pursuant to the terms hereof, the Company has directors&#146; and officers&#146; liability insurance in effect, the Company shall give
prompt notice of the commencement of such proceeding to the insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf
of the Indemnitee, all amounts payable as a result of such proceeding in accordance with the terms of such policies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) In the event of
any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee (other than insurance obtained on Indemnitee&#146;s own behalf), who shall execute all papers required and
take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) The Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable hereunder if and to the
extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract, agreement or otherwise (and Indemnitee shall reimburse the Company for any amounts paid by the Company and subsequently so recovered by
Indemnitee). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) The Company&#146;s obligation to indemnify or advance Expenses hereunder to Indemnitee who is or was serving as a
director, officer, employee or agent of any other Enterprise shall be reduced by any amount Indemnitee has actually received as indemnification or advancement of expenses from such other Enterprise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11. <U>Exception to Right of Indemnification</U>. Notwithstanding any provision in this Agreement, the Company shall not be obligated under
this Agreement to make any indemnity in connection with any claim made against Indemnitee: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) for which payment has actually been made
to or on behalf of Indemnitee under any insurance policy or other indemnity provision, except with respect to any excess beyond the amount paid under any insurance policy or other indemnity provision; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) for an accounting of profits made from the purchase and sale (or sale and purchase) by
Indemnitee of securities of the Company within the meaning of Section&nbsp;16(b) of the Securities Exchange Act of 1934, as amended, or similar provisions of state statutory law or common law; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) in connection with any Proceeding (or any part of any Proceeding) voluntarily initiated by Indemnitee, including any Proceeding (or any
part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless (i)&nbsp;the Board authorized the Proceeding (or any such part of any Proceeding) prior to its initiation or
(ii)&nbsp;the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) if a final decision by a court of competent jurisdiction determines that such indemnification is prohibited by applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12. <U>Duration of Agreement</U>. All agreements and obligations of the Company contained herein shall continue for so long as Indemnitee may
have any liability or potential liability by virtue of serving or having served as an officer or director of the Company (or is or was serving at the request of the Company as a director, officer, partner, trustee, member, employee or agent of
another corporation, partnership, joint venture, trust, limited liability company or other Enterprise) and shall continue thereafter so long as Indemnitee shall be subject to any Proceeding (or any proceeding commenced under
<U>Section</U><U></U><U>&nbsp;8</U> hereof) by reason of such Indemnitee&#146;s Corporate Status, whether or not such Indemnitee is acting or serving in any such capacity at the time any liability or expense is incurred for which indemnification can
be provided under this Agreement. This Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective successors (including any direct or indirect successor by purchase, merger,
consolidation or otherwise to all or substantially all of the business or assets of the Company), assigns, spouses, heirs, executors and personal and legal representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13. <U>Miscellaneous</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)
The Company expressly confirms and agrees that it has entered into this Agreement and assumes the obligations imposed on it hereby in order to induce Indemnitee to serve as an officer or director of the Company, and the Company acknowledges that
Indemnitee is relying upon this Agreement in serving as an officer or director of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) This Agreement constitutes the entire
agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings, including any prior indemnification agreements between the Company and the Indemnitee, oral, written and implied,
between the parties hereto with respect to the subject matter hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) The Company shall not seek from a court, or agree to, a
&#147;bar order&#148; which would have the effect of prohibiting or limiting the Indemnitee&#146;s rights to receive advancement of expenses under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14. <U>Definitions</U>. For purposes of this Agreement: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) &#147;<B><I>Corporate Status</I></B>&#148; describes the status of a person who is or was a director, officer, partner, trustee, member,
employee, agent or fiduciary of the Company or of any other corporation, partnership, joint venture, trust, limited liability company, employee benefit plan or other Enterprise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) &#147;<B><I>Disinterested Director</I></B>&#148; means a director of the Company who is not and was not a party to the Proceeding in
respect of which indemnification is sought by Indemnitee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) &#147;<B><I>Enterprise</I></B>&#148; shall mean the Company and any other
corporation, partnership, joint venture, trust, employee benefit plan or other enterprise that Indemnitee is or was serving at the express written request of the Company as a director, officer, employee, agent or fiduciary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) &#147;<B><I>Expenses</I></B>&#148; shall include all reasonable attorneys&#146; fees, retainers, court costs, transcript costs, fees of
experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees and all other disbursements or expenses of the types customarily incurred in connection with prosecuting,
defending, preparing to prosecute or defend, investigating, participating, or being or preparing to be a witness in a Proceeding, or responding to, or objecting to, a request to provide discovery in any Proceeding. Expenses also shall include
Expenses incurred in connection with any appeal resulting from any Proceeding and any federal, state, local or foreign taxes imposed on the Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement, including
without limitation the premium, security for, and other costs relating to any cost bond, supersede as bond, or other appeal bond or its equivalent. Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of
judgments or fines against Indemnitee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) &#147;<B><I>Independent Counsel</I></B>&#148; means a law firm, or a member of a law firm,
that is experienced in matters of corporation law and neither presently is, nor in the past five years has been, retained to represent: (i)&nbsp;the Company or Indemnitee in any matter material to either such party (other than with respect to
matters concerning Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements), or (ii)&nbsp;any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the
foregoing, the term &#147;<B><I>Independent Counsel</I></B>&#148; shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or
Indemnitee in an action to determine Indemnitee&#146;s rights under this Agreement. The Company agrees to pay the reasonable fees of the Independent Counsel referred to above and to fully indemnify such counsel against any and all Expenses, claims,
liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f)
&#147;<B><I>Proceeding</I></B>&#148; includes any threatened, pending or completed action, suit, arbitration, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed
proceeding, whether brought by or in the right of the Company or otherwise and whether civil, criminal, administrative or investigative, in which Indemnitee was, is or will be involved as a party or otherwise, by reason of such Indemnitee&#146;s
Corporate Status, by reason of any action taken by Indemnitee or of any inaction on Indemnitee&#146;s part while acting in such Indemnitee&#146;s Corporate Status; in each case whether or not such Indemnitee is acting or serving in any such capacity
at the time any liability or expense is incurred for which indemnification can be provided under this Agreement; including one pending on or before the date of this Agreement, but excluding one initiated by an Indemnitee pursuant to
<U>Section</U><U></U><U>&nbsp;8</U> hereof to enforce such Indemnitee&#146;s rights under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) References to &#147;<B><I>serving at the request of the Company</I></B>&#148; include
any service as a director, officer, employee or agent of the Company which imposes duties on, or involves services by, such director, officer, employee or agent with respect to any employee benefit plan, its participants or beneficiaries; and a
person who acted in good faith and in a manner he or she reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan will be deemed to have acted in a manner &#147;<B><I>not opposed to the best
interests of the Company</I></B>&#148; as referred to under applicable law or in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15. <U>Severability</U>; Prior
Indemnification Agreements. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision. Without limiting the generality of the foregoing, this Agreement is intended to
confer upon Indemnitee indemnification rights to the fullest extent permitted by applicable laws. In the event any provision hereof conflicts with any applicable law, such provision shall be deemed modified, consistent with the aforementioned
intent, to the extent necessary to resolve such conflict. This Agreement shall supersede and replace any prior indemnification agreements entered into by and between the Company or its subsidiaries and the Indemnitee and any such prior agreements
shall be terminated upon execution of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">16. <U>Modification and Waiver</U>. No supplement, modification, termination or
amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto. No failure or delay of either party in exercising any right or remedy hereunder shall operate as a waiver thereof, and no single or partial
exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such right or power, or any course of conduct, shall preclude any other or further exercise thereof or the exercise of any other right or power. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">17. <U>Notice By Indemnitee</U>. Indemnitee agrees promptly to notify the Company in writing upon being served with or otherwise receiving any
summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding or matter which may be subject to indemnification covered hereunder. The failure to so notify the Company shall not relieve the Company of
any obligation which it may have to Indemnitee under this Agreement or otherwise unless and only to the extent that such failure or delay materially prejudices the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">18. <U>Notices</U>. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed
effectively given: (a)&nbsp;upon personal delivery to the party to be notified, (b)&nbsp;when sent by confirmed electronic mail or facsimile if sent during normal business hours of the recipient, and if not so confirmed, then on the next business
day, (c)&nbsp;five days after having been sent by registered or certified mail, return receipt requested, postage prepaid or (d)&nbsp;one day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written
verification of receipt. All communications shall be sent: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) To Indemnitee at the address set forth below Indemnitee signature hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) To the Company at: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">19120 Kenswick Drive </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Humble, Texas 77338 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: Adam Anderson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8201;Kendal Reed </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or to such other address as may have been furnished to Indemnitee by the Company or to the Company by Indemnitee, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">19. <U>Counterparts</U>. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of
which together shall constitute one and the same Agreement. This Agreement may also be executed and delivered by facsimile signature and in two or more counterparts, each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">20. <U>Employment Contract</U>. This Agreement shall not be deemed an employment contract between
the Company and any Indemnitee who is an officer of the Company and/or its subsidiaries, and, if the Indemnitee is an officer, the Indemnitee specifically acknowledges that the Indemnitee may be discharged at any time for any reason, with or without
cause, and with or without severance compensation, except as may be otherwise provided in a separate written contract between the Indemnitee and the Company and/or its subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">21. <U>Headings</U>. The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute
part of this Agreement or to affect the construction thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">22. <U>Governing Law and Consent to Jurisdiction</U>. This Agreement and
the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules. The Company and Indemnitee hereby irrevocably and
unconditionally (i)&nbsp;agree that any action or proceeding arising out of or in connection with this Agreement shall be brought only in the Delaware Court, and not in any other state or federal court in the United States of America or any court in
any other country, (ii)&nbsp;consent to submit to the exclusive jurisdiction of the Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement, (iii)&nbsp;waive any objection to the laying of venue of
any such action or proceeding in the Delaware Court and (iv)&nbsp;waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the Delaware Court has been brought in an improper or inconvenient forum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SIGNATURE PAGE TO FOLLOW </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have executed this Indemnification Agreement on and
as of the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">INNOVEX INTERNATIONAL, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page to Indemnification Agreement</I> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">INDEMNITEE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page to Indemnification Agreement</I> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>8
<FILENAME>d802924dex108.htm
<DESCRIPTION>EX-10.8
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.8 </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g802924dsp94.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B><U>Dril-Quip, Inc. &middot; 2050 West Sam Houston Parkway S., Suite 1100, Houston, Texas &middot; 77042 &middot; Tel
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">713-939-7711</FONT></FONT></U></B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;6, 2024 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jeffrey
J. Bird </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Re:&#8195;Separation Agreement and Release </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Jeff: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This letter agreement (this
&#147;<B><I>Agreement</I></B>&#148;) confirms the terms and conditions concerning your termination of employment with the Company effective immediately following the closing of the mergers contemplated by the Agreement and Plan of Merger (the
&#147;<B><I>Merger Agreement</I></B>&#148;) dated March&nbsp;18, 2024 entered into by the Company, Innovex Downhole Solutions, Inc., and certain merger subsidiaries of the Company (the date of such closing under the Merger Agreement is herein
referred to as the &#147;<B><I>Separation Date</I></B>&#148;). For purposes of this Agreement, the &#147;<B><I>Company</I></B>&#148; means Dril-Quip, Inc. and any affiliate thereof, as well as their respective successors and assigns. You and the
Company are sometimes referred to as the parties in this Agreement. For purposes of this Agreement, the parties agree that your termination is a termination of employment by the Company without Cause during a Change of Control Period as described in
Section&nbsp;6(c) of the Employment Agreement between you and the Company dated as of December&nbsp;2, 2021 (the &#147;<B><I>Employment Agreement</I></B>&#148;) and that this Agreement is the written Notice of Termination of your employment for
purposes of the Employment Agreement. Capitalized terms not defined in this Agreement shall have the meaning given in the Employment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your acceptance of this Agreement must be indicated by signing on the last page of this Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Resignation from Officer and Director Positions </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon your execution of this Agreement, your employment will terminate and you shall be deemed to have resigned and not hold yourself out as a
director, officer, executive, employee, agent, member or representative of the Company and you agree to take any and all actions necessary effectuate any documentation the Company requests to effectuate the foregoing. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Accrued Salary and PTO Payment </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Section&nbsp;6(a) of the Employment Agreement, the Company shall pay you a <FONT STYLE="white-space:nowrap">lump-sum</FONT> cash payment
in an amount equal to the total of your (i)&nbsp;Base Salary earned through the Separation Date and (ii)&nbsp;accrued, but unpaid vacation time or <FONT STYLE="white-space:nowrap">paid-time-off</FONT> (PTO), in each case to the extent not previously
paid. This amount will be paid to you on the Separation Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided in this Agreement, all of your employee benefits
provided by the Company and your participation in the Company&#146;s 401(k) plan shall terminate on the Separation Date. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jeffrey J. Bird </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You will be reimbursed according to the Company&#146;s reimbursement policies for any
outstanding business expenses incurred up to the Separation Date, provided such expenses are timely submitted as required under the Company&#146;s reimbursement policies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Separation Pay and Benefits </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Section&nbsp;6(c) of the Employment Agreement and subject to your execution and return of this Agreement, and provided that you do
not later revoke your agreement and release of all claims as described below, you will receive the below COC Severance Benefits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>COC
Payments </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Company&#146;s first regular payroll date that is more than 8 days following the Separation Date, the Company shall
pay you a <FONT STYLE="white-space:nowrap">lump-sum</FONT> cash payment in the amount of $3,900,000, which is equal to the sum of three (3)&nbsp;times your Base Salary in effect as of the Separation Date and three (3)&nbsp;times the target amount of
your Annual Bonus for 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Company&#146;s first regular payroll date that is more than 8 days following the Separation Date, the
Company will pay you a <FONT STYLE="white-space:nowrap">lump-sum</FONT> cash payment equal to the product of $429,975, which is the target amount of your Annual Bonus for 2024 and a fraction, the numerator of which shall be the number of Business
Days from January&nbsp;1, 2024 to the Separation Date and the denominator of which is 260. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Restricted Stock Awards, Performance Unit
Awards and Restricted Stock Units </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of &#147;<B><I>Restricted Stock</I></B>&#148; granted to you under the Company&#146;s
2017 Omnibus Incentive Plan (the &#147;<B><I>Incentive Plan</I></B>&#148;) that are unvested immediately prior to the Separation Date will become 100% fully vested on the Separation Date. All award agreements between you and the Company are referred
to herein collectively as the &#147;<B><I>Award Agreements</I></B>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The &#147;<B><I>Performance Units</I></B>&#148; granted to you
under the Incentive Plan that are unvested immediately prior to the Separation Date will vest on the Separation Date based on the target level of performance for the Performance Units, and shares of Company common stock equal to that target number
of vested Performance Units will be issued and delivered to you on the Separation Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The &#147;<B><I>Restricted Stock
Units</I></B>&#148; granted to you under the Incentive Plan as additional incentive in relation to the Merger Agreement that are payable in stock and are unvested immediately prior to the Separation Date will become 100% fully vested on the
Separation Date. To the extent that the Restricted Stock Units granted to you under the Incentive Plan as additional incentive in relation to the Merger Agreement are payable in cash and vest upon closing of the mergers contemplated by the Merger
Agreement, the cash payments shall be made on the Company&#146;s first regular payroll date that is more than 8 days following the Separation Date, with the amount of such payment equal to the cash equivalent of such units using the closing price
per share of the Company&#146;s common stock on the last trading day prior to the date of such closing. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jeffrey J. Bird </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Continued Medical, Dental and Life Insurance at Company&#146;s Cost </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You will continue to receive medical, dental and life insurance coverage, at the same active employee premium cost charged to employees of the
Company, for yourself and your covered dependents (the &#147;<B><I>Continued Medical/Life Benefits</I></B>&#148;) following the Separation Date until the earlier of (i)&nbsp;your receipt of equivalent coverage and benefits under the plans and
programs of a subsequent employer (with such coverage and benefits determined on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">coverage-by-coverage</FONT></FONT> or <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">benefit-by-benefit</FONT></FONT> basis) or (ii) 3 years after the Separation Date. The premiums will be billed to you in arrears on a quarterly basis for each month that you continue to receive the Continued Medical/Life
Benefits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if you or your covered dependents are precluded from continuing participation in any benefit
plan or program as provided above, the Company will pay you the <FONT STYLE="white-space:nowrap">after-tax</FONT> economic equivalent of the benefits provided under the plan or program in which you or they are unable to participate for the period
described above, with such economic equivalent determined based on the cost that would be incurred by you in obtaining such benefit yourself on an individual basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The medical and dental benefits provided under the paragraph above are treated as your COBRA coverage and accordingly your COBRA continuation
period will begin on the Separation Date. Except for the Continued Medical/Life Benefits, coverage under all other Company welfare benefits will cease on the Separation Date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Continuing Obligations; <FONT STYLE="white-space:nowrap">Non-Competition,</FONT> <FONT STYLE="white-space:nowrap">Non-Solicitation</FONT> And
Confidentiality </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You expressly affirm and acknowledge your continuing obligations under the Employment Agreement to maintain the
confidentiality of the Company&#146;s confidential information, among other things, and that you are subject to, and will comply with, the <FONT STYLE="white-space:nowrap">non-competition</FONT> and
<FONT STYLE="white-space:nowrap">non-solicitation</FONT> obligations under the Employment Agreement (collectively, the &#147;<B><I>Covenants</I></B>&#148;). Further, you recognize and affirm that the Covenants (and the Company&#146;s right to relief
for your failure to comply with the Covenants) and Section&nbsp;6(f) (collectively, the &#147;<B><I>Surviving Provisions</I></B>&#148;) expressly survive the Separation Date and the termination of your employment with the Company pursuant to the
terms of the Employment Agreement and for any time periods specified therein. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Return of Company Property </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You agree as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On or prior to the Separation Date, you will return all Company property in your possession, custody, or control,
including all equipment such as your Company-issued laptop, documents and things, issued to you, except that you may keep your cellular phone and phone number. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On or prior to the Separation Date, you will return, if in your possession, any Company property, documents,
files or other paper or electronic media pertinent to the Company&#146;s business. You should keep your personal records, including your personal pay records and tax documents. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jeffrey J. Bird </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 4
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On or prior to the Separation Date, you will search for and delete all Company information, including all secret,
confidential or proprietary information, that may exist on your personal electronic devices such as a smartphone, laptop, tablet, personal computer, flash drive, or any other electronic storage device, other than the payroll information provided to
you that you may need to file your tax returns or keep your financial records. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">You have not and will not remove from the Company&#146;s premises any Company property, documents, files or other
paper or electronic media pertinent to the Company&#146;s business. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Release of Claims </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The payments and promises set forth in this Agreement are in full satisfaction of all accrued salary, vacation pay, termination benefits,
bonuses, equity compensation, or other compensation to which you may be entitled by virtue of your employment with the Company or your separation from the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You knowingly and voluntarily (for you, your family, and your heirs, executors, administrators and assigns) release and forever discharge the
Company and its officers, directors, employees and agents from any and all complaints, liabilities, claims, promises, agreements, controversies, damages, causes of action, suits or expenses of any nature whatsoever, known or unknown, which you now
have or own or claim to have or own against the Company including, without limitation, claims under any employment laws, including, but not limited to, claims of unlawful discharge, breach of contract, breach of the covenant of good faith and fair
dealing, fraud, violation of public policy, defamation, physical injury, emotional distress, claims for additional compensation or benefits arising out of your employment or your separation of employment, including the Employment Agreement and the
Award Agreements. This release applies to all claims or causes of action including, but not limited to, claims arising under the common law of the State of Texas or any state or federal statute such as Title VII of the Civil Rights Act of 1964,
42&nbsp;U.S.C. &#167;&nbsp;1981-1988, the Civil Rights Act of 1991, the Americans With Disabilities Act of 1990, the Family and Medical Leave Act of 1993, the Worker Adjustment and Retraining Notification Act, the Genetic Information <FONT
STYLE="white-space:nowrap">Non-Discrimination</FONT> Act, the Immigration Reform Control Act, the National Labor Relations Act, the Occupational Safety and Health Act, the Texas Labor Code (specifically including the Texas Payday Law, the Texas
Anti-Retaliation Act, Chapter 21 of the Texas Labor Code, and the Texas Whistleblower Act), or the Employee Retirement Income Security Act of 1974, all as amended, any federal, state or local anti-discrimination, anti-harassment or anti-retaliation
law, regulation or ordinance, any federal, state or local wage and hour law, and any federal, state or local laws, regulations, or ordinance relating to employment or employment discrimination, including, without limitation, claims based on age or
under the Age Discrimination in Employment Act of 1967 or Older Workers Benefit Protection Act, each as amended (collectively, the &#147;Released Claims&#148;). This Agreement is not intended to indicate that any such claims exist or that, if they
do exist, they are meritorious. Rather, you are simply agreeing that, in exchange for any consideration received by you pursuant to this Agreement, any and all potential claims of this nature that you may have against the Company, regardless of
whether they actually exist, are expressly settled, compromised and waived. THIS RELEASE INCLUDES MATTERS ATTRIBUTABLE TO THE SOLE OR PARTIAL NEGLIGENCE (WHETHER GROSS OR SIMPLE) OR OTHER FAULT, INCLUDING STRICT LIABILITY, OF THE COMPANY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jeffrey J. Bird </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 5
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, this release, however, does not waive any rights or claims
that may arise after the date you sign this Agreement or any rights to indemnification or directors and officer&#146;s liability insurance to which you may be entitled for actions during your period of employment. You also agree not to sue or join
in any suit against the Company for any claim relating to or arising out of your employment or your separation from employment with the Company, <I>provided, however</I>, that nothing will preclude you from (i)&nbsp;bringing a lawsuit or proceeding
against the Company to enforce the Company&#146;s obligations under this Agreement or to challenge the enforceability of the release under the Older Worker Benefit Protection Act, (ii)&nbsp;filing a charge or complaint with, providing information
to, or testifying or otherwise assisting in any investigation or proceeding brought by any state, federal or local regulatory or law enforcement agency or legislative body, or (iii)&nbsp;filing any claims that are not permitted to be waived or
released under applicable law (including a challenge to the validity of this Agreement) with the Equal Employment Opportunity Commission, National Labor Relations Board or comparable state or local agency. However, you understand and agree that you
are waiving your right to receive any relief (legal or equitable) directly from the Company based on any charge, complaint, or lawsuit against the Company filed by you or anyone else on your behalf other than for a breach of the Company&#146;s
obligations under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You further acknowledge and agree that nothing in this Agreement prohibits you from reporting to any
governmental authority information concerning possible violations of law or regulation and that you shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of trade secret information in
confidence to a government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, and you may use such information in certain court proceedings provided you submit it under seal and consistent
with 18 U.S.C. 1833. Nothing contained in this Agreement prohibits you from voluntarily or anonymously contacting governmental authorities regarding possible violations of law or from recovering a whistleblower award. You will retain all rights and
consideration provided in this Agreement regardless of whether you communicate with any governmental authorities, or if you receive a whistleblower award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By signing this Agreement, you acknowledge and agree that, you are not entitled to and will not receive any further payments, compensation or
benefits under the Employment Agreement, the Incentive Plan or any other Company plan or program after the Separation Date or in respect of your employment with, or separation or termination from, the Company, that are in addition to the payments or
benefits described in this Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Representations and Warranties Regarding Claims </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You represent and warrant that, as of the time at which you sign this Agreement, you have not filed or joined any claims, complaints, charges,
or lawsuits against the Company with any governmental agency or with any state or federal court or arbitrator for, or with respect to, a matter, claim, or incident that occurred or arose out of one or more occurrences that took place on or prior to
the time at which you sign this Agreement (excluding, for the avoidance of doubt, any whistleblower complaints protected under applicable law), and you are not aware of any violation of any law, rule or regulation or any other misconduct by the
Company or any of its officers or employees. You further represent and warrant that you have not made any assignment, sale, delivery, transfer or conveyance of any rights you have asserted or may have against the Company with respect to any Released
Claim. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jeffrey J. Bird </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 6
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Severability </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any provision of this Agreement is held to be invalid or unenforceable, (i)&nbsp;this Agreement shall be considered divisible,
(ii)&nbsp;such provision shall be deemed inoperative to the extent it is deemed invalid or unenforceable, and (iii)&nbsp;in all other respects this Agreement shall remain in full force and effect; provided, however, that if any such provision may be
made valid or enforceable by limitation thereof, then such provision shall be deemed to be so limited and shall be valid and/or enforceable to the maximum extent permitted by applicable law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Release of Claims under the ADEA. </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>&#8195;&#8195;</U>By executing this Agreement, you will be releasing claims that you may have under the Age Discrimination in Employment Act
(&#147;ADEA&#148;). You will not be waiving any rights or claims under the ADEA that may arise after your execution of this Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Consideration Period </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You
acknowledge and understand that you have forty-five (45)&nbsp;days after you receive this Agreement to decide whether to sign this Agreement and be bound by its terms. You may take as much or as little of the forty-five (45)&nbsp;day period to
consider this Agreement as you wish. You have the right to discuss any aspect of this matter with an attorney of your choosing, and the Company recommends that you take advantage of this consideration period and consult with an attorney before
executing this Agreement. By executing this Agreement, you will be acknowledging that you considered its terms for forty-five (45)&nbsp;days or waived your right to do so, were advised in writing to seek legal counsel, and such earlier signature was
not induced by the Company through fraud, misrepresentation or a threat to withdraw or alter this Agreement prior to the expiration of such <FONT STYLE="white-space:nowrap">21-day</FONT> period. No changes (whether material or immaterial) to this
Agreement shall restart the running of this <FONT STYLE="white-space:nowrap">21-day</FONT> period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Revocation Period </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event you agree to its terms and execute this Agreement, you may nevertheless revoke it within seven (7)&nbsp;days thereafter. Thus, if
you subsequently change your mind, you have the option and right to revoke this Agreement, but you must do so within seven (7)&nbsp;days after signing it by providing written notification via overnight mail or U.S. Mail at the address listed on the
letterhead above to the attention of the Legal Department. This Agreement will not become effective until the seven (7)&nbsp;day revocation period has expired. Of course, if this Agreement is revoked, you will not receive the COC Severance Benefits.
If you do not revoke the Agreement within this time frame, it will become effective and both you and the Company will be bound by its terms. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jeffrey J. Bird </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 7
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Governing Law and Venue </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Texas, without regard to the
principles of conflicts of laws thereof. Venue for any action or proceeding relating to this Agreement and/or the employment relationship hereunder shall lie exclusively in courts in Harris County, Texas. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Withholding; Taxes </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company
may withhold from any amounts payable (including the vesting of stock awards) under this Agreement such federal, state, local or foreign taxes as shall be required to be withheld pursuant to any applicable law or regulation. You acknowledge and
agree that you are fully responsible for any taxes resulting from amounts payable under this Agreement and will not receive any tax <FONT STYLE="white-space:nowrap">gross-ups</FONT> or similar payments from the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Compliance with Section&nbsp;409A </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company intends that the payment and benefits under this Agreement shall be exempt from or comply with Section&nbsp;409A of the Internal
Revenue Code (&#147;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A</I></B>&#148;) and this Agreement shall be interpreted, operated and administered accordingly. To the extent that the reimbursements or other
<FONT STYLE="white-space:nowrap">in-kind</FONT> benefits hereunder are &#147;nonqualified deferred compensation&#148; for purposes of Section&nbsp;409A, (a)&nbsp;all such expenses or other reimbursements shall be made on or prior to the last day of
the taxable year following the taxable year in which such expenses were incurred by you, (b)&nbsp;any right to reimbursements or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits shall not be subject to liquidation or exchange for another
benefit, and (c)&nbsp;no such reimbursement, expenses eligible for reimbursement, or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits provided in any taxable year shall in any way affect the expenses eligible for reimbursement, or <FONT
STYLE="white-space:nowrap">in-kind</FONT> benefits to be provided, in any other taxable year. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Entire Agreement </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement, the Award Agreements, and the Surviving Provisions constitute the entire agreement between the parties hereto concerning the
subject matter hereof, and from and after the date of this Agreement, this Agreement shall supersede any other prior agreement or understanding, both written and oral, between the parties with respect to such subject matter. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Acknowledgment and Acceptance of Agreement </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By signing this Agreement in the space provided below, you acknowledge that you have carefully read and fully understand all of the provisions
of this Agreement, that you have accepted its terms and that you are voluntarily entering into this Agreement without any undue influence or coercion from the Company. You have the right to discuss any aspect of this matter with an attorney of your
choosing, and the Company recommends that you take advantage of this time to consider this Agreement and consult with an attorney before executing this Agreement. In addition, please feel free to contact me to ask any questions regarding the
Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John V. Lovoi</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">John V. Lovoi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chairman of the Board of Directors</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to CIC Termination Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B><U>AGREED AND ACCEPTED</U></B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>9/6/2024&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>/s/ Jeffrey J. Bird&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Jeffrey J. Bird</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to CIC Termination Agreement</I>] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>9
<FILENAME>d802924dex109.htm
<DESCRIPTION>EX-10.9
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.9</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.9 </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g802924dsp94.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><U>Dril-Quip, Inc. &middot; 2050 West Sam Houston Parkway S., Suite 1100, Houston, Texas &middot; 77042 &middot; Tel
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">713-939-7711</FONT></FONT></U></B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;6, 2024 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kyle F.
McClure </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Separation Agreement and Release </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Kyle: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This letter agreement (this
&#147;<B><I>Agreement</I></B>&#148;) confirms the terms and conditions concerning your termination of employment with the Company effective immediately following the closing of the mergers contemplated by the Agreement and Plan of Merger (the
&#147;<B><I>Merger Agreement</I></B>&#148;) dated March&nbsp;18, 2024 entered into by the Company, Innovex Downhole Solutions, Inc., and certain merger subsidiaries of the Company (the date of such closing under the Merger Agreement is herein
referred to as the &#147;<B><I>Separation Date</I></B>&#148;). For purposes of this Agreement, the &#147;<B><I>Company</I></B>&#148; means Dril-Quip, Inc. and any affiliate thereof, as well as their respective successors and assigns. You and the
Company are sometimes referred to as the parties in this Agreement. For purposes of this Agreement, the parties agree that your termination is a termination of employment by the Company without Cause during a Change of Control Period as described in
Section&nbsp;6(c) of the Employment Agreement between you and the Company dated as of December&nbsp;2, 2021 (the &#147;<B><I>Employment Agreement</I></B>&#148;) and that this Agreement is the written Notice of Termination of your employment for
purposes of the Employment Agreement. Capitalized terms not defined in this Agreement shall have the meaning given in the Employment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your acceptance of this Agreement must be indicated by signing on the last page of this Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Resignation from Officer and Director Positions </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon your execution of this Agreement, your employment will terminate and you shall be deemed to have resigned and not hold yourself out as a
director, officer, executive, employee, agent, member or representative of the Company and you agree to take any and all actions necessary effectuate any documentation the Company requests to effectuate the foregoing. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Accrued Salary and PTO Payment </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Section&nbsp;6(a) of the Employment Agreement, the Company shall pay you a <FONT STYLE="white-space:nowrap">lump-sum</FONT> cash payment
in an amount equal to the total of your (i)&nbsp;Base Salary earned through the Separation Date and (ii)&nbsp;accrued, but unpaid vacation time or <FONT STYLE="white-space:nowrap">paid-time-off</FONT> (PTO), in each case to the extent not previously
paid. This amount will be paid to you on the Separation Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided in this Agreement, all of your employee benefits
provided by the Company and your participation in the Company&#146;s 401(k) plan shall terminate on the Separation Date. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kyle F. McClure </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You will be reimbursed according to the Company&#146;s reimbursement policies for any
outstanding business expenses incurred up to the Separation Date, provided such expenses are timely submitted as required under the Company&#146;s reimbursement policies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Separation Pay and Benefits </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Section&nbsp;6(c) of the Employment Agreement and subject to your execution and return of this Agreement, and provided that you do
not later revoke your agreement and release of all claims as described below, you will receive the below COC Severance Benefits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>COC
Payments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Company&#146;s first regular payroll date that is more than 8 days following the Separation Date, the Company shall
pay you a <FONT STYLE="white-space:nowrap">lump-sum</FONT> cash payment in the amount of $1,548,000, which is equal to the sum of two (2)&nbsp;times your Base Salary in effect as of the Separation Date and two (2)&nbsp;times the target amount of
your Annual Bonus for 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Company&#146;s first regular payroll date that is more than 8 days following the Separation Date, the
Company will pay you a <FONT STYLE="white-space:nowrap">lump-sum</FONT> cash payment equal to the product of $227,556, which is the target amount of your Annual Bonus for 2024 and a fraction, the numerator of which shall be the number of Business
Days from January&nbsp;1, 2024 to the Separation Date and the denominator of which is 260. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Restricted Stock Awards, Performance Unit
Awards and Restricted Stock Units </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of &#147;<B><I>Restricted Stock</I></B>&#148; granted to you under the Company&#146;s
2017 Omnibus Incentive Plan (the &#147;<B><I>Incentive Plan</I></B>&#148;) that are unvested immediately prior to the Separation Date will become 100% fully vested on the Separation Date. All award agreements between you and the Company are referred
to herein collectively as the &#147;<B><I>Award Agreements</I></B>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The &#147;<B><I>Performance Units</I></B>&#148; granted to you
under the Incentive Plan that are unvested immediately prior to the Separation Date will vest on the Separation Date based on the target level of performance for the Performance Units, and shares of Company common stock equal to that target number
of vested Performance Units will be issued and delivered to you on the Separation Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The &#147;<B><I>Restricted Stock
Units</I></B>&#148; granted to you under the Incentive Plan as additional incentive in relation to the Merger Agreement that are payable in stock and are unvested immediately prior to the Separation Date will become 100% fully vested on the
Separation Date. To the extent that the Restricted Stock Units granted to you under the Incentive Plan as additional incentive in relation to the Merger Agreement are payable in cash and vest upon closing of the mergers contemplated by the Merger
Agreement, the cash payments shall be made on the Company&#146;s first regular payroll date that is more than 8 days following the Separation Date, with the amount of such payment equal to the cash equivalent of such units using the closing price
per share of the Company&#146;s common stock on the last trading day prior to the date of such closing. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kyle F. McClure </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Continued Medical, Dental and Life Insurance at Company&#146;s Cost </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You will continue to receive medical, dental and life insurance coverage, at the same active employee premium cost charged to employees of the
Company, for yourself and your covered dependents (the &#147;<B><I>Continued Medical/Life Benefits</I></B>&#148;) following the Separation Date until the earlier of (i)&nbsp;your receipt of equivalent coverage and benefits under the plans and
programs of a subsequent employer (with such coverage and benefits determined on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">coverage-by-coverage</FONT></FONT> or <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">benefit-by-benefit</FONT></FONT> basis) or (ii) 2 years after the Separation Date. The premiums will be billed to you in arrears on a quarterly basis for each month that you continue to receive the Continued Medical/Life
Benefits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if you or your covered dependents are precluded from continuing participation in any benefit
plan or program as provided above, the Company will pay you the <FONT STYLE="white-space:nowrap">after-tax</FONT> economic equivalent of the benefits provided under the plan or program in which you or they are unable to participate for the period
described above, with such economic equivalent determined based on the cost that would be incurred by you in obtaining such benefit yourself on an individual basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The medical and dental benefits provided under the paragraph above are treated as your COBRA coverage and accordingly your COBRA continuation
period will begin on the Separation Date. Except for the Continued Medical/Life Benefits, coverage under all other Company welfare benefits will cease on the Separation Date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Continuing Obligations; <FONT STYLE="white-space:nowrap">Non-Competition,</FONT> <FONT STYLE="white-space:nowrap">Non-Solicitation</FONT> And
Confidentiality </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You expressly affirm and acknowledge your continuing obligations under the Employment Agreement to maintain the
confidentiality of the Company&#146;s confidential information, among other things, and that you are subject to, and will comply with, the <FONT STYLE="white-space:nowrap">non-competition</FONT> and
<FONT STYLE="white-space:nowrap">non-solicitation</FONT> obligations under the Employment Agreement (collectively, the &#147;<B><I>Covenants</I></B>&#148;). Further, you recognize and affirm that the Covenants (and the Company&#146;s right to relief
for your failure to comply with the Covenants) and Section&nbsp;6(f) (collectively, the &#147;<B><I>Surviving Provisions</I></B>&#148;) expressly survive the Separation Date and the termination of your employment with the Company pursuant to the
terms of the Employment Agreement and for any time periods specified therein. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Return of Company Property </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You agree as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On or prior to the Separation Date, you will return all Company property in your possession, custody, or control,
including all equipment such as your Company-issued laptop, documents and things, issued to you, except that you may keep your cellular phone and phone number. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On or prior to the Separation Date, you will return, if in your possession, any Company property, documents,
files or other paper or electronic media pertinent to the Company&#146;s business. You should keep your personal records, including your personal pay records and tax documents. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On or prior to the Separation Date, you will search for and delete all Company information, including all secret,
confidential or proprietary information, that may exist on your personal electronic devices such as a smartphone, laptop, tablet, personal computer, flash drive, or any other electronic storage device, other than the payroll information provided to
you that you may need to file your tax returns or keep your financial records. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kyle F. McClure </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 4
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">You have not and will not remove from the Company&#146;s premises any Company property, documents, files or other
paper or electronic media pertinent to the Company&#146;s business. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Release of Claims </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The payments and promises set forth in this Agreement are in full satisfaction of all accrued salary, vacation pay, termination benefits,
bonuses, equity compensation, or other compensation to which you may be entitled by virtue of your employment with the Company or your separation from the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You knowingly and voluntarily (for you, your family, and your heirs, executors, administrators and assigns) release and forever discharge the
Company and its officers, directors, employees and agents from any and all complaints, liabilities, claims, promises, agreements, controversies, damages, causes of action, suits or expenses of any nature whatsoever, known or unknown, which you now
have or own or claim to have or own against the Company including, without limitation, claims under any employment laws, including, but not limited to, claims of unlawful discharge, breach of contract, breach of the covenant of good faith and fair
dealing, fraud, violation of public policy, defamation, physical injury, emotional distress, claims for additional compensation or benefits arising out of your employment or your separation of employment, including the Employment Agreement and the
Award Agreements. This release applies to all claims or causes of action including, but not limited to, claims arising under the common law of the State of Texas or any state or federal statute such as Title VII of the Civil Rights Act of 1964,
42&nbsp;U.S.C. &#167;&nbsp;1981-1988, the Civil Rights Act of 1991, the Americans With Disabilities Act of 1990, the Family and Medical Leave Act of 1993, the Worker Adjustment and Retraining Notification Act, the Genetic Information <FONT
STYLE="white-space:nowrap">Non-Discrimination</FONT> Act, the Immigration Reform Control Act, the National Labor Relations Act, the Occupational Safety and Health Act, the Texas Labor Code (specifically including the Texas Payday Law, the Texas
Anti-Retaliation Act, Chapter 21 of the Texas Labor Code, and the Texas Whistleblower Act), or the Employee Retirement Income Security Act of 1974, all as amended, any federal, state or local anti-discrimination, anti-harassment or anti-retaliation
law, regulation or ordinance, any federal, state or local wage and hour law, and any federal, state or local laws, regulations, or ordinance relating to employment or employment discrimination, including, without limitation, claims based on age or
under the Age Discrimination in Employment Act of 1967 or Older Workers Benefit Protection Act, each as amended (collectively, the &#147;Released Claims&#148;). This Agreement is not intended to indicate that any such claims exist or that, if they
do exist, they are meritorious. Rather, you are simply agreeing that, in exchange for any consideration received by you pursuant to this Agreement, any and all potential claims of this nature that you may have against the Company, regardless of
whether they actually exist, are expressly settled, compromised and waived. THIS RELEASE INCLUDES MATTERS ATTRIBUTABLE TO THE SOLE OR PARTIAL NEGLIGENCE (WHETHER GROSS OR SIMPLE) OR OTHER FAULT, INCLUDING STRICT LIABILITY, OF THE COMPANY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kyle F. McClure </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 5
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, this release, however, does not waive any rights or claims
that may arise after the date you sign this Agreement or any rights to indemnification or directors and officer&#146;s liability insurance to which you may be entitled for actions during your period of employment. You also agree not to sue or join
in any suit against the Company for any claim relating to or arising out of your employment or your separation from employment with the Company, <I>provided, however</I>, that nothing will preclude you from (i)&nbsp;bringing a lawsuit or proceeding
against the Company to enforce the Company&#146;s obligations under this Agreement or to challenge the enforceability of the release under the Older Worker Benefit Protection Act, (ii)&nbsp;filing a charge or complaint with, providing information
to, or testifying or otherwise assisting in any investigation or proceeding brought by any state, federal or local regulatory or law enforcement agency or legislative body, or (iii)&nbsp;filing any claims that are not permitted to be waived or
released under applicable law (including a challenge to the validity of this Agreement) with the Equal Employment Opportunity Commission, National Labor Relations Board or comparable state or local agency. However, you understand and agree that you
are waiving your right to receive any relief (legal or equitable) directly from the Company based on any charge, complaint, or lawsuit against the Company filed by you or anyone else on your behalf other than for a breach of the Company&#146;s
obligations under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You further acknowledge and agree that nothing in this Agreement prohibits you from reporting to any
governmental authority information concerning possible violations of law or regulation and that you shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of trade secret information in
confidence to a government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, and you may use such information in certain court proceedings provided you submit it under seal and consistent
with 18 U.S.C. 1833. Nothing contained in this Agreement prohibits you from voluntarily or anonymously contacting governmental authorities regarding possible violations of law or from recovering a whistleblower award. You will retain all rights and
consideration provided in this Agreement regardless of whether you communicate with any governmental authorities, or if you receive a whistleblower award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By signing this Agreement, you acknowledge and agree that, you are not entitled to and will not receive any further payments, compensation or
benefits under the Employment Agreement, the Incentive Plan or any other Company plan or program after the Separation Date or in respect of your employment with, or separation or termination from, the Company, that are in addition to the payments or
benefits described in this Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Representations and Warranties Regarding Claims </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You represent and warrant that, as of the time at which you sign this Agreement, you have not filed or joined any claims, complaints, charges,
or lawsuits against the Company with any governmental agency or with any state or federal court or arbitrator for, or with respect to, a matter, claim, or incident that occurred or arose out of one or more occurrences that took place on or prior to
the time at which you sign this Agreement (excluding, for the avoidance of doubt, any whistleblower complaints protected under applicable law), and you are not aware of any violation of any law, rule or regulation or any other misconduct by the
Company or any of its officers or employees. You further represent and warrant that you have not made any assignment, sale, delivery, transfer or conveyance of any rights you have asserted or may have against the Company with respect to any Released
Claim. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kyle F. McClure </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 6
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Severability </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any provision of this Agreement is held to be invalid or unenforceable, (i)&nbsp;this Agreement shall be considered divisible,
(ii)&nbsp;such provision shall be deemed inoperative to the extent it is deemed invalid or unenforceable, and (iii)&nbsp;in all other respects this Agreement shall remain in full force and effect; provided, however, that if any such provision may be
made valid or enforceable by limitation thereof, then such provision shall be deemed to be so limited and shall be valid and/or enforceable to the maximum extent permitted by applicable law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Release of Claims under the ADEA. </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By executing this Agreement, you will be releasing claims that you may have under the Age Discrimination in Employment Act (&#147;ADEA&#148;).
You will not be waiving any rights or claims under the ADEA that may arise after your execution of this Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Consideration Period
</U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You acknowledge and understand that you have forty-five (45)&nbsp;days after you receive this Agreement to decide whether to sign
this Agreement and be bound by its terms. You may take as much or as little of the forty-five (45)&nbsp;day period to consider this Agreement as you wish. You have the right to discuss any aspect of this matter with an attorney of your choosing, and
the Company recommends that you take advantage of this consideration period and consult with an attorney before executing this Agreement. By executing this Agreement, you will be acknowledging that you considered its terms for forty-five
(45)&nbsp;days or waived your right to do so, were advised in writing to seek legal counsel, and such earlier signature was not induced by the Company through fraud, misrepresentation or a threat to withdraw or alter this Agreement prior to the
expiration of such <FONT STYLE="white-space:nowrap">21-day</FONT> period. No changes (whether material or immaterial) to this Agreement shall restart the running of this <FONT STYLE="white-space:nowrap">21-day</FONT> period. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Revocation Period </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event
you agree to its terms and execute this Agreement, you may nevertheless revoke it within seven (7)&nbsp;days thereafter. Thus, if you subsequently change your mind, you have the option and right to revoke this Agreement, but you must do so within
seven (7)&nbsp;days after signing it by providing written notification via overnight mail or U.S. Mail at the address listed on the letterhead above to the attention of the Legal Department. This Agreement will not become effective until the seven
(7)&nbsp;day revocation period has expired. Of course, if this Agreement is revoked, you will not receive the COC Severance Benefits. If you do not revoke the Agreement within this time frame, it will become effective and both you and the Company
will be bound by its terms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Governing Law and Venue </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Texas, without regard to the
principles of conflicts of laws thereof. Venue for any action or proceeding relating to this Agreement and/or the employment relationship hereunder shall lie exclusively in courts in Harris County, Texas. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kyle F. McClure </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 7
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Withholding; Taxes </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may withhold from any amounts payable (including the vesting of stock awards) under this Agreement such federal, state, local or
foreign taxes as shall be required to be withheld pursuant to any applicable law or regulation. You acknowledge and agree that you are fully responsible for any taxes resulting from amounts payable under this Agreement and will not receive any tax <FONT
STYLE="white-space:nowrap">gross-ups</FONT> or similar payments from the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Compliance with Section&nbsp;409A </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company intends that the payment and benefits under this Agreement shall be exempt from or comply with Section&nbsp;409A of the Internal
Revenue Code (&#147;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A</I></B>&#148;) and this Agreement shall be interpreted, operated and administered accordingly. To the extent that the reimbursements or other
<FONT STYLE="white-space:nowrap">in-kind</FONT> benefits hereunder are &#147;nonqualified deferred compensation&#148; for purposes of Section&nbsp;409A, (a)&nbsp;all such expenses or other reimbursements shall be made on or prior to the last day of
the taxable year following the taxable year in which such expenses were incurred by you, (b)&nbsp;any right to reimbursements or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits shall not be subject to liquidation or exchange for another
benefit, and (c)&nbsp;no such reimbursement, expenses eligible for reimbursement, or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits provided in any taxable year shall in any way affect the expenses eligible for reimbursement, or <FONT
STYLE="white-space:nowrap">in-kind</FONT> benefits to be provided, in any other taxable year. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Entire Agreement </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement, the Award Agreements, and the Surviving Provisions constitute the entire agreement between the parties hereto concerning the
subject matter hereof, and from and after the date of this Agreement, this Agreement shall supersede any other prior agreement or understanding, both written and oral, between the parties with respect to such subject matter. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Acknowledgment and Acceptance of Agreement </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By signing this Agreement in the space provided below, you acknowledge that you have carefully read and fully understand all of the provisions
of this Agreement, that you have accepted its terms and that you are voluntarily entering into this Agreement without any undue influence or coercion from the Company. You have the right to discuss any aspect of this matter with an attorney of your
choosing, and the Company recommends that you take advantage of this time to consider this Agreement and consult with an attorney before executing this Agreement. In addition, please feel free to contact me to ask any questions regarding the
Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John V. Lovoi</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">John V. Lovoi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chairman of the Board of Directors</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to CIC Termination Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U><B>AGREED AND ACCEPTED</B>:</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">9/6/2024</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kyle F. McClure</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Kyle F. McClure</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to CIC Termination Agreement</I>] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>10
<FILENAME>d802924dex1010.htm
<DESCRIPTION>EX-10.10
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.10</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.10 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g802924dsp94.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B><U>Dril-Quip, Inc. &middot; 2050 West Sam Houston Parkway S., Suite 1100, Houston, Texas &middot; 77042 &middot; Tel
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">713-939-7711</FONT></FONT></U></B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;6, 2024 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">James
C. Webster </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Separation Agreement and Release </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear James: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This letter agreement (this
&#147;<B><I>Agreement</I></B>&#148;) confirms the terms and conditions concerning your termination of employment with the Company effective immediately following the closing of the mergers contemplated by the Agreement and Plan of Merger (the
&#147;<B><I>Merger Agreement</I></B>&#148;) dated March&nbsp;18, 2024 entered into by the Company, Innovex Downhole Solutions, Inc., and certain merger subsidiaries of the Company (the date of such closing under the Merger Agreement is herein
referred to as the &#147;<B><I>Separation Date</I></B>&#148;). For purposes of this Agreement, the &#147;<B><I>Company</I></B>&#148; means Dril-Quip, Inc. and any affiliate thereof, as well as their respective successors and assigns. You and the
Company are sometimes referred to as the parties in this Agreement. For purposes of this Agreement, the parties agree that your termination is a termination of employment by the Company without Cause during a Change of Control Period as described in
Section&nbsp;6(c) of the Employment Agreement between you and the Company dated as of December&nbsp;2, 2021 (the &#147;<B><I>Employment Agreement</I></B>&#148;) and that this Agreement is the written Notice of Termination of your employment for
purposes of the Employment Agreement. Capitalized terms not defined in this Agreement shall have the meaning given in the Employment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your acceptance of this Agreement must be indicated by signing on the last page of this Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Resignation from Officer and Director Positions </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon your execution of this Agreement, your employment will terminate and you shall be deemed to have resigned and not hold yourself out as a
director, officer, executive, employee, agent, member or representative of the Company and you agree to take any and all actions necessary effectuate any documentation the Company requests to effectuate the foregoing. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Accrued Salary and PTO Payment </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Section&nbsp;6(a) of the Employment Agreement, the Company shall pay you a <FONT STYLE="white-space:nowrap">lump-sum</FONT> cash payment
in an amount equal to the total of your (i)&nbsp;Base Salary earned through the Separation Date and (ii)&nbsp;accrued, but unpaid vacation time or <FONT STYLE="white-space:nowrap">paid-time-off</FONT> (PTO), in each case to the extent not previously
paid. This amount will be paid to you on the Separation Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided in this Agreement, all of your employee benefits
provided by the Company and your participation in the Company&#146;s 401(k) plan shall terminate on the Separation Date. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">James C. Webster </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You will be reimbursed according to the Company&#146;s reimbursement policies for any
outstanding business expenses incurred up to the Separation Date, provided such expenses are timely submitted as required under the Company&#146;s reimbursement policies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Separation Pay and Benefits </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Section&nbsp;6(c) of the Employment Agreement and subject to your execution and return of this Agreement, and provided that you do
not later revoke your agreement and release of all claims as described below, you will receive the below COC Severance Benefits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>COC
Payments </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Company&#146;s first regular payroll date that is more than 8 days following the Separation Date, the Company shall
pay you a <FONT STYLE="white-space:nowrap">lump-sum</FONT> cash payment in the amount of $1,440,000, which is equal to the sum of two (2)&nbsp;times your Base Salary in effect as of the Separation Date and two (2)&nbsp;times the target amount of
your Annual Bonus for 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Company&#146;s first regular payroll date that is more than 8 days following the Separation Date, the
Company will pay you a <FONT STYLE="white-space:nowrap">lump-sum</FONT> cash payment equal to the product of $211,680, which is the target amount of your Annual Bonus for 2024 and a fraction, the numerator of which shall be the number of Business
Days from January&nbsp;1, 2024 to the Separation Date and the denominator of which is 260. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Restricted Stock Awards, Performance Unit
Awards and Restricted Stock Units </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of &#147;<B><I>Restricted Stock</I></B>&#148; granted to you under the Company&#146;s
2017 Omnibus Incentive Plan (the &#147;<B><I>Incentive Plan</I></B>&#148;) that are unvested immediately prior to the Separation Date will become 100% fully vested on the Separation Date. All award agreements between you and the Company are referred
to herein collectively as the &#147;<B><I>Award Agreements</I></B>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The &#147;<B><I>Performance Units</I></B>&#148; granted to you
under the Incentive Plan that are unvested immediately prior to the Separation Date will vest on the Separation Date based on the target level of performance for the Performance Units, and shares of Company common stock equal to that target number
of vested Performance Units will be issued and delivered to you on the Separation Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The &#147;<B><I>Restricted Stock
Units</I></B>&#148; granted to you under the Incentive Plan as additional incentive in relation to the Merger Agreement that are payable in stock and are unvested immediately prior to the Separation Date will become 100% fully vested on the
Separation Date. To the extent that the Restricted Stock Units granted to you under the Incentive Plan as additional incentive in relation to the Merger Agreement are payable in cash and vest upon closing of the mergers contemplated by the Merger
Agreement, the cash payments shall be made on the Company&#146;s first regular payroll date that is more than 8 days following the Separation Date, with the amount of such payment equal to the cash equivalent of such units using the closing price
per share of the Company&#146;s common stock on the last trading day prior to the date of such closing. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">James C. Webster </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Continued Medical, Dental and Life Insurance at Company&#146;s Cost </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You will continue to receive medical, dental and life insurance coverage, at the same active employee premium cost charged to employees of the
Company, for yourself and your covered dependents (the &#147;<B><I>Continued Medical/Life Benefits</I></B>&#148;) following the Separation Date until the earlier of (i)&nbsp;your receipt of equivalent coverage and benefits under the plans and
programs of a subsequent employer (with such coverage and benefits determined on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">coverage-by-coverage</FONT></FONT> or <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">benefit-by-benefit</FONT></FONT> basis) or (ii) 2 years after the Separation Date. The premiums will be billed to you in arrears on a quarterly basis for each month that you continue to receive the Continued Medical/Life
Benefits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if you or your covered dependents are precluded from continuing participation in any benefit
plan or program as provided above, the Company will pay you the <FONT STYLE="white-space:nowrap">after-tax</FONT> economic equivalent of the benefits provided under the plan or program in which you or they are unable to participate for the period
described above, with such economic equivalent determined based on the cost that would be incurred by you in obtaining such benefit yourself on an individual basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The medical and dental benefits provided under the paragraph above are treated as your COBRA coverage and accordingly your COBRA continuation
period will begin on the Separation Date. Except for the Continued Medical/Life Benefits, coverage under all other Company welfare benefits will cease on the Separation Date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Continuing Obligations; <FONT STYLE="white-space:nowrap">Non-Competition,</FONT> <FONT STYLE="white-space:nowrap">Non-Solicitation</FONT> And
Confidentiality </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You expressly affirm and acknowledge your continuing obligations under the Employment Agreement to maintain the
confidentiality of the Company&#146;s confidential information, among other things, and that you are subject to, and will comply with, the <FONT STYLE="white-space:nowrap">non-competition</FONT> and
<FONT STYLE="white-space:nowrap">non-solicitation</FONT> obligations under the Employment Agreement (collectively, the &#147;<B><I>Covenants</I></B>&#148;). Further, you recognize and affirm that the Covenants (and the Company&#146;s right to relief
for your failure to comply with the Covenants) and Section&nbsp;6(f) (collectively, the &#147;<B><I>Surviving Provisions</I></B>&#148;) expressly survive the Separation Date and the termination of your employment with the Company pursuant to the
terms of the Employment Agreement and for any time periods specified therein. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Return of Company Property </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You agree as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On or prior to the Separation Date, you will return all Company property in your possession, custody, or control,
including all equipment such as your Company-issued laptop, documents and things, issued to you, except that you may keep your cellular phone and phone number. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On or prior to the Separation Date, you will return, if in your possession, any Company property, documents,
files or other paper or electronic media pertinent to the Company&#146;s business. You should keep your personal records, including your personal pay records and tax documents. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On or prior to the Separation Date, you will search for and delete all Company information, including all secret,
confidential or proprietary information, that may exist on your personal electronic devices such as a smartphone, laptop, tablet, personal computer, flash drive, or any other electronic storage device, other than the payroll information provided to
you that you may need to file your tax returns or keep your financial records. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">James C. Webster </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 4
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">You have not and will not remove from the Company&#146;s premises any Company property, documents, files or other
paper or electronic media pertinent to the Company&#146;s business. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Release of Claims </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The payments and promises set forth in this Agreement are in full satisfaction of all accrued salary, vacation pay, termination benefits,
bonuses, equity compensation, or other compensation to which you may be entitled by virtue of your employment with the Company or your separation from the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You knowingly and voluntarily (for you, your family, and your heirs, executors, administrators and assigns) release and forever discharge the
Company and its officers, directors, employees and agents from any and all complaints, liabilities, claims, promises, agreements, controversies, damages, causes of action, suits or expenses of any nature whatsoever, known or unknown, which you now
have or own or claim to have or own against the Company including, without limitation, claims under any employment laws, including, but not limited to, claims of unlawful discharge, breach of contract, breach of the covenant of good faith and fair
dealing, fraud, violation of public policy, defamation, physical injury, emotional distress, claims for additional compensation or benefits arising out of your employment or your separation of employment, including the Employment Agreement and the
Award Agreements. This release applies to all claims or causes of action including, but not limited to, claims arising under the common law of the State of Texas or any state or federal statute such as Title VII of the Civil Rights Act of 1964,
42&nbsp;U.S.C. &#167;&nbsp;1981-1988, the Civil Rights Act of 1991, the Americans With Disabilities Act of 1990, the Family and Medical Leave Act of 1993, the Worker Adjustment and Retraining Notification Act, the Genetic Information <FONT
STYLE="white-space:nowrap">Non-Discrimination</FONT> Act, the Immigration Reform Control Act, the National Labor Relations Act, the Occupational Safety and Health Act, the Texas Labor Code (specifically including the Texas Payday Law, the Texas
Anti-Retaliation Act, Chapter 21 of the Texas Labor Code, and the Texas Whistleblower Act), or the Employee Retirement Income Security Act of 1974, all as amended, any federal, state or local anti-discrimination, anti-harassment or anti-retaliation
law, regulation or ordinance, any federal, state or local wage and hour law, and any federal, state or local laws, regulations, or ordinance relating to employment or employment discrimination, including, without limitation, claims based on age or
under the Age Discrimination in Employment Act of 1967 or Older Workers Benefit Protection Act, each as amended (collectively, the &#147;Released Claims&#148;). This Agreement is not intended to indicate that any such claims exist or that, if they
do exist, they are meritorious. Rather, you are simply agreeing that, in exchange for any consideration received by you pursuant to this Agreement, any and all potential claims of this nature that you may have against the Company, regardless of
whether they actually exist, are expressly settled, compromised and waived. THIS RELEASE INCLUDES MATTERS ATTRIBUTABLE TO THE SOLE OR PARTIAL NEGLIGENCE (WHETHER GROSS OR SIMPLE) OR OTHER FAULT, INCLUDING STRICT LIABILITY, OF THE COMPANY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">James C. Webster </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 5
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, this release, however, does not waive any rights or claims
that may arise after the date you sign this Agreement or any rights to indemnification or directors and officer&#146;s liability insurance to which you may be entitled for actions during your period of employment. You also agree not to sue or join
in any suit against the Company for any claim relating to or arising out of your employment or your separation from employment with the Company, <I>provided, however</I>, that nothing will preclude you from (i)&nbsp;bringing a lawsuit or proceeding
against the Company to enforce the Company&#146;s obligations under this Agreement or to challenge the enforceability of the release under the Older Worker Benefit Protection Act, (ii)&nbsp;filing a charge or complaint with, providing information
to, or testifying or otherwise assisting in any investigation or proceeding brought by any state, federal or local regulatory or law enforcement agency or legislative body, or (iii)&nbsp;filing any claims that are not permitted to be waived or
released under applicable law (including a challenge to the validity of this Agreement) with the Equal Employment Opportunity Commission, National Labor Relations Board or comparable state or local agency. However, you understand and agree that you
are waiving your right to receive any relief (legal or equitable) directly from the Company based on any charge, complaint, or lawsuit against the Company filed by you or anyone else on your behalf other than for a breach of the Company&#146;s
obligations under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You further acknowledge and agree that nothing in this Agreement prohibits you from reporting to any
governmental authority information concerning possible violations of law or regulation and that you shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of trade secret information in
confidence to a government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, and you may use such information in certain court proceedings provided you submit it under seal and consistent
with 18 U.S.C. 1833. Nothing contained in this Agreement prohibits you from voluntarily or anonymously contacting governmental authorities regarding possible violations of law or from recovering a whistleblower award. You will retain all rights and
consideration provided in this Agreement regardless of whether you communicate with any governmental authorities, or if you receive a whistleblower award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By signing this Agreement, you acknowledge and agree that, you are not entitled to and will not receive any further payments, compensation or
benefits under the Employment Agreement, the Incentive Plan or any other Company plan or program after the Separation Date or in respect of your employment with, or separation or termination from, the Company, that are in addition to the payments or
benefits described in this Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Representations and Warranties Regarding Claims </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You represent and warrant that, as of the time at which you sign this Agreement, you have not filed or joined any claims, complaints, charges,
or lawsuits against the Company with any governmental agency or with any state or federal court or arbitrator for, or with respect to, a matter, claim, or incident that occurred or arose out of one or more occurrences that took place on or prior to
the time at which you sign this Agreement (excluding, for the avoidance of doubt, any whistleblower complaints protected under applicable law), and you are not aware of any violation of any law, rule or regulation or any other misconduct by the
Company or any of its officers or employees. You further represent and warrant that you have not made any assignment, sale, delivery, transfer or conveyance of any rights you have asserted or may have against the Company with respect to any Released
Claim. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">James C. Webster </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 6
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Severability </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any provision of this Agreement is held to be invalid or unenforceable, (i)&nbsp;this Agreement shall be considered divisible,
(ii)&nbsp;such provision shall be deemed inoperative to the extent it is deemed invalid or unenforceable, and (iii)&nbsp;in all other respects this Agreement shall remain in full force and effect; provided, however, that if any such provision may be
made valid or enforceable by limitation thereof, then such provision shall be deemed to be so limited and shall be valid and/or enforceable to the maximum extent permitted by applicable law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Release of Claims under the ADEA. </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>&#8195;&#8195;</U>By executing this Agreement, you will be releasing claims that you may have under the Age Discrimination in Employment Act
(&#147;ADEA&#148;). You will not be waiving any rights or claims under the ADEA that may arise after your execution of this Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Consideration Period </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You
acknowledge and understand that you have forty-five (45)&nbsp;days after you receive this Agreement to decide whether to sign this Agreement and be bound by its terms. You may take as much or as little of the forty-five (45)&nbsp;day period to
consider this Agreement as you wish. You have the right to discuss any aspect of this matter with an attorney of your choosing, and the Company recommends that you take advantage of this consideration period and consult with an attorney before
executing this Agreement. By executing this Agreement, you will be acknowledging that you considered its terms for forty-five (45)&nbsp;days or waived your right to do so, were advised in writing to seek legal counsel, and such earlier signature was
not induced by the Company through fraud, misrepresentation or a threat to withdraw or alter this Agreement prior to the expiration of such <FONT STYLE="white-space:nowrap">21-day</FONT> period. No changes (whether material or immaterial) to this
Agreement shall restart the running of this <FONT STYLE="white-space:nowrap">21-day</FONT> period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Revocation Period </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event you agree to its terms and execute this Agreement, you may nevertheless revoke it within seven (7)&nbsp;days thereafter. Thus, if
you subsequently change your mind, you have the option and right to revoke this Agreement, but you must do so within seven (7)&nbsp;days after signing it by providing written notification via overnight mail or U.S. Mail at the address listed on the
letterhead above to the attention of the Legal Department. This Agreement will not become effective until the seven (7)&nbsp;day revocation period has expired. Of course, if this Agreement is revoked, you will not receive the COC Severance Benefits.
If you do not revoke the Agreement within this time frame, it will become effective and both you and the Company will be bound by its terms. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Governing Law and Venue </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Texas, without regard to the principles of conflicts of laws thereof. Venue for any action or proceeding relating to this Agreement and/or the
employment relationship hereunder shall lie exclusively in courts in Harris County, Texas. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">James C. Webster </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 7
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Withholding; Taxes </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may withhold from any amounts payable (including the vesting of stock awards) under this Agreement such federal, state, local or
foreign taxes as shall be required to be withheld pursuant to any applicable law or regulation. You acknowledge and agree that you are fully responsible for any taxes resulting from amounts payable under this Agreement and will not receive any tax <FONT
STYLE="white-space:nowrap">gross-ups</FONT> or similar payments from the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Compliance with Section&nbsp;409A </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company intends that the payment and benefits under this Agreement shall be exempt from or comply with Section&nbsp;409A of the Internal
Revenue Code (&#147;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A</I></B>&#148;) and this Agreement shall be interpreted, operated and administered accordingly. To the extent that the reimbursements or other
<FONT STYLE="white-space:nowrap">in-kind</FONT> benefits hereunder are &#147;nonqualified deferred compensation&#148; for purposes of Section&nbsp;409A, (a)&nbsp;all such expenses or other reimbursements shall be made on or prior to the last day of
the taxable year following the taxable year in which such expenses were incurred by you, (b)&nbsp;any right to reimbursements or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits shall not be subject to liquidation or exchange for another
benefit, and (c)&nbsp;no such reimbursement, expenses eligible for reimbursement, or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits provided in any taxable year shall in any way affect the expenses eligible for reimbursement, or <FONT
STYLE="white-space:nowrap">in-kind</FONT> benefits to be provided, in any other taxable year. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Entire Agreement </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement, the Award Agreements, and the Surviving Provisions constitute the entire agreement between the parties hereto concerning the
subject matter hereof, and from and after the date of this Agreement, this Agreement shall supersede any other prior agreement or understanding, both written and oral, between the parties with respect to such subject matter. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Acknowledgment and Acceptance of Agreement </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By signing this Agreement in the space provided below, you acknowledge that you have carefully read and fully understand all of the provisions
of this Agreement, that you have accepted its terms and that you are voluntarily entering into this Agreement without any undue influence or coercion from the Company. You have the right to discuss any aspect of this matter with an attorney of your
choosing, and the Company recommends that you take advantage of this time to consider this Agreement and consult with an attorney before executing this Agreement. In addition, please feel free to contact me to ask any questions regarding the
Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John V. Lovoi</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">John V. Lovoi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chairman of the Board of Directors</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to CIC Termination Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B><U>AGREED AND ACCEPTED:</U></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">9/6/2024</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James C. Webster</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">James C. Webster</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to CIC Termination Agreement</I>] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>11
<FILENAME>d802924dex1011.htm
<DESCRIPTION>EX-10.11
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.11</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.11 </B></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g802924dsp94.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><U>Dril-Quip, Inc. &middot; 2050 West Sam Houston Parkway S., Suite 1100, Houston, Texas &middot; 77042 &middot; Tel
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">713-939-7711</FONT></FONT></U></B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;6, 2024 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Don
Underwood </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Separation Agreement and Release </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Don: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This letter agreement (this
&#147;<B><I>Agreement</I></B>&#148;) confirms the terms and conditions concerning your termination of employment with the Company effective immediately following the closing of the mergers contemplated by the Agreement and Plan of Merger (the
&#147;<B><I>Merger Agreement</I></B>&#148;) dated March&nbsp;18, 2024 entered into by the Company, Innovex Downhole Solutions, Inc., and certain merger subsidiaries of the Company (the date of such closing under the Merger Agreement is herein
referred to as the &#147;<B><I>Separation Date</I></B>&#148;). For purposes of this Agreement, the &#147;<B><I>Company</I></B>&#148; means Dril-Quip, Inc. and any affiliate thereof, as well as their respective successors and assigns. You and the
Company are sometimes referred to as the parties in this Agreement. For purposes of this Agreement, the parties agree that your termination is a termination of employment by the Company without Cause during a Change of Control Period as described in
Section&nbsp;6(c) of the Employment Agreement between you and the Company effective as of October&nbsp;25, 2022 (the &#147;<B><I>Employment Agreement</I></B>&#148;) and that this Agreement is the written Notice of Termination of your employment for
purposes of the Employment Agreement. Capitalized terms not defined in this Agreement shall have the meaning given in the Employment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your acceptance of this Agreement must be indicated by signing on the last page of this Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Resignation from Officer and Director Positions </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon your execution of this Agreement, your employment will terminate and you shall be deemed to have resigned and not hold yourself out as a
director, officer, executive, employee, agent, member or representative of the Company and you agree to take any and all actions necessary effectuate any documentation the Company requests to effectuate the foregoing. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Accrued Salary and PTO Payment </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Section&nbsp;6(a) of the Employment Agreement, the Company shall pay you a <FONT STYLE="white-space:nowrap">lump-sum</FONT> cash payment
in an amount equal to the total of your (i)&nbsp;Base Salary earned through the Separation Date and (ii)&nbsp;accrued, but unpaid vacation time or <FONT STYLE="white-space:nowrap">paid-time-off</FONT> (PTO), in each case to the extent not previously
paid. This amount will be paid to you on the Separation Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided in this Agreement, all of your employee benefits
provided by the Company and your participation in the Company&#146;s 401(k) plan shall terminate on the Separation Date. </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Don Underwood </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You will be reimbursed according to the Company&#146;s reimbursement policies for any
outstanding business expenses incurred up to the Separation Date, provided such expenses are timely submitted as required under the Company&#146;s reimbursement policies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Separation Pay and Benefits </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Section&nbsp;6(c) of the Employment Agreement and subject to your execution and return of this Agreement, and provided that you do
not later revoke your agreement and release of all claims as described below, you will receive the below COC Severance Benefits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>COC
Payments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Company&#146;s first regular payroll date that is more than 8 days following the Separation Date, the Company shall
pay you a <FONT STYLE="white-space:nowrap">lump-sum</FONT> cash payment in the amount of $1,056,000, which is equal to the sum of two (2)&nbsp;times your Base Salary in effect as of the Separation Date and two (2)&nbsp;times the target amount of
your Annual Bonus for 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Company&#146;s first regular payroll date that is more than 8 days following the Separation Date, the
Company will pay you a <FONT STYLE="white-space:nowrap">lump-sum</FONT> cash payment equal to the product of $130,977, which is the target amount of your Annual Bonus for 2024 and a fraction, the numerator of which shall be the number of Business
Days from January&nbsp;1, 2024 to the Separation Date and the denominator of which is 260. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Restricted Stock Awards, Performance Unit
Awards and Restricted Stock Units </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of &#147;<B><I>Restricted Stock</I></B>&#148; granted to you under the Company&#146;s
2017 Omnibus Incentive Plan (the &#147;<B><I>Incentive Plan</I></B>&#148;) that are unvested immediately prior to the Separation Date will become 100% fully vested on the Separation Date. All award agreements between you and the Company are referred
to herein collectively as the &#147;<B><I>Award Agreements</I></B>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The &#147;<B><I>Performance Units</I></B>&#148; granted to you
under the Incentive Plan that are unvested immediately prior to the Separation Date will vest on the Separation Date based on the target level of performance for the Performance Units, and shares of Company common stock equal to that target number
of vested Performance Units will be issued and delivered to you on the Separation Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The &#147;<B><I>Restricted Stock
Units</I></B>&#148; granted to you under the Incentive Plan as additional incentive in relation to the Merger Agreement that are payable in stock and are unvested immediately prior to the Separation Date will become 100% fully vested on the
Separation Date. To the extent that the Restricted Stock Units granted to you under the Incentive Plan as additional incentive in relation to the Merger Agreement are payable in cash and vest upon closing of the mergers contemplated by the Merger
Agreement, the cash payments shall be made on the Company&#146;s first regular payroll date that is more than 8 days following the Separation Date, with the amount of such payment equal to the cash equivalent of such units using the closing price
per share of the Company&#146;s common stock on the last trading day prior to the date of such closing. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Don Underwood </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Continued Medical, Dental and Life Insurance at Company&#146;s Cost </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You will continue to receive medical, dental and life insurance coverage, at the same active employee premium cost charged to employees of the
Company, for yourself and your covered dependents (the &#147;<B><I>Continued Medical/Life Benefits</I></B>&#148;) following the Separation Date until the earlier of (i)&nbsp;your receipt of equivalent coverage and benefits under the plans and
programs of a subsequent employer (with such coverage and benefits determined on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">coverage-by-coverage</FONT></FONT> or <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">benefit-by-benefit</FONT></FONT> basis) or (ii) 2 years after the Separation Date. The premiums will be billed to you in arrears on a quarterly basis for each month that you continue to receive the Continued Medical/Life
Benefits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if you or your covered dependents are precluded from continuing participation in any benefit
plan or program as provided above, the Company will pay you the <FONT STYLE="white-space:nowrap">after-tax</FONT> economic equivalent of the benefits provided under the plan or program in which you or they are unable to participate for the period
described above, with such economic equivalent determined based on the cost that would be incurred by you in obtaining such benefit yourself on an individual basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The medical and dental benefits provided under the paragraph above are treated as your COBRA coverage and accordingly your COBRA continuation
period will begin on the Separation Date. Except for the Continued Medical/Life Benefits, coverage under all other Company welfare benefits will cease on the Separation Date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Continuing Obligations; <FONT STYLE="white-space:nowrap">Non-Competition,</FONT> <FONT STYLE="white-space:nowrap">Non-Solicitation</FONT> And
Confidentiality </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You expressly affirm and acknowledge your continuing obligations under the Employment Agreement to maintain the
confidentiality of the Company&#146;s confidential information, among other things, and that you are subject to, and will comply with, the <FONT STYLE="white-space:nowrap">non-competition</FONT> and
<FONT STYLE="white-space:nowrap">non-solicitation</FONT> obligations under the Employment Agreement (collectively, the &#147;<B><I>Covenants</I></B>&#148;). Further, you recognize and affirm that the Covenants (and the Company&#146;s right to relief
for your failure to comply with the Covenants) and Section&nbsp;6(f) (collectively, the &#147;<B><I>Surviving Provisions</I></B>&#148;) expressly survive the Separation Date and the termination of your employment with the Company pursuant to the
terms of the Employment Agreement and for any time periods specified therein. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Return of Company Property </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You agree as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On or prior to the Separation Date, you will return all Company property in your possession, custody, or control,
including all equipment such as your Company-issued laptop, documents and things, issued to you, except that you may keep your cellular phone and phone number. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On or prior to the Separation Date, you will return, if in your possession, any Company property, documents,
files or other paper or electronic media pertinent to the Company&#146;s business. You should keep your personal records, including your personal pay records and tax documents. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On or prior to the Separation Date, you will search for and delete all Company information, including all secret,
confidential or proprietary information, that may exist on your personal electronic devices such as a smartphone, laptop, tablet, personal computer, flash drive, or any other electronic storage device, other than the payroll information provided to
you that you may need to file your tax returns or keep your financial records. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Don Underwood </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 4
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">You have not and will not remove from the Company&#146;s premises any Company property, documents, files or other
paper or electronic media pertinent to the Company&#146;s business. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Release of Claims </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The payments and promises set forth in this Agreement are in full satisfaction of all accrued salary, vacation pay, termination benefits,
bonuses, equity compensation, or other compensation to which you may be entitled by virtue of your employment with the Company or your separation from the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You knowingly and voluntarily (for you, your family, and your heirs, executors, administrators and assigns) release and forever discharge the
Company and its officers, directors, employees and agents from any and all complaints, liabilities, claims, promises, agreements, controversies, damages, causes of action, suits or expenses of any nature whatsoever, known or unknown, which you now
have or own or claim to have or own against the Company including, without limitation, claims under any employment laws, including, but not limited to, claims of unlawful discharge, breach of contract, breach of the covenant of good faith and fair
dealing, fraud, violation of public policy, defamation, physical injury, emotional distress, claims for additional compensation or benefits arising out of your employment or your separation of employment, including the Employment Agreement and the
Award Agreements. This release applies to all claims or causes of action including, but not limited to, claims arising under the common law of the State of Texas or any state or federal statute such as Title VII of the Civil Rights Act of 1964,
42&nbsp;U.S.C. &#167;&nbsp;1981-1988, the Civil Rights Act of 1991, the Americans With Disabilities Act of 1990, the Family and Medical Leave Act of 1993, the Worker Adjustment and Retraining Notification Act, the Genetic Information <FONT
STYLE="white-space:nowrap">Non-Discrimination</FONT> Act, the Immigration Reform Control Act, the National Labor Relations Act, the Occupational Safety and Health Act, the Texas Labor Code (specifically including the Texas Payday Law, the Texas
Anti-Retaliation Act, Chapter 21 of the Texas Labor Code, and the Texas Whistleblower Act), or the Employee Retirement Income Security Act of 1974, all as amended, any federal, state or local anti-discrimination, anti-harassment or anti-retaliation
law, regulation or ordinance, any federal, state or local wage and hour law, and any federal, state or local laws, regulations, or ordinance relating to employment or employment discrimination, including, without limitation, claims based on age or
under the Age Discrimination in Employment Act of 1967 or Older Workers Benefit Protection Act, each as amended (collectively, the &#147;Released Claims&#148;). This Agreement is not intended to indicate that any such claims exist or that, if they
do exist, they are meritorious. Rather, you are simply agreeing that, in exchange for any consideration received by you pursuant to this Agreement, any and all potential claims of this nature that you may have against the Company, regardless of
whether they actually exist, are expressly settled, compromised and waived. THIS RELEASE INCLUDES MATTERS ATTRIBUTABLE TO THE SOLE OR PARTIAL NEGLIGENCE (WHETHER GROSS OR SIMPLE) OR OTHER FAULT, INCLUDING STRICT LIABILITY, OF THE COMPANY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Don Underwood </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 5
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, this release, however, does not waive any rights or claims
that may arise after the date you sign this Agreement or any rights to indemnification or directors and officer&#146;s liability insurance to which you may be entitled for actions during your period of employment. You also agree not to sue or join
in any suit against the Company for any claim relating to or arising out of your employment or your separation from employment with the Company, <I>provided, however</I>, that nothing will preclude you from (i)&nbsp;bringing a lawsuit or proceeding
against the Company to enforce the Company&#146;s obligations under this Agreement or to challenge the enforceability of the release under the Older Worker Benefit Protection Act, (ii)&nbsp;filing a charge or complaint with, providing information
to, or testifying or otherwise assisting in any investigation or proceeding brought by any state, federal or local regulatory or law enforcement agency or legislative body, or (iii)&nbsp;filing any claims that are not permitted to be waived or
released under applicable law (including a challenge to the validity of this Agreement) with the Equal Employment Opportunity Commission, National Labor Relations Board or comparable state or local agency. However, you understand and agree that you
are waiving your right to receive any relief (legal or equitable) directly from the Company based on any charge, complaint, or lawsuit against the Company filed by you or anyone else on your behalf other than for a breach of the Company&#146;s
obligations under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You further acknowledge and agree that nothing in this Agreement prohibits you from reporting to any
governmental authority information concerning possible violations of law or regulation and that you shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of trade secret information in
confidence to a government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, and you may use such information in certain court proceedings provided you submit it under seal and consistent
with 18 U.S.C. 1833. Nothing contained in this Agreement prohibits you from voluntarily or anonymously contacting governmental authorities regarding possible violations of law or from recovering a whistleblower award. You will retain all rights and
consideration provided in this Agreement regardless of whether you communicate with any governmental authorities, or if you receive a whistleblower award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By signing this Agreement, you acknowledge and agree that, you are not entitled to and will not receive any further payments, compensation or
benefits under the Employment Agreement, the Incentive Plan or any other Company plan or program after the Separation Date or in respect of your employment with, or separation or termination from, the Company, that are in addition to the payments or
benefits described in this Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Representations and Warranties Regarding Claims </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You represent and warrant that, as of the time at which you sign this Agreement, you have not filed or joined any claims, complaints, charges,
or lawsuits against the Company with any governmental agency or with any state or federal court or arbitrator for, or with respect to, a matter, claim, or incident that occurred or arose out of one or more occurrences that took place on or prior to
the time at which you sign this Agreement (excluding, for the avoidance of doubt, any whistleblower complaints protected under applicable law), and you are not aware of any violation of any law, rule or regulation or any other misconduct by the
Company or any of its officers or employees. You further represent and warrant that you have not made any assignment, sale, delivery, transfer or conveyance of any rights you have asserted or may have against the Company with respect to any Released
Claim. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Don Underwood </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 6
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Severability </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any provision of this Agreement is held to be invalid or unenforceable, (i)&nbsp;this Agreement shall be considered divisible,
(ii)&nbsp;such provision shall be deemed inoperative to the extent it is deemed invalid or unenforceable, and (iii)&nbsp;in all other respects this Agreement shall remain in full force and effect; provided, however, that if any such provision may be
made valid or enforceable by limitation thereof, then such provision shall be deemed to be so limited and shall be valid and/or enforceable to the maximum extent permitted by applicable law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Release of Claims under the ADEA. </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By executing this Agreement, you will be releasing claims that you may have under the Age Discrimination in Employment Act (&#147;ADEA&#148;).
You will not be waiving any rights or claims under the ADEA that may arise after your execution of this Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Consideration Period
</U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You acknowledge and understand that you have forty-five (45)&nbsp;days after you receive this Agreement to decide whether to sign
this Agreement and be bound by its terms. You may take as much or as little of the forty-five (45)&nbsp;day period to consider this Agreement as you wish. You have the right to discuss any aspect of this matter with an attorney of your choosing, and
the Company recommends that you take advantage of this consideration period and consult with an attorney before executing this Agreement. By executing this Agreement, you will be acknowledging that you considered its terms for forty-five
(45)&nbsp;days or waived your right to do so, were advised in writing to seek legal counsel, and such earlier signature was not induced by the Company through fraud, misrepresentation or a threat to withdraw or alter this Agreement prior to the
expiration of such <FONT STYLE="white-space:nowrap">21-day</FONT> period. No changes (whether material or immaterial) to this Agreement shall restart the running of this <FONT STYLE="white-space:nowrap">21-day</FONT> period. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Revocation Period </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event
you agree to its terms and execute this Agreement, you may nevertheless revoke it within seven (7)&nbsp;days thereafter. Thus, if you subsequently change your mind, you have the option and right to revoke this Agreement, but you must do so within
seven (7)&nbsp;days after signing it by providing written notification via overnight mail or U.S. Mail at the address listed on the letterhead above to the attention of the Legal Department. This Agreement will not become effective until the seven
(7)&nbsp;day revocation period has expired. Of course, if this Agreement is revoked, you will not receive the COC Severance Benefits. If you do not revoke the Agreement within this time frame, it will become effective and both you and the Company
will be bound by its terms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Governing Law and Venue </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Texas, without regard to the
principles of conflicts of laws thereof. Venue for any action or proceeding relating to this Agreement and/or the employment relationship hereunder shall lie exclusively in courts in Harris County, Texas. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Don Underwood </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 6, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 7
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Withholding; Taxes </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may withhold from any amounts payable (including the vesting of stock awards) under this Agreement such federal, state, local or
foreign taxes as shall be required to be withheld pursuant to any applicable law or regulation. You acknowledge and agree that you are fully responsible for any taxes resulting from amounts payable under this Agreement and will not receive any tax <FONT
STYLE="white-space:nowrap">gross-ups</FONT> or similar payments from the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Compliance with Section&nbsp;409A </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company intends that the payment and benefits under this Agreement shall be exempt from or comply with Section&nbsp;409A of the Internal
Revenue Code (&#147;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A</I></B>&#148;) and this Agreement shall be interpreted, operated and administered accordingly. To the extent that the reimbursements or other
<FONT STYLE="white-space:nowrap">in-kind</FONT> benefits hereunder are &#147;nonqualified deferred compensation&#148; for purposes of Section&nbsp;409A, (a)&nbsp;all such expenses or other reimbursements shall be made on or prior to the last day of
the taxable year following the taxable year in which such expenses were incurred by you, (b)&nbsp;any right to reimbursements or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits shall not be subject to liquidation or exchange for another
benefit, and (c)&nbsp;no such reimbursement, expenses eligible for reimbursement, or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits provided in any taxable year shall in any way affect the expenses eligible for reimbursement, or <FONT
STYLE="white-space:nowrap">in-kind</FONT> benefits to be provided, in any other taxable year. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Entire Agreement </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement, the Award Agreements, and the Surviving Provisions constitute the entire agreement between the parties hereto concerning the
subject matter hereof, and from and after the date of this Agreement, this Agreement shall supersede any other prior agreement or understanding, both written and oral, between the parties with respect to such subject matter. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Acknowledgment and Acceptance of Agreement </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By signing this Agreement in the space provided below, you acknowledge that you have carefully read and fully understand all of the provisions
of this Agreement, that you have accepted its terms and that you are voluntarily entering into this Agreement without any undue influence or coercion from the Company. You have the right to discuss any aspect of this matter with an attorney of your
choosing, and the Company recommends that you take advantage of this time to consider this Agreement and consult with an attorney before executing this Agreement. In addition, please feel free to contact me to ask any questions regarding the
Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John V. Lovoi</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">John V. Lovoi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chairman of the Board of Directors</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to CIC Termination Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U><B>AGREED AND ACCEPTED</B>:</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">9/6/2024</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Don M. Underwood</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Don M. Underwood</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to CIC Termination Agreement</I>] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>12
<FILENAME>d802924dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Innovex and Dril-Quip Complete Merger, Creating Unique Energy Industrial Platform </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Innovex International to Begin Trading on NYSE Under Symbol &#147;INVX&#148; on September&nbsp;9, 2024 </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">HOUSTON &#150; September&nbsp;6, 2024 &#150; Dril-Quip, Inc. (NYSE: DRQ) (&#147;Dril-Quip&#148; or the &#147;Company&#148;), a leading developer, manufacturer
and provider of highly engineered equipment and services for the global offshore and onshore oil and gas industry, today announced it has completed its previously announced merger with Innovex Downhole Solutions, Inc., a designer and manufacturer of
products to support global upstream onshore and offshore activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This combined company has assumed the Innovex International, Inc.
(&#147;Innovex&#148;) name and will begin trading on the New York Stock Exchange on September&nbsp;9, 2024, under the ticker symbol &#147;INVX.&#148; In connection with the close of the transaction, Dril-Quip&#146;s common stock ceased trading on
the New York Stock Exchange under the ticker symbol &#147;DRQ&#148; as of the close of trading on September&nbsp;6, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We&#146;re thrilled to
complete the Innovex and Dril-Quip merger, creating a differentiated business with a curated portfolio of technologies that support our customers throughout the well&#146;s lifecycle. I&#146;d like to thank the employees of our combined company for
all they have done to bring us to this milestone. Leveraging our talent and &#145;No Barriers&#146; culture, we will deliver superior growth, cash flow and returns creating value for our employees and our shareholders,&#148; said Adam Anderson, CEO
of Innovex International. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Innovex International </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Innovex International, Inc. (NYSE: INVX) is a Houston-based company established in 2024 following the merger of Dril-Quip, Inc. and Innovex Downhole Solutions.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our comprehensive portfolio extends throughout the lifecycle of the well; and innovative product integration ensures seamless transitions from one well
phase to the next, driving efficiency, lowering cost, and reducing the rig site service footprint for the customer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With locations throughout North
America, Latin America, Europe, the Middle East and Asia, no matter where you need us, our team is readily available with technical expertise, conventional and innovative technologies, and ever-present customer service. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contact Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Relations: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Erin Fazio, Director of Corporate Finance </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>erin_fazio@dril-quip.com </U></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Relations: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nichola Alexander, Director of Marketing </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT
STYLE="white-space:nowrap">nichola.alexander@innovex-inc.com</FONT></U> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Statement Regarding Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Statements contained herein relating to future operations and financial results or that are otherwise not limited to historical facts are forward-looking
statements within the meaning of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), and the Securities Exchange Act of 1934, as amended, including, but not limited to, those related to projections as to the anticipated benefits
of the merger, the impact of the merger on Dril-Quip&#146;s and Innovex&#146;s businesses and future financial and operating results, the amount and timing of synergies from the merger, and the combined company&#146;s projected revenues, adjusted
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
EBITDA and free cash flow, accretion, business and expansion opportunities, plans and amounts of any future dividends or return of capital to shareholders, are based on management&#146;s
estimates, assumptions and projections, and are subject to significant uncertainties and other factors, many of which are beyond Dril-Quip&#146;s and Innovex&#146;s control. These factors and risks include, but are not limited to: the impact of
actions taken by the Organization of Petroleum Exporting Countries (OPEC) and <FONT STYLE="white-space:nowrap">non-OPEC</FONT> nations to adjust their production levels, risks related to the proposed transaction, including, the prompt and effective
integration of Dril-Quip&#146;s and Innovex&#146;s businesses and the ability to achieve the anticipated synergies and value-creation contemplated by the merger; unanticipated difficulties or expenditures relating to the merger, the response of
business partners and retention as a result of the merger; and the diversion of management time on merger related issues, the impact of general economic conditions, including inflation, on economic activity and on Dril-Quip&#146;s and Innovex&#146;s
operations, the general volatility of oil and natural gas prices and cyclicality of the oil and gas industry, declines in investor and lender sentiment with respect to, and new capital investments in, the oil and gas industry, project terminations,
suspensions or scope adjustments to contracts, uncertainties regarding the effects of new governmental regulations, Dril-Quip&#146;s and Innovex&#146;s international operations, operating risks, the impact of our customers and the global energy
sector shifting some of their asset allocation from fossil fuel production to renewable energy resources, and other factors detailed in Dril-Quip&#146;s public filings with the Securities and Exchange Commission (the &#147;SEC&#148;). Investors are
cautioned that any such statements are not guarantees of future performance and actual outcomes may vary materially from those indicated. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>13
<FILENAME>invx-20240906.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.0.2 -->
<!-- Creation date: 9/6/2024 4:14:49 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:invx="http://www.dril-quip.com/20240906"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:us-types="http://fasb.org/us-types/2023"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.dril-quip.com/20240906"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="invx-20240906_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="invx-20240906_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="invx-20240906_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>000001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="invx_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="invx_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>invx-20240906_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.0.2 -->
<!-- Creation date: 9/6/2024 4:14:49 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="invx-20240906.xsd#DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="invx-20240906.xsd#invx_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="invx_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="invx-20240906.xsd#invx_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="invx_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:type="locator" xlink:label="dei_AddressTypeDomain" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:type="locator" xlink:label="dei_AddressTypeDomain_2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_FormerAddressMember" xlink:type="locator" xlink:label="dei_FormerAddressMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:type="locator" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="invx_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="invx_DocumentAndEntityInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="0.01" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="23" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain_2" order="23.0001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_AddressTypeDomain" xlink:to="dei_FormerAddressMember" order="24" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="26.131" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="26.231" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="30.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="30.011" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="32.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="26.011" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="36.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="37.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="38.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="39.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="40.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="41.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="42.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="43.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="45.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="46.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="47.001" priority="2" use="optional" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>invx-20240906_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.0.2 -->
<!-- Creation date: 9/6/2024 4:14:49 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="invx-20240906.xsd#invx_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="invx_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="invx_DocumentAndEntityInformationTable" xlink:to="invx_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="invx_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="invx_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="invx-20240906.xsd#invx_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="invx_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="invx_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="invx_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="invx_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:type="locator" xlink:label="dei_AddressTypeDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AddressTypeDomain" xlink:to="dei_AddressTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AddressTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Address Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AddressTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Address Type [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Addresses Address Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Addresses Address Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_FormerAddressMember" xlink:type="locator" xlink:label="dei_FormerAddressMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_FormerAddressMember" xlink:to="dei_FormerAddressMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_FormerAddressMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Former Address [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_FormerAddressMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Former Address [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line 1</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line 1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line 2</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line 2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:type="locator" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Information Former Legal Or Registered Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Information Former Legal Or Registered Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>invx-20240906_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.0.2 -->
<!-- Creation date: 9/6/2024 4:14:49 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="invx-20240906.xsd#DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="invx-20240906.xsd#invx_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="invx_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="invx_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="invx-20240906.xsd#invx_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="invx_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationTable" xlink:to="invx_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="0.01" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:type="locator" xlink:label="dei_AddressTypeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_FormerAddressMember" xlink:type="locator" xlink:label="dei_FormerAddressMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AddressTypeDomain" xlink:to="dei_FormerAddressMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="26.131" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="26.231" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="30.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:type="locator" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="26.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="invx_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g802924dsp94.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g802924dsp94.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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E323/3HX2C0_AQL;:JJ*%50JCH , 5B=(M !0 4 % !0 4 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139830241843648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 06, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_invx_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep.  06,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INNOVEX INTERNATIONAL, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-13439<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">74-2162088<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">19120 Kenswick Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Humble<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">77338<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">398-0000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information Former Legal Or Registered Name</a></td>
<td class="text">Dril-Quip, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">INVX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001042893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember', window );">Former Address [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_invx_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">2050 West Sam Houston Parkway S.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Suite 1100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">77042<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invx_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">invx_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>invx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>20
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M8Z% JU2@N'M_TM):D4"/QG&6[$S.U,+A0DL>&71N5E% <1^?JT@&TLID13[
MM-221[4\N$HC3Q4%%'?NF19Y\PCPA6(A))(0>O9NN3PP\'"]1K(J!2CNV_\@
MFQB3 5DC("[;!,@J_V>X8\]%D&DW,2A[( MIOW7OW>H6%W%OF*]55/!X0E*N
MR1./,D%^]$X]2E)X4;/F&@6N<H$UF+CFH1MX\VW\H&J'78/ 9/H1RP&VMV/
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M#RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q
M_G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"
MIQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " ".BR99EXJ[',
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M)ED<.&7J/P$  #P"   /    >&PO=V]R:V)O;VLN>&ULC5'+;L) #/R5U7Y
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M%0:P;W(@"2[)E1M27>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04
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MUDX:?^:+X3]>?P%02P$"% ,4    " ".BR99!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( (Z+)EG>
MS1IZ[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( (Z+)EF97)PC$ 8  )PG   3              "  <T!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ CHLF65\%27PE!0
MAQ8  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( (Z+)EF?H!OPL0(  .(,   -              "  6D-
M  !X;"]S='EL97,N>&UL4$L! A0#%     @ CHLF69>*NQS     $P(   L
M             ( !11   %]R96QS+RYR96QS4$L! A0#%     @ CHLF61PX
M9>H_ 0  / (   \              ( !+A$  'AL+W=O<FMB;V]K+GAM;%!+
M 0(4 Q0    ( (Z+)EDD'INBK0   /@!   :              "  9H2  !X
M;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( (Z+)EEED'F2
M&0$  ,\#   3              "  7\3  !;0V]N=&5N=%]4>7!E<UTN>&UL
64$L%!@     )  D /@(  ,D4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d802924d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d802924d8k.htm">d802924d8k.htm</File>
    <File>invx-20240906.xsd</File>
    <File>invx-20240906_def.xml</File>
    <File>invx-20240906_lab.xml</File>
    <File>invx-20240906_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>26
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d802924d8k.htm": {
   "nsprefix": "invx",
   "nsuri": "http://www.dril-quip.com/20240906",
   "dts": {
    "inline": {
     "local": [
      "d802924d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "invx-20240906.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "invx-20240906_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "invx-20240906_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "invx-20240906_pre.xml"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 31,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 29
   },
   "report": {
    "R1": {
     "role": "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "000001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-09-06_to_2024-09-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d802924d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-09-06_to_2024-09-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d802924d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "terseLabel": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "invx_DocumentAndEntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dril-quip.com/20240906",
     "localname": "DocumentAndEntityInformationLineItems",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "invx_DocumentAndEntityInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dril-quip.com/20240906",
     "localname": "DocumentAndEntityInformationTable",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "terseLabel": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 2",
        "terseLabel": "Entity Address Address Line 2",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses Address Type [Axis]",
        "terseLabel": "Entity Addresses Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information Former Legal Or Registered Name",
        "terseLabel": "Entity Information Former Legal Or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "terseLabel": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.dril-quip.com//20240906/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>27
<FILENAME>0001193125-24-215264-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-215264-xbrl.zip
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M,I]%/E_+_AO"$3J%5E@9;BH.!\9'@NJ*0CBEV$045-P^QUAH9Z[LJW&.25)
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M8WM?I6 LG!A5O%S73 R3CB0@HXKM':2^3Y!?.XSV.\%H(%:S@?O\8>CU +!
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MY$TNV@6#<JT=JI6S0<,XPW(;F;[Z+-H$]X%0YV!D#P8(=3G\Y-MLR.SH/K0
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M=VWK4&B41D['H3[XU,"#35%=;\+B7 7../3)YS)1\I/)U,POP8@FV;516'9
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M6GMS@*;KQ<7(W*(A'7-F.+'=3@6M<E1PMQM66,>4U<GY;JH%U-2^,4\26%U
MSV>&X)-:B%@D^(IKCL3L-KG+,J6L2JZJ-*(3FY;EW#\&]'052AOKX%%5T<O,
MEC%8]:!5\OO$=4;BA/I\8\39>\!*#W1#P#&?RA9>.1B"\Q6EF0!X$S8T"&[Q
M";0+.K3NGRGW_R:-POOXZT2AA$.QKEA7(1?FNT0 2D4==BS7>L_'AJ"114FH
M,FFX$FQO_5A'+UQS33U67:Q:']_/X3 0_VR*CR%PXH:X4>+)^Z;X.1V/&^(4
M")0G3O !4.:!_M+[[V7P!\!5(#XUT3;]U9R9*O=(#J<"$7F6 .EJ.NU%^L15
MZ/U\H65!&&SK@C7Z<LTN*1=)AVUQ;A^<%$N- 1:J7V[XOF;=9-I HXDJ$:H<
MY'RZ&(-"S?U*OK[<^X"CMQ&@C4[Z*Y+2I9:*09525HY;""X1NNT410VH8[(R
M).WLR(;R^.6M/P" 3M0?,BBW<V[[QP7#]V1R+POMKK2RD*%KC<>!#:B/T;-1
M-'V&:-T5$GR;IH\<5Q;H=%;7T48TBVP;&8$(3YD(4J"7!NZ3%'TXIWK,+%#!
M0/1I-I^ZM4O5%H,225Q3F$N*'[&V"U6-L]ZR:93=;\$L$ZEAW2KA6U";L<9<
M,&UEI3G,)+$Y"T5C'W4<FO?FUK#<]N^*V]?<<\;*YMOY77'?BA=/'[NPHWGV
M<5<Z81(*5K$)XJ)W93A!;C@OG!3O,<<H10%#="'EN#S>R DJF.R?/+;AZ=)+
M;4^++5FQB8?4$KYE+L2AJNI']5K4;X5"*79GNMP$#7;5T#Q!:-=AB4V;0QV,
ME/$PRF\SD^MB@!Q@R^EL<;E=N!AR_;BA9$G&0%BN;%\6\UNK!!!OKLR1?6[]
M2S<\(-\F18<6+")7OJ,"H7*VD9=D8+ -F=4!V[E"J%/8MPUT&=_6-DV+4Q?,
M%M51@E=H%7 U#-2TFK!K+_T"IR@^ )7KG_I49*YJU']B"=NJH:UX&&MHLV('
M#_,4$$WVT*LYS^ -JX1G&L32I]FN)6BJB1.IJI 98SR#2_F5NHR&8<V1%!:/
M[J2T%TL'OB/7>VS4NT#K=Z43,ZYI,J%P.0ZB-KH& =4M:5CAKIFA9TJ5\Z<6
M/<\1ULJ=1W3Y!O07)S[34*U!Q1+8.W'WL3/)RIIR>Z0D5NSP%D^6"B!S? +-
MH+)[YE)B(GD7LC:@U1B*>HK1U%A(':=!58]5I/IHP:!L'"Q?F(^.O\Y>SW0,
MJUDA5XH N(@R?8Y"1N-P)"O&!@%]X-Q5FO8*%34-";9<XI5012!* 9M>)O7K
MZ(=Q&"=*OQMQA?4["0B7Q(T* 9Z)@OEH$#IO"61,G//*S2VK0MF<\%&L+^88
MA- DTF"$;E=/>*#+<>D*B[KBB(ET (G,VNP4BZ2-:#\[H*Y&$Z5ZDN;9P3(_
M"<!Z+C(UQKSG;@/_O\NG G]U&E9A/*IE6VW4/&&E^(ND,-NYDTS:K>U?-$!7
MZ\T?9"_*UM\Y:&@EW*W2?@RI>X$7B$KU>79]=F_@^MO[# *-"??O[$VY/KRM
MO1=R/2\N@KR2T"U85Z5J*&T01@&X&/%->'5(>'5$_V^W-':U7U53X()?H$2N
M7V;=%>41-UINS@Y?J#9M\*6N!QF)LQ%<E#<&="JYV!OB%QFXA&@, C1VM218
M&&M@?@\K?U<E0RS9EQF7$WV%V5P7*5+-9G*RW269!4]&0)GZSC/@::8E\D/*
M709BQM ;QZJV3+DFM]E,(.^Q@(NYSNR$M$I0##E\[/M<;UYIDW;N;=;JP13,
M5A5B["*8*G!/.RFQ\ "FIN75(#*N[K8P6%*%K:1\"O/D9?[2G(5GW^;V9D0T
MS"0?-N*9'= _EA')8*;*H'7JD7&Y%&XMD^9*D8(BTD<+WAW[TCJM]GY3G%!#
MIC]"KC"X^)2-BETBJUC&58=)<_TT5@X6BAZ5MUY?W$;A/97!=^T*Q,"G^%E*
MZ0\X\13MZC :MS%@HA,"5I Z"0#3'P:A']ZJNKR8QHHB1#J.,=U])!!QL:$P
MY48/!NH#"B^J?F,8^>X]D)^F^("!KIU6JX,#P='N5AV(NG8O4%(:6G@"S-NS
M*NZ":"6YA/I[!],K?TIOAZA(:_$)S8R>#US==[/:2GU3U]R4/2AKOD@Q?L.F
M<A&HS<WKICCSN$AO(__<1[3O:BK:J!F(!LBJP\368*B[)W"\GVA3$>WEVH%5
MB9/(Z7DP)%J-8RG)EQQ282UL%=QHM5JF%P4K4=FOW[7Y+'L8S<#EJR+LYYNJ
M!@85R]3)[4"!%!4VU]3>5=>T/^6:IF/G#0+(9\\7-V'HPQH^7C78Z8==-X!9
MPI6F RS*%2ENAJ7V'=_GM_O6R8VU*4)[ N%^Z0WJ4 % <NM0@B1LI8J6H(D/
M:?HG)U:M!][KY-H3%RN'FK!K"L8^2[]2@#=> 4;5$A8!K('$[;-R>]WWE+M,
M7$D4]64Z$N<!D%O)H>LTSBF:IATWA,>'(0<H?L)9GYKM+DFX+9FFEFR3P(,D
M<CEZY@4$<0A796#-?$-G -9^.#;6#N38E!_@B*]RLKI(B 0!V)><X3VR3)IY
MFFH*?S , P5F:"(+BG0B$#A@5R#\H_$S#+]JOPK"#6VL3D*,XW2$4R/]%&CI
M5<5:QFB5 31'X!Q@Z,3:C;*XVK.*W&Q+>C?174V$7E6RH%' %$4^D<4% INE
MQA4@C[3.ZFMZ3\(S^CV<. ,"7W)T K[A#2;<< ,[E<:J]X;+G)-KV-ZAF).0
M<%WDD/FN,_GEP@(IU[R.!C+H2J.1<&2$26RQ2"F\]PO*RJ^-!I*>E:=^2XZH
ME+8B1;TF"71Y85.3TASDL9J(U))J%N'=Z.IT9(XOT]S?I._G9!BZ5&658EH-
M4L(G1U,X)F6?#1(86D;OZ>?XG:@_1#V]S5":AWMVI%NJ*F5'H>!!YY.]W!0_
M,4;8]4'@Y?)6K$7A#'GA!&23-UKCYB(1*Y'W$6KB,2Z@V])XGN2E5I1-B+VD
M?N+!,1,'RVXEDU8U'])14OI&LLY;@4#:+*[ADH>POP<G,[-_"?M?0=Q$L1/K
MSJQ#^%<>PO^*,LI.L"X1FT !T$_SG;@O\IVX0<>:8.;D&\$9-TSN8]B.^!?
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M+YZ]]-:,B&#-]W7_'+(7Q":=1?4!-ZXVE9Y448N\*4Z ((V- )D?!XM_IU$
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M#8A6]^ESGG/M(^GX;/"Q73L^,^K-6KET/&@-VD;-^&-W_T5U_WA/_8KK>WJ
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M+IVD0FDM@0+URHKI7%%*+\G^J%$&@![0A7TQTA_(7PL]>02N\*_!X7#+IL.
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M%'E9X3DSBNN"3<$I\J7.T%Z._K;>1^ 7!*YM]!.FUL5'(]OL:4*2B3K<Y+?
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M.D9_B'PPVADN::;:04A^2)WX,,_F,VJVQR-%M/Y.XDJHGR\Z7M=3E"9:.@;
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MV)X$7R0Q1717$C940@\BM8)JH3=*K;*10'$!'"J7EQ*#F0B ('Q%%JXK%1D
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MPF5XUI<"GAC9AC>R5 [3+,4>")$YQA$Y2HR"VM/(Q!P -$T/)W("$^!U;'3
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M.>R)U2\?>_#(N?AP?GIQ@0]=]#^='??6\,]3NO/+_N?C061F A<=S.WS_N%
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M:UO\A*D-\='*-G>&D&2BB36%_3.!S$M&A!,502D>E^9SZS@LRQ.KL .\<12
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M X4!C\W,]Z5_1LA^1LCNCI#M_NDB9'@B 3]]")SU5@SDC7K:XW?6]D4SY-J
M%AR7HO;.VC6U7FT6^5..GNU&TP.</K*PUEVC119OLU8],N4UF,9#OJ2L!^%$
M!KVMW2>53'$1@HG!N[#$F:!MUA8U,A*F)&]Q_8?->7#O<8R<H2>#8[F>4 08
MW '/"E?-6&IAJ'/E"Q.[>%S^'D=!+LM"Z_5ZJH/FICJ%394^)[S@O.!CA#%
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M)G-HLW7DU1_VZ^HFR;Y46M65+?:FI?E/]-GO!+&LYR_<H\CAD*\MQ"2OR7*
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M<"6F81 RN%26ZV@!(F*WK-141+W_"U)KC&W,]X-?"K]C+J ";!'WTIT3;IL
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ML8\U39QTQ(:/AK+4++G%OYFZ>E=(UU;XHH=,RJ7HK*XBD#P<F0B[.V=SC$%
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M.>KE(@1<:FNH\39GYB3WN9>E"&[JR<.$LE2(^SB8C#H-6#(2>@E39KG%"F>
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M.:MZ4*?43X RK47%1N'YC83W>- /91[#99SJBSG#@_"+R5HN_-!!+A8+!ML
MQ3 K&#K-+08GNQ4Z[TV'^XEKD(4J$QY\D!ZV]7OZ@ -KZ$B]0B>?%$+$)C,$
M=WU9B8JV\)[-P_9?<+%M)8%$U8QA@!8'[$HR'O%-]#%0M1[@Y VV?TMEX].<
M0"94&-9%0&6EZ#H:.(E;V]%>MU,V5C>FB\O43%=2DKAGM 4<Z8?)MH17P5;
M8!6]E>:D*L3PZ2TV"=\EZ7$,YIGDH]-=F\ X36U,8P*4*:;0E,6%Z[3LTBE_
MP]'0R\#O%1S$H)FF(K3'V!"/Y-[*F9VP+,[@F/%"HJQW>O<VHK\>$I&^Y>3C
M%[YUQA0:Q)03FL+YRA6Q%RZI&%QQC]#H3K(/04)?3=M!9^QRA(90$9;,P)!_
M1$I,:T-D%LM&URIG<QLS\',*_IOV!A9WW5\M5FWR0@=8=]A 3Y!*5N=LLTD;
M5CHPU"1IT$/S4*2:^X*A8<E-<=A<:UNR16V'\-\NXT_T2VZ R0$QYY?G"S96
M& !!_W6UCH2$"P<?W'6O[X+M"](-H\F^+9D^\LBT<S'@G#3?!0Z.Q6)5RWEU
M4CB##GISFRC+0#WZ=<')5D(#1R*]!X:MI"S'DVQ/"6),!&^C/*TST*0<&!1Y
M(K5(2=#O34Q/<H19.W&$2+PCEK'"4J1M TO"ZA/L@5)30K,U9@;0+XH5058U
MWH/*A:S.D8=YY1#*94DW1MJA$P#2N'?E#/6*+ZF& [-#[>X4F+N_-Y7)DM]@
MK'6VK %4-]1@6L'*N) ,*CD*(2T0-JNVMAXP6^#=>E/9Z5C2C_<*>2_"%@5I
MG_C60E.18U&W,I:5)M&T.:DI*P6O;$U\%EEZ26XI;$_.I6!IE3BB.2VI=&OK
MP\-G7H[JS$R8Z2^B-A>9;N. ODLTX]X/-./Z*^"%7</9<E)%0>$?KC@'U9<.
MLAU@U@K#4 ),?VN5<:QK97.<VX.1><A'> @\#W]B]R\M%A[?N7L[^S^Z[L[*
MZ>?L58M<:<.LQD[W>F?U>K4 >R_/CO47T'8?/KQW[]'V)W702YW@)]E!H1;9
M 44_ TO;^LS^]I='=Q[__'3L7W=OWWD*)UR 7/L >MN5J/]2\^%T1*_:@+FD
MJG/:& DZT/GKLILS8N1=V6&QV3Z\/%'ZYU@3BF^K8CTF%0N]GQC&!KI*9[H(
M!HJ2*,F^8=F?42[^ CT04^_W>2;]GT2=C=$."IXK3]BQA>X)3KO!%D3X>-^<
ML*_&)HA)^@ Y+PQL0&6CQS.7J*2G%!JW<R:/*\M[!GN<1N78K4"BU[RX++4V
MSE$:6QSZD]O5=D",NURY]M!5;7LIY5N2Q)&JPVIQ7I,$0C\W\! 7)XT#-(<E
M3/P\ER@VDJNGQK@2:;E4"3\"EX+!\OA;5@U!HZ,TL#A/)WY:+@-"#10+6 3E
M8TUQ&H;0<VO]2O 6G#J6R6)U//H.- *$=Q&XH-S>NA-KV'55EW<[B\]OJ:Y@
M "!31%Q,:&F\\RG0[0+[N@76=)<KKKSF%H"6+9&KGC[QH"QUTJKE?*P_%EPE
M,$/$%XL][W5- 55L(CM[+Z1@:LYJ[J?+Q1]:WWWCP^+TFW8U-=%YUY*M<_G-
MXV3J7]D, HOGC02(P44V33+^PTL:3]YKKML%:S)9BY58/&K1"'AO8$3+!T_H
MC<1?F<1E/X3_"@97),JW\:7DJJ*CK8+-1>&>4J:"@!^-1 .TJRJN:Q>5ES))
M?VVK3YLI.;IHN:L:@;_2FI2N0R:G,\WEJIO A=;/-A[&\20;5XY@N!(W0D1I
M2L#*PC$\J>T-9-J;V 365+B.!B($'+PJH=(RQ.\U94K07M+.'F!OV*GR$<^>
M4@+\= R0>&@4N["XJ:,;X N+LG?0DJF8&A0AD",,%T 7T,^AN<Z=##JB$];,
M>V0:G)@)5VHM!4Z #U#2OGB'J6YO:C+)P\BX3\2I_\+<):IRF_<F6V(+4^$2
M6*2)2W%SQ* EIO%7&Z)(3\%VA/ >PU)^"VRLPPAU65N&1]N_6ER-E7\-LO 1
M_CHX_OW#8?;^X-?#[/A=]LN[-V_>??I^H9+[/Z"2#=+JTL;@T5N8_O';PX\?
MLT^O#S\<OOLE3V7'D@UFU7FZ_:-N[XS];G"UK3@A!!'N)P8^2SMVCO 476D@
MI;TUW'7$.$J;/BW2)LLID+N'#N'9\<&+-X?9R\,W;SZ^/WAY]/;7O]^X?8/^
M?G_PZI7Y6X[R/I[DBW<?7AU^H(]E5OS)33C^-P?O/QX^,?^Q<8_C \$#9CH]
M_O!<_N.5>?'#O]X @CY^Y;[XARR%%^N(S3P8_O[Q7?,Y_-\'[TUF"1Z]@VX&
MVNL3==J417;))423@X.!O7R'6_L6+PJ0U=MW_SC\S^P(;P%PH*-W;P_>Y/#G
MRUMN=N',O%=X;WA]>/3KZV-8[X-PO=[G[L5W_;5_JW4_?[%^XL\L.C!+F<,G
MZ-<7ONMW\*,)Y7"[C[YD5&DC^\MM^M]ED2!W:;[]MGW%GKT%*_W)]S7E8VQJ
M\L2_F? O9$G/68I=TD+Y&A'Z[.CY1PNZO$?'CT/3AMP<P[:,VO+O*V^_9YEQ
MY\%7"HU']_Y5A,:KP]_>'AT?'EY91@3C?7L.$;S^7YNS?[?B]H"] S]D[K<5
M8#_V[/O?LW\7I>/93R_>O?HG?/CZ^+<WS_\_4$L#!!0    ( (Z+)EFPYY4$
M.",  .^9   1    9#@P,CDR-&1E>#$P."YH=&WM/6EOVTB6WP7H/Q3<VPT;
MH,^XDSB' 1_J1 W']MI*9[.+_4"1)8L=BM2P2-N:7[_OJ(L4Y:/CV-.S;F F
M,H\Z7KW[XKN/@T]'N^\^]O8.=[N==X/^X*BWV_NOU<V-M=?OUOE/N+ZN'Q#O
M]D\.OXK]#P<G1R=G[Y>^?.P/>DOB?/#UJ/=^*4TRN3J6R<6X?'.<%Y,P7=H5
MW0Z\?R"S4A:[[P[[?YB'KY*X'+]YO?9KDBV),$TN,AA CLHEFN;4/#8)BXLD
M6RWSZ9N-:?E6Z+^'>5GF$[XTRK-R527_E&\VW=^C<)*DLS>#9"*5.)97XBR?
MA##3WE'_P_'[I0(7N;3[;G^W=SU.ADDI<,?BW?K^[KOUTUUO 6[TK6T8O;&>
MN>4L[?Z2#=7T+8Y"6Q_L[1_UQ$'OZ.C\=.^@?_SA_=+&$OU]NG=X:/[^TC\<
M?'R_M+FQ\?.2V#\Y.^R=T76]"+ZR"E _VCL][[TQ/V[<;!,R=O,1G<82K4_@
M$L]V]8]#NY!??P;HK \.W9T_]-N\5[=D\V!]@-?;YCK\WYDWE=G2-+R0J\-"
MAM]6DTPEL7P37N9)+.ZWI=W&XN!<>%]PN?_I@S@_.WB_=/%Z8VMG:SM6TYWM
MM3^G%PB(P?NEHY,/)TN$W6[UC4W:PUS\!*#0N\^[AT62KOYGE4P#T<^B-?'+
M)(GC')!Q:^/7#?%%JE*<AQ/Q,:]4F6?B-"R^784S<;X6B/,J*:78A*,/S/U
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MT:ML&H)->QE&&I4 5HC!M^X(7UO%IU>!-LRVEN%T5P)DXS)$O0J7J7<"YX4
M17(#VKA,P(Y,P9[!8=8$Z=5Z_T3,0]0#$B)9A+#&\<:^UOZ*%?1=B-.[1F&
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M!'L8!+J@(["8&'CYIX%V.L#2%#T<AQ.8 *]CHP*.D>LD;571"@M7.H0W806
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MFIJGSL.1+!D:'X'X 'KV.3YW'N8@CZ58UI$1 %DZ:Z W/WP:SC 3\RB\\H8
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M/P7)%;*AE38LU$_5J_"=\%Z=>0.$BSJ*Q;=N\6O16!00FBQDF0 O[I\72LU
M, J9C<6I2I743 &>^BWM P@_C@H/E2P$DN*K:PC^V8J92G55P@Z. 8Y7N[_<
M<>;A--$B527H!B$=.M9+N-SM_/4OV[O/7Z.8&^PY7+UY/" !@3=?O'XDXCR;
M),5,BW*J8"WX"[$)E\<)8EGCSU@569*=BT5>%?10DO$6Y!.A9O,T7]"\ETDY
MI7%Z^6PNLX50DXF*R^1"B60V4^-$EBI= $1IFE_B>/ALG.8:?\-0^.=,%>>J
MH%E+'!I>&8O1@N[5-_PDE;2 #_0& JWJ,)L;*T$?T]@?9!%/F4.V7QBQ1<H6
M[B59F=O)#4RH)K+\0EV)P_PRF^; C&=Y6A&J6(5$C$!5E#+)##Q"5R/@T406
M"6R@ =5B"5=.B\$;NHJG#B<5D$5!SS9A$;#O4UACDG4[A9JH I<+BY6\D2$:
M HXYA$D:6-@4O^:%F%?%/-=V:3"VFRA:&L\LNSX.P"F!5IK:%#&!(,K))$EQ
M^W&T0N63"%=ZJ=+4K#@I1*'TW% +("%66N<%$Z/4&FQ-O2F^Y!5=H*VVZ),@
M]G4^4R4Q1PLR /P2T0Z[48?M=K#;UXF_X(HLE_D WI+7,$:=A(A/\JH4/5F!
MP!I7!>ZU%+VIS,Z)"'I _$6>BA-5)#G"+\9*QT4R(IKL=LX03WEF=.UZ_,B2
M5-_/Z4EEI,I+I3)<M<6>6PKS@"3@#U4<J/ =XH5MILYP_]OF:+(63P.8JB,4
M\83#718)B*Q,?,S+)":(AW7<$8(#!$[RHMNI;U0[L)N U'E2@G/R#Z0!DF=9
M7@+^)N#IC)=I0.BI!"J<R@MEY(\D47<.=)CQXZMF8G_A;GKEFZ3]%\2*!-:8
MES)CO#6 F8$5"OL-ZQXGL16=R#PD81F85,(S:#TLOW\]3"^^AZYDJ_M4X:)X
MNR=%/A/'("!B5&) .(=) ?0-G'D"4I!UD#=K5R[OA^C73_,\,\1XI>+*DF=3
M3#3)]3(!DK+B0!%0R'Q,:K ]8WR11!3174'80#Z$!Y%:0:W0&X56Z42@J  .
ME=W.V& F@D40OB*[K@L5F04H^ 6;B\N:$3N+'&7K'":!BY+D:T,!V?49"9>+
M4GY5PM[!-<N8]R%3*)=E855[Q>"!',GC:L;C&S*S@Q?J[Q5X41K'#5["1X"K
MU7D.I'EO=+<?QT4%B#Z3*0)!9L3P&+PZWK<'(S/2\PVI+J^5ZE$-R4Q9<W!,
M:1_%C1YD6LWF&[J:&;=1Q%)/\7T<NML!L0>VE9SE%4P)^R=3H@JT$'.0K4Y"
MKR>/>+4':'D;I((QC+1<3HN\.F=[L&&"$-[7$_NRY$V)Q @(O<KF,AF+"QD;
M4@)<(07?"!&^MH%/;P!O6+#687<?12C&E42["I=I((']0H0BNP%O7"3@P*<+
M4#(PS*8@N]K 3\P\0CL@(99%#!L:;\"U^4?\W6\BG/X5*@.4#O,BOP GL$7#
M1<3!=:4*;#Y2&>C$$OP$]VK#3#%BH6 +*$[FQM:I\3=J_&>OM=C=VE[_^DC,
MT2AG:O3R[SIL87CB</ ;L)P).%+0"5W..?NZ=2RJV1(2\5+@#(\4BI57,KV4
M"XV^Z>,Y3O+^5)P-_@?VY,F:'9<"HJ_^\I+^:\3SC,_9ZW\<]D__8$CT1P9%
M;>1#A(&/%2+KN\SG CSBYMC.=YD0A#*8*(##'<0CS35?,=?25"*<ZT4SPGNW
M17^KQ>;D!SAKLQ&J]#':<'DQ)@\X;V,F]RC)_'F> O?!P$#8J&R['; (-)B
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M;)%SPV1F@AJ<&PR " HD<ZH7J^O 3+&21*%BSOH!\[*,(B'CY<$$C/<L3KQ
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M.A.<R L?3S E:HQ&?"K(I^"Q5#90E09'84';9R)+ET3Z6H."Y+<$._!X?,P
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M[UO^T!JWD:=Z()V+!YD>!O]+\"^KUC^O4@5Q=GSX!2Z^'WXXVOM_4$L#!!0
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MC1X-I%F^1KG$W'VYKVO8_P!.Y^8;NU[N_OIE%W8U_3# JX?[NNYDEU_>T^P
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MM",O/&^>P;7LO,> (6RW:"K_OO6IWR%*&L']@DWU8G)S$\H\DG0IO$]2.I^
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M-E,T&T_0^^>]/^'AR>C=Z>'_ 5!+ P04    " ".BR99FJB@0N9G   ;.0(
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MN58)OEQ^MR +F&+&DA/1(BLT!93/([AIQR&B _&/I,_,)<MYC#_.A@M5/BB
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M+#Y\QWX>HKK$, ;Q!F7YHEA4[ R:)E=X?2555K4C#Z#N]B5*)9Y6<%S,NZ_
M ;PBQ@2!\ R1PYH<R2X_"5Z(<]J8ON63%[L\M/5_M&=RUX*LJ_6FUZ78^85R
MTX' L8[Y,)O#N^J6.QN7!4YWUHA^#F(.PRK&N?NFXLO\3X!;?GKOT?L\DG-1
MH7J%^^].<Z%_W+Q;"Z-WY+Y*RH]IMP8,XB ?97,,?@F=K\W<3#4[6GEN^O5!
MXHE%%]H&Q[O*)>O >0O[H(6 !&H-WC&CI()!^P!NM,I5V*/;2.IN_\N\&&7P
M'BD^YZ(Q(D8;9#A(/%@1%]GQC;F4W*J84CHVHPO<ZN%S\-O9?%I<I:E$46N)
M/>&H5..*,(B$)(PH8;>W\(&X^TT$+[!X@VM<3T_-];3N;WX,KC0SCZS+]L2K
MF ,8;W$70IXCN+[&75[D8XR2HZE3;5)WZ]Y(;UW&^UWAVX8;![<MRSOZLX_2
M8QCO'J"Y>=CBJC%_!JCF5S9H/]9K!@._D<'^X_?]]^T,%2XC8-E9*9.)7!R!
M^Z!/.\=982:/Z)(*5R"D%+1Z4$]1.1DQJ0/:"IAF2[^[TF( H7X3*:7&!.V$
M6KZC]+%L-DO':/=,$2F:CH0V>+BH_84:LT$RWFQBV>]_/SEL:RRF)L%E"H85
M,FO#-4<.E52<239]R&"I#"7(1IA+/W""/_E/X#EH2B$XE0>U/8MV$N/9 C,U
M+Q8Y$6TCF*5)1L!X3<&^2-,E[K6"P5JSI!HML!9*'$U2)+/+"1*2IPL$^Z!.
M4#V/X*+@-SHP"%FE<A(KQH@$G[3H?Z&1D7$!,K"85THZ%\N"!!]679]"OW7Q
MD#6F*,?5]A:\<9I]3&'_(BRYBQ]YJ)3CWA*GWTK;;?H<?@GT?#R(FIT6O&#0
M.X'?M#[+I"6<6/\I[3;YPDU@D_H?'5"75"D"ATI>$DYMHY(?L'))*;S_E4-B
M-Z8]E6E?M'>7)]W2?1:[@4I/"^VB8F)1!E3D7<C',LN.N)V6A[Y4X0T=XG;@
MZ>^T+>C49.!.G9"_,\7^98:^D/E\>L581%;04:%GIRJTB6-FZ-9\ND#J%-JD
M4D2!P+W8 ?X0P6+!:ZA]ZB\=@RD_K(3ST+&SSIV.,RYLZ:@PP]EH'"S\=S?%
M53>A52S/K?42H<BNRP7E$#0Q:\SQS@$+_!GRQ+@M050E8.ID8[)%!-6F,EQ8
MX9E?%2R8D3J(&A ^WR68HO/>*5*V<9D40P*""__#\\I[R7BBV,"@>ZS"<C6.
MJ*7K%2K9\9K2\U^2HW $9@D:*'R#R4;WF]N5$?AV/5K?WWNT[O*F!>7@\6YD
M2UGMWDGIJI^NVQ&XRU&G[:277*'#_M#3'_D(9Y4FYG;]RP;1/C,#,?^C@]#?
M)JT_-I%.9.!H7"/%7!,LMK<HMP)].<@879% @KO;4'8DD5H5.7-R2'C0@^5]
ML:L>?M)!S AGN@*#'R.8MAEW=#E1';1%7G<@N5LGBM%OUD( S7J>E'R)4IA#
M(T<!7J W^*1H;!77SL5#?3)(:X'I4T:"!/-ZO))B)_#H*,7"4?89B\41Q04<
M*<SKC<$.)_K14<3A)0TH,0N@1II:X:7M+1=?"C)_EM8NZ%K=[AS6P6YTVNQX
M-$...V]?F@E;P@J&'C)\LHMI1K#JV'&="45-=_1.$T7P0A>(^RP%)71<"<J=
MV/@DHP?5S5WL..X4EVL!FQ2VEB<8I!H@FL^24<$8.!<2KN5C9O?W, U _APZ
M6I!5VMEAHT/V;:-)[^20;IF5:NEFR%)HZGU0),P%X!0 X$#I 7:?907FR)S!
MF4+EBKFJ8]Q7O@(>VN&N>E] '-+<P7B<:R1^@ WQGT\>\14/(G&:M<KR]9$K
MP X[1$;P<:99ZZ3[S;%R3%))2!^F"Q,G2W0$DWK%EK5=I:E/NME[%%D._LJ(
M7QJ+)BW9)>5%[I4OT3KBY3HQ5Q>P9B'@*>'RJ%%_Q =$FGFN,/D723;%^1C@
MBHO?F8(N' OP^2.4(WJ3-!*3RQKRR)VV9@]!&9A0X=8,XP"P,^!\@*"H6.7$
MA]:+RVYO2?Y7OR ;\$9'YF-*"2S8=%V#/!D!0@7_UV^QR.PPLVDRH?;",\?&
MV=(!0$=^4E(A7ZN+O$93^2<E"V8M%E^\BB>4+QK<II1(7;,1IOF$%UEZ*=H\
M1=>73=)N=)"L%0A?8[[UG'#)//6'K96G%&:F7HG0Y@O.H6[((Z'BG$PTE .Z
MS2--TRE=C&QX%99($G((!0C<*KOZ5IO<$DBN,^5]YWP@()E0H8*SN!KX3SR8
M?"B\#H$^ CT8<9CI3I,F,$VY&4$+QA[G*=J?>$/B?9=7BS)U^Q*ZXA>HO2.6
MK(("773MF)_SULLFGHJ4[C0>?A_1='!%+:<MMTG?//3)4B9W2D==>IIBXW1=
M09G.>P\=+G<[22ZC&J_AY7(M4SJ&FUQS3+!<T?O@B)NT5X)9J0Y1GV,V]56:
ME)7G0.]5YJ4H:.'T>&::\C,1H 953\:$F(LL&V#ET4\(K(IV/B$!!%^<J(9J
MQNYY5HZI,QV:0IF2?I# R;A<3Q^X!H0M=ERP]'O=3'K(XO516@-M=0T<$Y>B
M(S?619&Q&D Y[8MA'2A+ZI4J0,?@2HJD?31U)XZHW*&N1&0>=-OC0"SDS2D5
M%(UW@7AR_V7D$NQ6S"=+:^]]#7Z$;!#]GJ&M$CT1G<+K)5(KM5,W=TCH-4&#
M+E%Y0DY-%-ZLA?3;O=?'%U[R2)Y^SR,116C0H8G'RUP$NE#K78!Q)">UGRZF
MH??RP#M->N8Z&(M:*-9GG<W4B: Z36B'6CD4M]>J3\VXE1[M%6/6EV9)9ME
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M!E4O8JF UREM?<)05^%N2KF"D2++,A-RQ=]T73MK1.YEPE9J$B+DUB@,',9
M?6!O<LO G@VL?DS3^5).5>,%6G[:5\1_S9IBI5QX\=PV;NI.GQI$!MXN+EIQ
M[;L!C6:F-Y<MGY5]1Y&P62O;SHO\H<W.UA<1M)(=;M3C&L33O]J]7C>,2SC%
M, V<P9O9)$"O]%K4K5-VI[BSS+J9"/>ARH#H&E4;(-P-2V(UI_) R#!Y>J)F
MLY9P6*I(B5VGADJ?@]+V V%1K7!A#VI-\CC"$@_+ZRO0_J7=[C$P&=H;$M=)
M69)0&Y8KIDX^IIC^/OJ&"4'^>A\"^,QF%=A5#3T)+R"V\"NZ@?II!^AG0K1
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M"=K6=9?WUD[2:\.\5CC203 X()7-9PM/>H-=$L%7F>&T=OZ^$I&+&LHW7KQ
M]IAR\+U&JCH(E\(W6N%=I6*P?0LHI%H+*UX1<BEDI=+JX26R*$?GJ!)H$'5[
MRS!?[GE6#!E"0&;A ZGFB;X]QJ]4_B 7Z_*.@IU/,IQ5*N+*.^PF.N+V%L/R
M""3,(UD/7-.Q.B7[3]@3OG.E^+Q.Z?+MLF#L/;[W6=ZE!/OYY8LGN]'QP:^'
M)Z?'^Z>'[XZB_:/7T8>CUP?'OQ\?GIX>'$7O?OGEX/CPZ-?H_?&[5P>O/QP?
MG.PRP<,M$]&OW=M3!L!K7BV?>G;TM=-_\!P8A"='VP691H4@EN HUJ"K;5+8
M^Q"4.!?1@#+.%Y]/4W5I?Q8"%;=2ESB^@:6;)/YBR'>OQ6FN?72X/$/*V0?&
M16)BYT]])ISG7S(4F0PZPXN=:< ZP,]3>[VKV*-+3.G(Q RR7#K2+QKL3QV+
M93'![P/&,=HY#L,85E(1!&3+&I#7(AP6[QYE,#C0K'WD+W!HR!RNNWE1JI)"
MDX9Y+QS![.\WLD5E X%'XW7/P?-(2\XZESILXT699]6Y,PEL<!/SF^"<!C73
M@X=&Q5SP@XF6=?$5GYH$;M"BU:R0L'L)63>H(Z74N/)WMC;.%8:K0K(.G2Y@
MBK_3\YPGQ'F*0<=-=I%+UJ+TLF"[2,=K+>_5315#>6&,Z[QJGWS+2^\J9MQT
M,[FD4:N6DA-0>>96L)D1W:U9R+[B*-B9;FP =[30TKM&TKK=PL! ,\4%Q\8,
M])W8X!&VA5D!"/S> +QBV"/3NG-VXW4@B3@[*]GJEDJP+KSF&B*,D6*<6]@C
MREBH,*E2UH!EW%K,-=#MKHR<7*RNDEPD+"%,SB=H LQMF2K3J'*8FYJAA"2@
MGQ UF&>]Q.J?P1A4SEGBI_ BUX,DV1(V@&O$ \4?#9NZ< /I=>6W<4DL(YSF
MT@GB'7"E0 ?4B+T]>E>2MTOJA#54>I9UE; Q&^:JN5W 7KR[:_%KWRX#0ZUB
MU+Y_A[NL%]7_I[[+,$?)7&;15W^7C=;7S[NN'\W00VG6WC,B9,R&Q67+C,_G
M9EJJHK[,WMGQE--ZG?E.K*Z4M:3W$[Q7/=V(OC%6(8!+/K?),&ZXQ#C NP%%
MO#5H+\_QG*V=!9:)<21YCSW '>HOCP=7!\E* KH(39\ 8Q1V+/20(H4AV^!%
MDDT=]@E%XX(E26MP),KI#2QDR CQGD3W'&RM$=)2BHO5$1;WBQB44W;>@F->
M=@Z^DDS)9NG4;]A9]N3>67;7/(BG#?$5K;I]P\)XW74#;<)ULX!W[Y5LRR5[
MIWY?DF,5M]4;D00K7$5&0!*=>4B*1^>-Y7U'@59V,9@2!M/D$M_[,4WGRV]X
MGZ9KDS$['6.F))0Z U9<VM3IX94C5.FJ$\GNBB6E;UHDP=87V+N,#"L.UG%U
MT2];YU99,R+F7B."X5XN2A,.ZN-P:55_K9[;>@%<._X\[=*U!'4YXQI=@:+%
ME['F<61< :.+(I^W)6J51?ASM1%<!+%51%12M!\_?1ZY0'S20\1/1Q4I5=L[
MV!TPS]&_K-Z0'HON"BLF)4P\$<*_8R^@OMP#FUJ[%%RK9AX2ZJ8UUZ&P9@1/
MF(Y5*1@ZIB4CC<,!Z[,94A=0A$LVO+"!+J77)=;\;"+GV?8C,R7^<#N$<J"1
MJX!Y]6P9P19?3)UK.I1] Q5VHC,$K\O[UO^YF$P7LJU1@A2L#!'^6*T;ER1K
MTXGTM#9E#PK/519**RE=B.#6N16<A1BF1Y>+5*ST&8RN3AM^4%"'972D!4L^
MZ]A$ '4\#/.2@,@2&Y[,X'E:HK2K]&'%>+%%F$Y)^:HPPJR  *V+'$PPM<4Y
MV6$!5V-!-UT2=H<2*F)5-E5>Y ^9N$03JNPN:2B3>IE+ KW'>S><'IO@74X[
M] U:=L[,)/5<)D;V9>7%61/UW[X<1)(%WO^."[9OCWL\S?5O8 V&]^6S?G$;
M=M*>:B>[&P0/16A<+:U+NLXY?^:]<HB2(H],TN'3Z!;AF.7>2VQ1]'?-%1T*
MRHY1JK$,S#'NT,W[W-=LN;3Y*R),F+BMD=>AZ<\D^]P=K/RMZ#Q++[6\0+/
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M_Z>2\W\.OQL(ZG>O_PD?OCG][>V+_PM02P,$%     @ CHLF6>:;^,!26
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MVS2;1'2#+*;0<UF1F*0Y;A"VCO!(':^:<;)]LP%G)H+E'44YIOO!7\30]0:
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MH>L7=(A1+O)=8L2(L&0N0E!(-?K+.S"X5+>[&OB+\P#0D?PGK/R(*@+-C<?
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M<B)N.3:+!2:EC6BNJ8(OSL&.NF"F%;#:X,&QG6%6+K-DN/7;%3Y6PI"BK_G
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MI9T2<QBC#RZWQX>I79,/U5AE]1NB7<<>.?OTYI+8.MCX<-NZ3)!+2CB'6?7
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M:=M*%II;F47>KD)G)>BK(M-'BY-I3%KHB/R#4_8^24,[C<_F-CB35U##7DI
M%- \_[1OC7E1,)=9T,Q.(SC88X*;<0JK*CY38ML(W3IR76<Z0S^+DG0N"HO3
M3@DK6KZA/P&!1*C0L!2H=0]&X!P1RVL#%R0^<!T/1GA,,8X"=,,9^4[NREO]
M/(=WNQDL)O?.97FXM+;(W8:+F0M(-VO[M8['S.D8;_$QU*WFY,G-ACPZ2L[
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MU;N$\^E<:EO\@>%_^BK+\,#J"*7AP/9K]O3CCYBX(*"R;K8#-5:*1OZ7)M/
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M501B49UAL^$QF>I,2:.C4, XNK3-(S$<7%=E6-M-;\D>:=Y=RPN)MK6+,ZG
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M8\N2,RB)BCMHAKN!65 ;$3_!7J7SJ8R+N-*1"+[!U"7=\; 4FR0V/:+2+*\
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M[%-^V2AR-U;D'K8FYSOD'X8Z9X.);8&O.!%HWD =[IRL0:=[MK>K/B+B6[\
M)E$$JC\'+J)V@:I^^& ^I-C\-PF45NZ>/=O;*'<;Y>Z>9?Z7'3B%6+8'IQ(3
M^R:3J_MUA;[Y&$WB/ _AXW"8WK>:\ 6C2 <\L34IE%KK>XB[CP$GWOW_"#5W
MEHH3UI)NJLA]UQ"F3!%W-(3OTB4QVKCT_?\K-<3[U@B^H(MTF,X(4U+R.DR0
MR^G:S/[+;:/'_%"MY2LF;+V?3V<!J@GA',%9/X3S*.,U^_=P.GNEWD63D0*I
M^>-U&/A''::(-18FF-.S$ZC]_=?]3S6D\.L+>/H%NLF'X>0I16M>$H<ISE__
M#'>\4>\FZ7+,[8WJLU%][MR3\ATN*4>KNE=_U$-WV7P,"S#W+M4_0&(E:7[?
MDG+ZE=_S'P27##R11>2/%(\_.O'C%XHEO^,TG&8#:X8S3&#3<64?'J@""^1T
MS*36F SB$GB)7*:[X3!EF'?)CN,\:7ROY%!IG WN4J$SJ&T@C^K,I1K:+8:F
MZR232,6$R"5P.ID:>>C*.&KJ2Z"Q!<=ZXE(<+/F1;O00@XY._9$>'K67EU2I
MB-H5#CG%@P+B<PVL@V)^/G7"R>>16XV<^P#OC.^NAVJS6X9AAK@ DJR&T/LV
M*<U-1Z-0_B/.&_EUDS=RCV?]5SKK'6Y%:5(]ZK,XL2\#5RDP4!G>(ZDB!J2D
MA@ Q@;D&C5@C8#$XO7 )2BD3]-LDM?BSU*W0HE51^\)+JL#FIJ+#]")*0CG?
MWHCRU5\ND$C\IRT +,X1/M1K.MML\#I(FK#DH^+?U56;8XY+-$*FISLO2#*D
M4P""3R@-^S0J+J,H\9:S/!7B5_Y<UI\W^!OG#;K02,#GCFGB9EWR5^KMU22\
MU(F$O"V8%HF,5'(G/?CX.A3]:I\*$%?5?"7= 9Y:2HQM^JA[.PLLTW/$$ *F
ML<!['03D\DLKV,(\L1U&)ZC+B[342C+N+)/^SY2BSLFUU0Z;GJPR0I!%!B;Z
ME*51M2U)ZO9U=7-A,7.1H+473@81>#GYGW5E08!>O#+Z.*^;&'\G8L2N]U>T
MR<>2MB5TUZ4<32[ 4[KS[ BOIMH,G>/%.@;W4C79H(&&$,/<K6DTHAKF;&Y3
M09L-45$XJ1][Y6;<IF84C4.J#<S@?8D#LTJ"WM4TZA+Q='E&#!L59Y:<ZT<5
M4+ZIW%'(<4!]B#/",?N]5%1%#[MNJ(%M 0*D&N5#4G:$"W(+:]UQBQ\J_0RO
M70)Z!*N0!C%:;Y16Z-P-XSZM./Y &$9@<_0SK\P++_T:<P_IX7F8P>'!MU@>
M:\JJW'1=^>[:@=-640*OR_]EE?0*:P1Y?(&ICG'?[+$DV[.M6M\5J"EVGER2
MCFGK4 B SL]+EW0Y;@;NU1_2 .6!G$5*A$1R5KH"U%(EH8E/D#6[2%)85,5H
MM3H_FL^$9<[SZ7P2<GE1PM4VX42RGRZBM9>^[#XC#L(-;7")0?B\4G\'KIR/
M!,2TV?ABS@_\@&@"<3A94P^R<+NL@>A:%"RQFV,38!:'6%A'7(Y2VD'CXDXX
M:%#PP76;/B_(!&XVN.4,R9I L!8T<Z$N$ES+,ZJIA&()3L+%R$A*B1\K9->@
MW6'1KA7Z9"PBXAWVE1*+CY^;:$9F2RQ8.160TEBR\>GYMOKF+*::/(&"AB?,
MN*/HA%%%3;L<(^?@;QHN/JS9T,WPJ,A;(+1DN*YAIR>(B&4(_H#+]Z=#/>L!
M9NXR4_YS/F( 3>IK%HVXYY;&PG*)!KMUW))J A4Y"I%6:>>)87+<LH%P0-CD
M=M>)"Z*B9&Z@M#65@,8R9P;:/D?J0JLX(YB3:ZXR=1Z</^RIT<V&]_+T0O,[
M_EF $U&W1TW>/+N6C-46@65%WPA0%-4(;/$42[JQ'FS=^W2O,I1]%ZS31=^&
MDWG.R?582 26!>+&80XV6DEXSZ<D9HPIK.^$%[$B+H/4->GF:_^\)2.&D -*
MCB;H@) GVS)4\G"P.@KD<\;VB]:6!4L>[PXGT6A'$QK)E!IJJ_4*">!S.&*R
MT()C&L&YM7T=J.\)MV[030"MO6![4(Y,F959HCI; W2U9<9&S<MDJH3X!7>(
MW\DI-"H#"C/FGX:*O0ZUX<6Z8-6&VZK3:G\0""2#J8202F__4%]:A)@E"$_O
M/AT>=OH#U?GG (' 3CJ]C]V!($2U3DX.NVT*.1RVOJA!K]LZQ.___JGW!V)V
MM8[P[X-N&[\_Z1VW.QV,0<!/GX\//^-?<$6S<=#MGWP:= +5/CX:](X_=WK]
M/Q"/J7W8ZGY4K5ZWCY<B !,,^!A!O0X%F>N80:H,Q-0C]H']MO&!W:>*Q[@O
M?:PR%>@./GQ?SJ,$O\3"&JH&%1&V!'6!(%=UE11,?P8FA-,Y2D#%0]W>QBFM
M1_$&2Z)17<H<""O,X^M!'^*<6N;(XT&6XR-!O@"O.V-XT7GB%EB+=:9]2OSN
MFGZ/L588K) *I)V5O"1&K5[>([T>G5<Q((H-=8>Z 8?QYMM)N6X*_X6GY.VN
M+TJCCJM3+&U:K(**&'*UBIS*J_#[ZQ?+CO$\!#G)M'$:<;%3$5*C .T&7+?9
MLB>.71J]]>F23\HS;\.A:5(BF*73-(E H(73$+]B/5<7RB?-!@B\?\T99I.\
M'J+[4M-B:Y*+,N0Y9AV'9Z4*5UR^A5\GO1 ]@8V-F B^D':[D><7J&@0MKJ?
M$'9-4UBB,YD+Z@U4TQ87IK*,=905FG$D:?*4O03P;%U)R&M-I?VD9AID$1X4
M#/-/4(%U _0I=O+,KAA8/HRYY60V<M"9%:HU7(%'A>YC?32'6@<=$O9^V<Z
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M$/\.3(!7BA BH+0,NK+"&BJ:\3B46!2JE,J":8@R9+E%[81)15'(3 J=@1'
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MS?^("+&MQ/#'FWE>.*;2]7'@)FW<"."VS$IU"%2/?<>'%0J)K,>Q /X-&;,
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M%G=<R"WUGNM\%\W>]BSW_ ]02P,$%     @ CHLF6:C6/XEL!0  13L  !4
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M+FAT;5!+ 0(4 Q0    ( (Z+)EG)=,6S+B,  /:;   2              "
M 797  !D.# R.3(T9&5X,3 Q,"YH=&U02P$"% ,4    " ".BR99W^)6I2LC
M  #6FP  $@              @ '4>@  9#@P,CDR-&1E>#$P,3$N:'1M4$L!
M A0#%     @ CHLF6?/*6'VG.@  S!<! !$              ( !+YX  &0X
M,#(Y,C1D97@Q,#<N:'1M4$L! A0#%     @ CHLF6;#GE00X(P  [YD  !$
M             ( !!=D  &0X,#(Y,C1D97@Q,#@N:'1M4$L! A0#%     @
MCHLF61L<0(H@(P  E9L  !$              ( !;/P  &0X,#(Y,C1D97@Q
M,#DN:'1M4$L! A0#%     @ CHLF6? Y85!J!0  _!,  !
M ( !NQ\! &0X,#(Y,C1D97@S,2YH=&U02P$"% ,4    " ".BR997BL A"0:
M  !*?P  $               @ %3)0$ 9#@P,CDR-&1E>#,R+FAT;5!+ 0(4
M Q0    ( (Z+)EF:J*!"YF<  !LY @ 0              "  :4_ 0!D.# R
M.3(T9&5X-#$N:'1M4$L! A0#%     @ CHLF6>:;^,!26   ;"@" !
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2     !  $ #W P  OB("

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>d802924d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="invx-20240906.xsd" xlink:type="simple"/>
    <context id="duration_2024-09-06_to_2024-09-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001042893</identifier>
        </entity>
        <period>
            <startDate>2024-09-06</startDate>
            <endDate>2024-09-06</endDate>
        </period>
    </context>
    <context id="duration_2024-09-06_to_2024-09-06_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001042893</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:FormerAddressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-06</startDate>
            <endDate>2024-09-06</endDate>
        </period>
    </context>
    <dei:CurrentFiscalYearEndDate
      contextRef="duration_2024-09-06_to_2024-09-06"
      id="Hidden_dei_CurrentFiscalYearEndDate_duration_2024-09-06_to_2024-09-06">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-09-06_to_2024-09-06"
      id="Hidden_dei_EntityCentralIndexKey_duration_2024-09-06_to_2024-09-06">0001042893</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="duration_2024-09-06_to_2024-09-06"
      id="Hidden_dei_AmendmentFlag_duration_2024-09-06_to_2024-09-06">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_0">2024-09-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_14">INNOVEX INTERNATIONAL, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_8">001-13439</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_9">74-2162088</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_29">19120 Kenswick Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_25">Humble</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_26">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_24">77338</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_28">346</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_27">398-0000</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_2">Dril-Quip, Inc.</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:EntityAddressAddressLine1
      contextRef="duration_2024-09-06_to_2024-09-06_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember"
      id="Fact_3">2050 West Sam Houston Parkway S.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="duration_2024-09-06_to_2024-09-06_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember"
      id="Fact_4">Suite 1100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="duration_2024-09-06_to_2024-09-06_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember"
      id="Fact_5">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="duration_2024-09-06_to_2024-09-06_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember"
      id="Fact_6">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="duration_2024-09-06_to_2024-09-06_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember"
      id="Fact_32">77042</dei:EntityAddressPostalZipCode>
    <dei:WrittenCommunications contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_11">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_16">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_18">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_20">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_21">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_22">INVX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_23">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-09-06_to_2024-09-06" id="Fact_13">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
